acc	mainIsoAcc	varId	featType	shortFeatType	begin	end	origAa	mutAa	dbSnpId	disRelated	disease	disCode	pmid	longName	shortName	syns	subCellLoc	comment
P00519	P00519-1	PRO_0000088050	chain	chain	1	1131				noEvidence				Tyrosine-protein kinase ABL1	ABL	ABL; JTK7; p150; Proto-oncogene c-Abl; Abelson tyrosine-protein kinase 1; Abelson murine leukemia viral oncogene homolog 1; IA; IB		
P00519	P00519-1		domain	domain	61	122				notDisRelated								SH3
P00519	P00519-1		domain	domain	127	218				notDisRelated								SH2
P00519	P00519-1		domain	domain	242	494				notDisRelated								Protein kinase
P00519	P00519-1		region of interest	interest	1	61				noEvidence								CAP
P00519	P00519-1		region of interest	interest	518	997				notDisRelated								Disordered
P00519	P00519-1		region of interest	interest	869	969				notDisRelated								DNA-binding
P00519	P00519-1		region of interest	interest	953	1131				noEvidence								F-actin-binding
P00519	P00519-1		short sequence motif	motif	381	406				noEvidence								Kinase activation loop
P00519	P00519-1		short sequence motif	motif	605	610				notDisRelated								Nuclear localization signal 1
P00519	P00519-1		short sequence motif	motif	709	716				notDisRelated								Nuclear localization signal 2
P00519	P00519-1		short sequence motif	motif	762	770				notDisRelated								Nuclear localization signal 3
P00519	P00519-1		short sequence motif	motif	1090	1101				notDisRelated								Nuclear export signal
P00519	P00519-1		compositionally biased region	biased	533	550				notDisRelated								Basic and acidic residues
P00519	P00519-1		compositionally biased region	biased	579	602				notDisRelated								Basic and acidic residues
P00519	P00519-1		compositionally biased region	biased	622	639				notDisRelated								Basic and acidic residues
P00519	P00519-1		compositionally biased region	biased	685	704				notDisRelated								Polar residues
P00519	P00519-1		compositionally biased region	biased	735	754				notDisRelated								Polar residues
P00519	P00519-1		compositionally biased region	biased	758	773				notDisRelated								Basic and acidic residues
P00519	P00519-1		compositionally biased region	biased	870	895				notDisRelated								Basic and acidic residues
P00519	P00519-1		active site	enzyme act site	363	364				notDisRelated								Proton acceptor
P00519	P00519-1		binding site	bind	248	257				noEvidence								
P00519	P00519-1		binding site	bind	271	272				noEvidence								
P00519	P00519-1		binding site	bind	316	323				noEvidence								
P00519	P00519-1		site	site	26	28				disRelated			15361874,3021337					Breakpoint for translocation to form BCR-ABL and NUP214-ABL1 fusion proteins
P00519	P00519-1		modified residue	phos	50	51				notDisRelated			16543148					Phosphoserine
P00519	P00519-1		modified residue	phos	70	71				notDisRelated			16912036,18775435					Phosphotyrosine; by autocatalysis
P00519	P00519-1		modified residue	phos	115	116				notDisRelated			16912036					Phosphotyrosine
P00519	P00519-1		modified residue	phos	128	129				notDisRelated			16912036					Phosphotyrosine
P00519	P00519-1		modified residue	phos	139	140				notDisRelated			16912036					Phosphotyrosine
P00519	P00519-1		modified residue	phos	172	173				notDisRelated			16912036					Phosphotyrosine
P00519	P00519-1		modified residue	phos	185	186				notDisRelated			16912036					Phosphotyrosine
P00519	P00519-1		modified residue	phos	215	216				notDisRelated			16912036					Phosphotyrosine
P00519	P00519-1		modified residue	phos	226	227				notDisRelated			16912036					Phosphotyrosine; by autocatalysis
P00519	P00519-1		modified residue	phos	229	230				notDisRelated								Phosphoserine
P00519	P00519-1		modified residue	phos	253	254				notDisRelated								Phosphotyrosine
P00519	P00519-1		modified residue	phos	257	258				notDisRelated								Phosphotyrosine
P00519	P00519-1		modified residue	phos	393	394				notDisRelated			16912036					Phosphotyrosine; by autocatalysis and SRC-type Tyr-kinases
P00519	P00519-1		modified residue	phos	413	414				notDisRelated								Phosphotyrosine
P00519	P00519-1		modified residue	phos	446	447				notDisRelated								Phosphoserine
P00519	P00519-1		modified residue	phos	559	560				notDisRelated								Phosphoserine
P00519	P00519-1		modified residue	phos	569	570				notDisRelated								Phosphoserine
P00519	P00519-1		modified residue	phos	618	619				notDisRelated			18161990					Phosphoserine; by PAK2
P00519	P00519-1		modified residue	phos	619	620				notDisRelated			18161990					Phosphoserine; by PAK2
P00519	P00519-1		modified residue	phos	620	621				notDisRelated								Phosphoserine
P00519	P00519-1		modified residue	phos	659	660				notDisRelated								Phosphoserine
P00519	P00519-1		modified residue	phos	683	684				notDisRelated								Phosphoserine
P00519	P00519-1		modified residue	acetyl	711	712				notDisRelated			16648821					N6-acetyllysine; by EP300
P00519	P00519-1		modified residue	phos	718	719				notDisRelated								Phosphoserine
P00519	P00519-1		modified residue	phos	735	736				notDisRelated			15696159					Phosphothreonine
P00519	P00519-1		modified residue	phos	751	752				notDisRelated								Phosphothreonine
P00519	P00519-1		modified residue	phos	781	782				notDisRelated								Phosphothreonine
P00519	P00519-1		modified residue	phos	814	815				notDisRelated								Phosphothreonine
P00519	P00519-1		modified residue	phos	823	824				notDisRelated								Phosphothreonine
P00519	P00519-1		modified residue	phos	844	845				notDisRelated								Phosphothreonine
P00519	P00519-1		modified residue	phos	852	853				notDisRelated								Phosphothreonine
P00519	P00519-1		modified residue	phos	855	856				notDisRelated								Phosphoserine
P00519	P00519-1		modified residue	phos	917	918				notDisRelated								Phosphoserine
P00519	P00519-1		modified residue	phos	977	978				notDisRelated								Phosphoserine
P00519	P00519-1	VSP_004957	splice variant	splicing	1	27	MLEICLKLVGCKSKKGLSSSSSCYLE	MGQQPGKVLGDQRRPSLPALHFIKGAGKKESSRHGGPHCNVFVEH		notDisRelated			15489334					In isoform IB.
P00519	P00519-1	VAR_032676	sequence variant	variant	47	48	R	G		notDisRelated	a lung large cell carcinoma sample	a lung large cell carcinoma sample	17344846					somatic mutation
P00519	P00519-1	VAR_051692	sequence variant	variant	140	141	L	P	rs1064152	disRelated			3021337					
P00519	P00519-1	VAR_032677	sequence variant	variant	166	167	R	K		notDisRelated	a melanoma sample	a melanoma sample	17344846					somatic mutation
P00519	P00519-1	VAR_079482	sequence variant	variant	226	227	Y	C	rs1060499547	disRelated	Congenital heart defects and skeletal malformations syndrome	CHDSKM	28288113					increases kinase activity; no effect on protein levels
P00519	P00519-1	VAR_051693	sequence variant	variant	247	248	K	R	rs34549764	noEvidence								
P00519	P00519-1	VAR_079483	sequence variant	variant	337	338	A	T	rs1060499548	disRelated	Congenital heart defects and skeletal malformations syndrome	CHDSKM	28288113					increases kinase activity; no effect on protein levels
P00519	P00519-1	VAR_025043	sequence variant	variant	706	707	G	V	rs34634745	notDisRelated			17344846					
P00519	P00519-1	VAR_032678	sequence variant	variant	810	811	P	L	rs2229071	notDisRelated			17344846					
P00519	P00519-1	VAR_025044	sequence variant	variant	852	853	T	P	rs1588283506	notDisRelated								
P00519	P00519-1	VAR_025045	sequence variant	variant	900	901	P	S	rs35266696	notDisRelated								
P00519	P00519-1	VAR_051694	sequence variant	variant	968	969	S	P	rs1064165	noEvidence								
P00519	P00519-1	VAR_025046	sequence variant	variant	972	973	S	L	rs2229067	notDisRelated			17344846					
P00519	P00519-1		mutagenesis site	mutagen	735	736	T	A		notDisRelated			15696159					Abolishes phosphorylation. Loss of binding YWHAS and YWHAZ. Localizes to the nucleus. No effect on kinase activity.
P00519	P00519-1		sequence conflict	conflict	159	160	G	S		notDisRelated								In Ref. 1; AAA51561.
P00519	P00519-1		sequence conflict	conflict	424	426	AF	GK		notDisRelated								In Ref. 9.
P00519	P00519-1		sequence conflict	conflict	445	446	L	R		notDisRelated								In Ref. 1; AAA51561.
P00519	P00519-1		sequence conflict	conflict	459	460	E	K		notDisRelated								In Ref. 1; AAA51561.
P00519	P00519-1		sequence conflict	conflict	520	521	S	T		notDisRelated								In Ref. 1; AAA51561.
P00519	P00519-1		sequence conflict	conflict	719	720	A	V		notDisRelated								In Ref. 1; AAA51561.
P00519	P00519-1		sequence conflict	conflict	837	838	G	E		notDisRelated								In Ref. 2; CAA34438.
P00519	P00519-1		sequence conflict	conflict	837	838	G	W		notDisRelated								In Ref. 1; AAA51561.
P00519	P00519-1		sequence conflict	conflict	863	864	G	R		notDisRelated								In Ref. 1; AAA51561.
P00519	P00519-1		sequence conflict	conflict	894	895	R	K		notDisRelated								In Ref. 1; AAA51561.
P00519	P00519-1		sequence conflict	conflict	917	920	SPS	RPG		notDisRelated								In Ref. 1; AAA51561.
P00519	P00519-1		sequence conflict	conflict	952	953	G	A		notDisRelated								In Ref. 1; AAA51561.
P00519	P00519-1		sequence conflict	conflict	967	969	QS	HP		notDisRelated								In Ref. 1; AAA51561.
P00519	P00519-1		sequence conflict	conflict	982	983	P	PL		notDisRelated								In Ref. 1; AAA51561.
P00519	P00519-1		sequence conflict	conflict	1022	1023				notDisRelated								In Ref. 1; AAA51561.
P00519	P00519-1		sequence conflict	conflict	1045	1046	R	G		notDisRelated								In Ref. 1; AAA51561.
P00519	P00519-1		sequence conflict	conflict	1103	1104	T	S		notDisRelated								In Ref. 1; AAA51561.
P00519	P00519-1		strand	beta	26	33				notDisRelated								
P00519	P00519-1		strand	beta	39	45				notDisRelated								
P00519	P00519-1		turn	turn	45	48				notDisRelated								
P00519	P00519-1		helix	helix	49	54				notDisRelated								
P00519	P00519-1		helix	helix	58	61				notDisRelated								
P00519	P00519-1		strand	beta	65	71				notDisRelated								
P00519	P00519-1		strand	beta	76	80				notDisRelated								
P00519	P00519-1		strand	beta	87	94				notDisRelated								
P00519	P00519-1		strand	beta	97	105				notDisRelated								
P00519	P00519-1		strand	beta	107	113				notDisRelated								
P00519	P00519-1		helix	helix	113	116				notDisRelated								
P00519	P00519-1		strand	beta	116	119				notDisRelated								
P00519	P00519-1		helix	helix	122	125				notDisRelated								
P00519	P00519-1		strand	beta	128	132				notDisRelated								
P00519	P00519-1		helix	helix	134	141				notDisRelated								
P00519	P00519-1		turn	turn	141	144				notDisRelated								
P00519	P00519-1		strand	beta	148	154				notDisRelated								
P00519	P00519-1		strand	beta	155	158				notDisRelated								
P00519	P00519-1		strand	beta	161	168				notDisRelated								
P00519	P00519-1		strand	beta	170	176				notDisRelated								
P00519	P00519-1		strand	beta	177	180				notDisRelated								
P00519	P00519-1		turn	turn	180	183				notDisRelated								
P00519	P00519-1		strand	beta	184	188				notDisRelated								
P00519	P00519-1		strand	beta	190	195				notDisRelated								
P00519	P00519-1		helix	helix	195	203				notDisRelated								
P00519	P00519-1		strand	beta	209	212				notDisRelated								
P00519	P00519-1		strand	beta	226	229				notDisRelated								
P00519	P00519-1		strand	beta	229	232				notDisRelated								
P00519	P00519-1		turn	turn	233	236				notDisRelated								
P00519	P00519-1		helix	helix	239	242				notDisRelated								
P00519	P00519-1		strand	beta	242	248				notDisRelated								
P00519	P00519-1		helix	helix	248	252				notDisRelated								
P00519	P00519-1		strand	beta	254	262				notDisRelated								
P00519	P00519-1		helix	helix	262	265				notDisRelated								
P00519	P00519-1		strand	beta	266	272				notDisRelated								
P00519	P00519-1		turn	turn	275	278				notDisRelated								
P00519	P00519-1		helix	helix	280	291				notDisRelated								
P00519	P00519-1		strand	beta	301	306				notDisRelated								
P00519	P00519-1		strand	beta	307	311				notDisRelated								
P00519	P00519-1		strand	beta	312	317				notDisRelated								
P00519	P00519-1		strand	beta	319	323				notDisRelated								
P00519	P00519-1		helix	helix	323	330				notDisRelated								
P00519	P00519-1		turn	turn	332	335				notDisRelated								
P00519	P00519-1		helix	helix	337	357				notDisRelated								
P00519	P00519-1		strand	beta	359	362				notDisRelated								
P00519	P00519-1		helix	helix	366	369				notDisRelated								
P00519	P00519-1		strand	beta	369	372				notDisRelated								
P00519	P00519-1		helix	helix	373	376				notDisRelated								
P00519	P00519-1		strand	beta	377	380				notDisRelated								
P00519	P00519-1		helix	helix	381	384				notDisRelated								
P00519	P00519-1		helix	helix	384	388				notDisRelated								
P00519	P00519-1		helix	helix	390	393				notDisRelated								
P00519	P00519-1		strand	beta	393	397				notDisRelated								
P00519	P00519-1		strand	beta	399	402				notDisRelated								
P00519	P00519-1		helix	helix	403	406				notDisRelated								
P00519	P00519-1		helix	helix	408	414				notDisRelated								
P00519	P00519-1		helix	helix	418	434				notDisRelated								
P00519	P00519-1		helix	helix	445	448				notDisRelated								
P00519	P00519-1		helix	helix	448	454				notDisRelated								
P00519	P00519-1		helix	helix	466	476				notDisRelated								
P00519	P00519-1		helix	helix	480	483				notDisRelated								
P00519	P00519-1		helix	helix	486	497				notDisRelated								
P00519	P00519-1		strand	beta	498	501				notDisRelated								
P00519	P00519-1		helix	helix	503	507				notDisRelated								
P00519	P00519-1		turn	turn	510	513				notDisRelated								
P00519	P00519-1		helix	helix	1029	1046				notDisRelated								
P00519	P00519-1		turn	turn	1046	1049				notDisRelated								
P00519	P00519-1		helix	helix	1053	1071				notDisRelated								
P00519	P00519-1		helix	helix	1071	1074				notDisRelated								
P00519	P00519-1		helix	helix	1080	1098				notDisRelated								
P00519	P00519-1		strand	beta	1101	1105				notDisRelated								
P00519	P00519-1		strand	beta	1106	1109				notDisRelated								
P00519	P00519-1		helix	helix	1115	1129				notDisRelated								
P00519	P00519-1		lipid moiety-binding region	lipid	2	3				notDisRelated								N-myristoyl glycine
O95831	O95831-1		transit peptide	trans pep	1	55				notDisRelated			15775970,16365034					Mitochondrion
O95831	O95831-1	PRO_0000401935	propeptide	propep	55	102				notDisRelated			16365034					Removed in mature form
O95831	O95831-1	PRO_0000022030	chain	chain	102	614				noEvidence				Apoptosis-inducing factor 1, mitochondrial	AIF	AIF; PDCD8; Programmed cell death protein 8; 1; 2; 3; 4; 5; 6; AIF; AIF2; AIFsh; AIFsh2; AIFsh3; AIF-exB		
O95831	O95831-1		region of interest	interest	100	128				notDisRelated								Disordered
O95831	O95831-1		region of interest	interest	134	484				notDisRelated								FAD-dependent oxidoreductase
O95831	O95831-1		region of interest	interest	513	555				notDisRelated								Disordered
O95831	O95831-1		short sequence motif	motif	1	32				notDisRelated								Mitochondrial localization signal
O95831	O95831-1		short sequence motif	motif	63	90				notDisRelated								Mitochondrial localization signal
O95831	O95831-1		short sequence motif	motif	446	452				notDisRelated								Nuclear localization signal
O95831	O95831-1		compositionally biased region	biased	514	547				notDisRelated								Polar residues
O95831	O95831-1		binding site	bind	138	143				notDisRelated			12198487,23217327,24914854,27178839,27818101					
O95831	O95831-1		binding site	bind	164	166				notDisRelated			12198487,23217327,24914854,27178839,27818101					
O95831	O95831-1		binding site	bind	172	173				notDisRelated			12198487,23217327,24914854,27178839,27818101					
O95831	O95831-1		binding site	bind	177	178				notDisRelated			12198487,24914854,27178839,27818101					
O95831	O95831-1		binding site	bind	196	197				notDisRelated			24914854					
O95831	O95831-1		binding site	bind	233	234				notDisRelated			12198487,23217327,24914854,27178839,27818101					
O95831	O95831-1		binding site	bind	285	286				notDisRelated			12198487,23217327,24914854,27178839,27818101					
O95831	O95831-1		binding site	bind	308	312				notDisRelated			24914854					
O95831	O95831-1		binding site	bind	336	337				notDisRelated			24914854					
O95831	O95831-1		binding site	bind	342	343				notDisRelated								
O95831	O95831-1		binding site	bind	399	400				notDisRelated			24914854					
O95831	O95831-1		binding site	bind	438	439				notDisRelated			12198487,23217327,24914854,27178839,27818101					
O95831	O95831-1		binding site	bind	453	455				notDisRelated			24914854					
O95831	O95831-1		binding site	bind	454	456				notDisRelated			12198487,24914854,27178839,27818101					
O95831	O95831-1		binding site	bind	483	484				notDisRelated			12198487,23217327,24914854,27178839,27818101					
O95831	O95831-1		binding site	bind	483	484				notDisRelated			24914854					
O95831	O95831-1		binding site	bind	493	494				notDisRelated			24914854					
O95831	O95831-1		binding site	bind	583	584				notDisRelated			24914854					
O95831	O95831-1		modified residue	phos	105	106				notDisRelated								Phosphothreonine
O95831	O95831-1		modified residue	modif	109	110				notDisRelated								N6-succinyllysine
O95831	O95831-1		modified residue	phos	116	117				notDisRelated								Phosphoserine
O95831	O95831-1		modified residue	phos	118	119				notDisRelated								Phosphoserine
O95831	O95831-1		modified residue	phos	268	269				notDisRelated								Phosphoserine
O95831	O95831-1		modified residue	phos	292	293				notDisRelated								Phosphoserine
O95831	O95831-1		modified residue	phos	371	372				notDisRelated								Phosphoserine
O95831	O95831-1		modified residue	acetyl	388	389				notDisRelated								N6-acetyllysine
O95831	O95831-1		modified residue	phos	521	522				notDisRelated								Phosphothreonine
O95831	O95831-1		modified residue	phos	524	525				notDisRelated								Phosphoserine
O95831	O95831-1		modified residue	phos	530	531				notDisRelated								Phosphoserine
O95831	O95831-1		modified residue	acetyl	593	594				notDisRelated								N6-acetyllysine
O95831	O95831-1		cross-link	cross-link	255	256				notDisRelated			22103349					Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin
O95831	O95831-1	VSP_046248	splice variant	splicing	1	353				notDisRelated			16365034					In isoform 5.
O95831	O95831-1	VSP_004357	splice variant	splicing	36	323				notDisRelated								In isoform 2.
O95831	O95831-1	VSP_022953	splice variant	splicing	36	83	GNLFQRWHVPLELQMTRQMASSGASGGKIDNSVLVLIVGLSTVGAGA	VVQSHHLGSPSRSLASTGASGKDGSNLVYFLIVGATVTGAGVY		notDisRelated			14702039,15489334					In isoform 3.
O95831	O95831-1	VSP_060785	splice variant	splicing	37	44	NLFQRWH	LQDYERG		notDisRelated								In isoform 6.
O95831	O95831-1	VSP_060786	splice variant	splicing	44	614				notDisRelated								In isoform 6.
O95831	O95831-1	VSP_043637	splice variant	splicing	323	325	AR	DI		notDisRelated			16644725					In isoform 4.
O95831	O95831-1	VSP_043638	splice variant	splicing	325	614				notDisRelated			16644725					In isoform 4.
O95831	O95831-1	VAR_063827	sequence variant	variant	201	202			rs387906500	disRelated	Combined oxidative phosphorylation deficiency 6	COXPD6	20362274					higher DNA binding affinity, partially impaired flavin binding and association with increased parthanatos-linked cell death
O95831	O95831-1	VAR_083739	sequence variant	variant	235	236	Q	H	rs377527583	disRelated	Spondyloepimetaphyseal dysplasia, X-linked, with hypomyelinating leukodystrophy	SEMDHL	28842795					severe decrease of protein expression
O95831	O95831-1	VAR_083740	sequence variant	variant	237	238	D	G	rs1202786652	disRelated	Spondyloepimetaphyseal dysplasia, X-linked, with hypomyelinating leukodystrophy	SEMDHL	28842795					
O95831	O95831-1	VAR_083741	sequence variant	variant	237	238	D	V	rs1202786652	disRelated	Spondyloepimetaphyseal dysplasia, X-linked, with hypomyelinating leukodystrophy	SEMDHL	28842795					
O95831	O95831-1	VAR_072791	sequence variant	variant	243	244	V	L	rs1603225138	disRelated	Combined oxidative phosphorylation deficiency 6	COXPD6	25583628,27178839					reduced protein amount in muscle compared to controls; no effect on reduction with NADH; strongly decreased NADH oxidase activity; no effect on dimerization; no effect on DNA-binding
O95831	O95831-1	VAR_076211	sequence variant	variant	260	261	T	A	rs863225432	disRelated	Deafness, X-linked, 5, with peripheral neuropathy	DFNX5	25986071					
O95831	O95831-1	VAR_083067	sequence variant	variant	262	263	G	S	rs1603224817	disRelated			25934856,27178839					Probable disease-associated variant found in patient with mitochondrial encephalomyopathy with moderate clinical severity and slow progressive course despite early onset as well as and cerebellar involvement; decreased protein level; strongly decreased redox potential; strongly decreased NADH oxidase activity; no effect on DNA-binding
O95831	O95831-1	VAR_067334	sequence variant	variant	308	309	G	E	rs1603224226	disRelated	Combined oxidative phosphorylation deficiency 6	COXPD6	22019070,26004228,27178839					with prenatal ventriculomegaly and severe postnatal encephalomyopathy; no effect on redox potential; slowered reduction with NADH; strongly decreased NADH oxidase activity; strongly decreased NADH oxidase activity; no effect on DNA-binding; decreased interaction with CHCHDE
O95831	O95831-1	VAR_083068	sequence variant	variant	338	339	G	E	rs1603223152	disRelated	Combined oxidative phosphorylation deficiency 6	COXPD6	26173962,27178839					with early-onset severe motor neuron involvement; decreased protein levels; decreased oxidoreductase activity on cytochrome C; slowered reduction with NADH; strongly decreased NADH oxidase activity; strongly decreased NADH oxidase activity; no effect on DNA-binding
O95831	O95831-1	VAR_076212	sequence variant	variant	344	345	L	F	rs184474885	disRelated	Deafness, X-linked, 5, with peripheral neuropathy	DFNX5	25986071					unknown pathological significance
O95831	O95831-1	VAR_076213	sequence variant	variant	360	361	G	R	rs724160026	disRelated	Deafness, X-linked, 5, with peripheral neuropathy	DFNX5	25986071					unknown pathological significance
O95831	O95831-1	VAR_076214	sequence variant	variant	422	423	R	Q	rs724160021	disRelated	Deafness, X-linked, 5, with peripheral neuropathy	DFNX5	25986071					
O95831	O95831-1	VAR_076215	sequence variant	variant	422	423	R	W	rs724160020	disRelated	Deafness, X-linked, 5, with peripheral neuropathy	DFNX5	25986071					
O95831	O95831-1	VAR_076216	sequence variant	variant	430	431	R	C	rs1223488720	disRelated	Deafness, X-linked, 5, with peripheral neuropathy	DFNX5	25986071					unknown pathological significance
O95831	O95831-1	VAR_076217	sequence variant	variant	451	452	R	Q	rs863225431	disRelated	Deafness, X-linked, 5, with peripheral neuropathy	DFNX5	25986071					
O95831	O95831-1	VAR_076218	sequence variant	variant	472	473	A	V		disRelated	Deafness, X-linked, 5, with peripheral neuropathy	DFNX5	25986071					unknown pathological significance
O95831	O95831-1	VAR_076219	sequence variant	variant	475	476	P	L	rs724160022	disRelated	Deafness, X-linked, 5, with peripheral neuropathy	DFNX5	25986071					unknown pathological significance
O95831	O95831-1	VAR_069468	sequence variant	variant	493	494	E	V	rs281864468	disRelated	Charcot-Marie-Tooth disease, X-linked recessive, 4, with or without cerebellar ataxia	CMTX4	23217327,26004228					increases affinity for NADH and electron transfer activity; increases affinity for DNA, resulting in increased apoptosis; no effect on interaction with CHCHD4
O95831	O95831-1	VAR_076220	sequence variant	variant	498	499	V	M	rs724160023	disRelated	Deafness, X-linked, 5, with peripheral neuropathy	DFNX5	25986071					unknown pathological significance
O95831	O95831-1	VAR_076221	sequence variant	variant	591	592	I	M		disRelated	Deafness, X-linked, 5, with peripheral neuropathy	DFNX5	25986071					unknown pathological significance
O95831	O95831-1		mutagenesis site	mutagen	196	197	W	A		notDisRelated			27818101					Increases protein dimerization at lower NADH levels.
O95831	O95831-1		mutagenesis site	mutagen	413	431	EIDSDFGGFRVNAELQAR	AIDSDFGGFAVNAELQAA		notDisRelated			24914854					Disrupts dimerization. Lower efficiency in stabilizing charge-transfer complexes upon coenzyme reduction.
O95831	O95831-1		mutagenesis site	mutagen	443	446	YDI	ADA		notDisRelated			27818101					Disrupts dimerization. Disrupts dimerization; when associated with A-477.
O95831	O95831-1		mutagenesis site	mutagen	454	455	H	A		notDisRelated			27818101					Allows dimerization in absence of NADH.
O95831	O95831-1		mutagenesis site	mutagen	477	478	W	A		notDisRelated			27818101					Disrupts dimerization; when associated with A-443--445-A.
O95831	O95831-1		mutagenesis site	mutagen	480	481	S	A		notDisRelated			27818101					Allows dimerization in absence of NADH.
O95831	O95831-1		mutagenesis site	mutagen	485	486	D	A		notDisRelated			27818101					Increases protein dimerization at lower NADH levels.
O95831	O95831-1		mutagenesis site	mutagen	529	530	R	A		notDisRelated			27818101					Increases protein dimerization at lower NADH levels.
O95831	O95831-1		mutagenesis site	mutagen	531	532	E	A		notDisRelated			27818101					Increases protein dimerization at lower NADH levels.
O95831	O95831-1		mutagenesis site	mutagen	533	534	E	A		notDisRelated			27818101					Increases protein dimerization at lower NADH levels.
O95831	O95831-1		mutagenesis site	mutagen	535	536	E	A		notDisRelated			27818101					Increases protein dimerization at lower NADH levels.
O95831	O95831-1		strand	beta	130	139				notDisRelated								
O95831	O95831-1		helix	helix	141	154				notDisRelated								
O95831	O95831-1		strand	beta	158	163				notDisRelated								
O95831	O95831-1		strand	beta	164	168				notDisRelated								
O95831	O95831-1		helix	helix	173	177				notDisRelated								
O95831	O95831-1		helix	helix	178	181				notDisRelated								
O95831	O95831-1		helix	helix	187	191				notDisRelated								
O95831	O95831-1		strand	beta	192	195				notDisRelated								
O95831	O95831-1		strand	beta	200	207				notDisRelated								
O95831	O95831-1		helix	helix	208	211				notDisRelated								
O95831	O95831-1		turn	turn	214	220				notDisRelated								
O95831	O95831-1		strand	beta	224	229				notDisRelated								
O95831	O95831-1		strand	beta	233	238				notDisRelated								
O95831	O95831-1		turn	turn	238	242				notDisRelated								
O95831	O95831-1		strand	beta	242	246				notDisRelated								
O95831	O95831-1		strand	beta	250	259				notDisRelated								
O95831	O95831-1		strand	beta	262	265				notDisRelated								
O95831	O95831-1		helix	helix	268	272				notDisRelated								
O95831	O95831-1		helix	helix	275	280				notDisRelated								
O95831	O95831-1		strand	beta	281	284				notDisRelated								
O95831	O95831-1		helix	helix	287	300				notDisRelated								
O95831	O95831-1		strand	beta	301	307				notDisRelated								
O95831	O95831-1		helix	helix	310	327				notDisRelated								
O95831	O95831-1		strand	beta	329	334				notDisRelated								
O95831	O95831-1		strand	beta	335	339				notDisRelated								
O95831	O95831-1		turn	turn	339	344				notDisRelated								
O95831	O95831-1		helix	helix	346	359				notDisRelated								
O95831	O95831-1		strand	beta	362	365				notDisRelated								
O95831	O95831-1		strand	beta	369	376				notDisRelated								
O95831	O95831-1		strand	beta	378	384				notDisRelated								
O95831	O95831-1		strand	beta	388	397				notDisRelated								
O95831	O95831-1		strand	beta	400	403				notDisRelated								
O95831	O95831-1		helix	helix	407	411				notDisRelated								
O95831	O95831-1		turn	turn	416	419				notDisRelated								
O95831	O95831-1		strand	beta	420	423				notDisRelated								
O95831	O95831-1		strand	beta	427	431				notDisRelated								
O95831	O95831-1		strand	beta	433	436				notDisRelated								
O95831	O95831-1		helix	helix	437	440				notDisRelated								
O95831	O95831-1		strand	beta	440	445				notDisRelated								
O95831	O95831-1		turn	turn	445	448				notDisRelated								
O95831	O95831-1		strand	beta	448	451				notDisRelated								
O95831	O95831-1		helix	helix	455	469				notDisRelated								
O95831	O95831-1		turn	turn	469	472				notDisRelated								
O95831	O95831-1		strand	beta	481	488				notDisRelated								
O95831	O95831-1		strand	beta	491	497				notDisRelated								
O95831	O95831-1		strand	beta	504	510				notDisRelated								
O95831	O95831-1		strand	beta	513	516				notDisRelated								
O95831	O95831-1		helix	helix	517	525				notDisRelated								
O95831	O95831-1		helix	helix	529	534				notDisRelated								
O95831	O95831-1		strand	beta	538	543				notDisRelated								
O95831	O95831-1		strand	beta	562	570				notDisRelated								
O95831	O95831-1		strand	beta	572	581				notDisRelated								
O95831	O95831-1		helix	helix	585	595				notDisRelated								
O95831	O95831-1		helix	helix	601	606				notDisRelated								
O95831	O95831-1		helix	helix	606	609				notDisRelated								
P14060	P14060		initiator methionine	init Met	1	2				notDisRelated			2779585					Removed
P14060	P14060	PRO_0000087774	chain	chain	2	374				noEvidence				3 beta-hydroxysteroid dehydrogenase/Delta 5-->4-isomerase type 1	3-beta-HSD I	3-beta-HSD I; 3BH; HSDB3A; Steroid Delta-isomerase; Trophoblast antigen FDO161G; Delta-5-3-ketosteroid isomerase; Dihydrotestosterone oxidoreductase; 3-beta-hydroxysteroid 3-dehydrogenase; 3-beta-hydroxy-5-ene steroid dehydrogenase; 3-beta-hydroxy-Delta(5)-steroid dehydrogenase; 3 beta-hydroxysteroid dehydrogenase/Delta 5-->4-isomerase type I		
P14060	P14060		transmembrane region	transmem	288	309				notDisRelated								Helical
P14060	P14060		active site	enzyme act site	159	160				notDisRelated								Proton donor
P14060	P14060		binding site	bind	10	16				notDisRelated								
P14060	P14060		binding site	bind	155	156				notDisRelated								
P14060	P14060		binding site	bind	159	160				notDisRelated								
P14060	P14060	VAR_048096	sequence variant	variant	54	55	T	I	rs3088283	noEvidence								
P14060	P14060	VAR_048097	sequence variant	variant	71	72	R	I	rs4986952	noEvidence								
P14060	P14060	VAR_014174	sequence variant	variant	79	80	I	V	rs6201	notDisRelated			10391209					
P14060	P14060	VAR_048098	sequence variant	variant	90	91	G	S	rs6684974	noEvidence								
P14060	P14060	VAR_014175	sequence variant	variant	286	287	F	L	rs6205	notDisRelated			10391209					
P14060	P14060	VAR_000005	sequence variant	variant	367	368	T	N	rs1047303	notDisRelated			15489334,2243100					
P26439	P26439-1	PRO_0000087775	chain	chain	1	373				noEvidence				3 beta-hydroxysteroid dehydrogenase/Delta 5-->4-isomerase type 2	3-beta-HSD II	3-beta-HSD II; HSDB3B; 3-beta-HSD adrenal and gonadal type; 3 beta-hydroxysteroid dehydrogenase/Delta 5-->4-isomerase type II; 1; 2		
P26439	P26439-1		transmembrane region	transmem	287	308				notDisRelated								Helical
P26439	P26439-1		active site	enzyme act site	154	155				notDisRelated								Proton acceptor
P26439	P26439-1		binding site	bind	158	159				notDisRelated								
P26439	P26439-1	VSP_037399	splice variant	splicing	103	223	GTQLLLEACVQASVPVFIYTSSIEVAGPNSYKEIIQNGHEEEPLENTWPTPYPYSKKLAEKAVLAANGWNLKNGDTLYTCALRPTYIYGEGGPFLSASINEALNNNGILSSVGKFSTVNP	ELQNKIKLTVLEGDILDEPFLKRACQDVSVVIHTACIIDVFGVTHRQSIMNVNVKGRVAWGGDKARWGNEDQKEGQEGKRSLSIEHLLCSGPSDFADHYQLGELKAAIFSFIDEKTRTEQ		notDisRelated			17974005					In isoform 2.
P26439	P26439-1	VSP_037400	splice variant	splicing	223	373				notDisRelated			17974005					In isoform 2.
P26439	P26439-1	VAR_010517	sequence variant	variant	10	11	A	E	rs28934880	disRelated	Adrenal hyperplasia 2	AH2	10599696,10843183					activity abolished
P26439	P26439-1	VAR_010518	sequence variant	variant	10	11	A	V	rs28934880	disRelated	Adrenal hyperplasia 2	AH2	10599696					nonsalt-wasting form
P26439	P26439-1	VAR_010519	sequence variant	variant	15	16	G	D		disRelated	Adrenal hyperplasia 2	AH2	10599696,7893703					activity abolished
P26439	P26439-1	VAR_048099	sequence variant	variant	74	75	D	N	rs4986954	noEvidence								
P26439	P26439-1	VAR_070028	sequence variant	variant	82	83	A	P		disRelated	Adrenal hyperplasia 2	AH2	22579964					
P26439	P26439-1	VAR_010520	sequence variant	variant	82	83	A	T	rs757033996	disRelated	Adrenal hyperplasia 2	AH2	10599696,8185809					
P26439	P26439-1	VAR_014818	sequence variant	variant	94	95	E	Q	rs6211	notDisRelated			17974005					
P26439	P26439-1	VAR_010521	sequence variant	variant	100	101	N	S	rs1388517943	disRelated	Adrenal hyperplasia 2	AH2	10599696,7608265					nonsalt-wasting form
P26439	P26439-1	VAR_010522	sequence variant	variant	108	109	L	W		disRelated	Adrenal hyperplasia 2	AH2	10599696,7833923					activity abolished
P26439	P26439-1	VAR_010523	sequence variant	variant	129	130	G	R	rs587628683	disRelated	Adrenal hyperplasia 2	AH2	10599696,10651755,7962268					nonsalt-wasting form
P26439	P26439-1	VAR_000006	sequence variant	variant	142	143	E	K	rs80358219	disRelated	Adrenal hyperplasia 2	AH2	10599696,12050213,8316254					activity abolished
P26439	P26439-1	VAR_010524	sequence variant	variant	155	156	P	L	rs779418168	disRelated	Adrenal hyperplasia 2	AH2	10599696					nonsalt-wasting form
P26439	P26439-1	VAR_010525	sequence variant	variant	167	168	A	V	rs35486059	disRelated	Adrenal hyperplasia 2	AH2	10599696					late onset; almost normal activity
P26439	P26439-1	VAR_010526	sequence variant	variant	173	174	L	R	rs762479018	disRelated	Adrenal hyperplasia 2	AH2	10599696,8060486					nonsalt-wasting form
P26439	P26439-1	VAR_010527	sequence variant	variant	186	187	P	L		disRelated	Adrenal hyperplasia 2	AH2	10599696,7833923					activity abolished
P26439	P26439-1	VAR_000007	sequence variant	variant	205	206	L	P		disRelated	Adrenal hyperplasia 2	AH2	10599696,7633426					
P26439	P26439-1	VAR_010528	sequence variant	variant	213	214	S	G	rs759422374	disRelated	Adrenal hyperplasia 2	AH2	10599696					late onset; partial loss of activity
P26439	P26439-1	VAR_010529	sequence variant	variant	216	217	K	E		disRelated	Adrenal hyperplasia 2	AH2	10599696					late onset; partial loss of activity
P26439	P26439-1	VAR_010530	sequence variant	variant	222	223	P	H		disRelated	Adrenal hyperplasia 2	AH2	10599696					nonsalt-wasting form; activity abolished
P26439	P26439-1	VAR_010531	sequence variant	variant	222	223	P	Q	rs765547422	disRelated	Adrenal hyperplasia 2	AH2	10599696,10651755					activity abolished
P26439	P26439-1	VAR_015411	sequence variant	variant	222	223	P	T	rs80358220	disRelated	Adrenal hyperplasia 2	AH2	12050213					
P26439	P26439-1	VAR_010532	sequence variant	variant	231	239				disRelated	Adrenal hyperplasia 2	AH2						activity abolished
P26439	P26439-1	VAR_010533	sequence variant	variant	236	237	L	S	rs35887327	disRelated	Adrenal hyperplasia 2	AH2	10599696,9719627					mild; 100% of activity
P26439	P26439-1	VAR_000008	sequence variant	variant	245	246	A	P		disRelated	Adrenal hyperplasia 2	AH2	10599696,8316254					loss of 88% of activity
P26439	P26439-1	VAR_083841	sequence variant	variant	250	251	G	V		disRelated	Adrenal hyperplasia 2	AH2	25322271					nonsalt-wasting form; loss of 75% of enzymatic activity for the conversion of pregnenolone to progesterone and dehydroepiandrosterone to androstenedione; no effect on endoplasmic reticulum location
P26439	P26439-1	VAR_000009	sequence variant	variant	253	254	Y	N	rs1399005702	disRelated	Adrenal hyperplasia 2	AH2	10599696,8316254					activity abolished
P26439	P26439-1	VAR_000010	sequence variant	variant	254	255	Y	D	rs1411029929	disRelated	Adrenal hyperplasia 2	AH2	10599696,8126127					activity abolished
P26439	P26439-1	VAR_010534	sequence variant	variant	259	260	T	M	rs80358221	disRelated	Adrenal hyperplasia 2	AH2	10599696,10651755					activity abolished
P26439	P26439-1	VAR_000011	sequence variant	variant	259	260	T	R		disRelated	Adrenal hyperplasia 2	AH2	10599696,7633460					activity abolished
P26439	P26439-1	VAR_010535	sequence variant	variant	294	295	G	V		disRelated	Adrenal hyperplasia 2	AH2	10599696					nonsalt-wasting form; activity abolished
P26439	P26439-1	VAR_065665	sequence variant	variant	341	342	P	L	rs121964897	disRelated	Adrenal hyperplasia 2	AH2	18252794					strongly reduced activity
P26439	P26439-1		sequence conflict	conflict	52	54	RT	KI		notDisRelated								In Ref. 8; AAD14329.
P26439	P26439-1		sequence conflict	conflict	92	95	HRE	RRQ		notDisRelated								In Ref. 8; AAD14329.
P26439	P26439-1		sequence conflict	conflict	232	233	H	L		notDisRelated								In Ref. 4; BAD96717.
Q9GZX5	Q9GZX5	PRO_0000047546	chain	chain	1	533				noEvidence				Zinc finger protein 350	ZBRK1	ZBRK1; Zinc finger protein ZBRK1; KRAB zinc finger protein ZFQR; Zinc finger and BRCA1-interacting protein with a KRAB domain 1		
Q9GZX5	Q9GZX5		domain	domain	8	80				notDisRelated								KRAB
Q9GZX5	Q9GZX5		zinc finger region	zinc finger	206	229				notDisRelated								C2H2-type 1
Q9GZX5	Q9GZX5		zinc finger region	zinc finger	234	257				notDisRelated								C2H2-type 2
Q9GZX5	Q9GZX5		zinc finger region	zinc finger	262	285				notDisRelated								C2H2-type 3
Q9GZX5	Q9GZX5		zinc finger region	zinc finger	290	313				notDisRelated								C2H2-type 4
Q9GZX5	Q9GZX5		zinc finger region	zinc finger	318	341				notDisRelated								C2H2-type 5
Q9GZX5	Q9GZX5		zinc finger region	zinc finger	346	369				notDisRelated								C2H2-type 6
Q9GZX5	Q9GZX5		zinc finger region	zinc finger	374	397				notDisRelated								C2H2-type 7
Q9GZX5	Q9GZX5		zinc finger region	zinc finger	402	425				notDisRelated								C2H2-type 8
Q9GZX5	Q9GZX5		region of interest	interest	427	466				notDisRelated								Disordered
Q9GZX5	Q9GZX5		compositionally biased region	biased	427	449				notDisRelated								Basic and acidic residues
Q9GZX5	Q9GZX5		compositionally biased region	biased	449	466				notDisRelated								Polar residues
Q9GZX5	Q9GZX5	VAR_046718	sequence variant	variant	37	38	M	I	rs4987241	noEvidence								
Q9GZX5	Q9GZX5	VAR_019902	sequence variant	variant	66	67	L	P	rs2278420	notDisRelated			11090615,12872252,14702039					
Q9GZX5	Q9GZX5	VAR_046719	sequence variant	variant	69	70	I	T	rs4987042	noEvidence								
Q9GZX5	Q9GZX5	VAR_046720	sequence variant	variant	132	133	R	C	rs28997584	noEvidence								
Q9GZX5	Q9GZX5	VAR_046721	sequence variant	variant	406	407	E	K	rs3764539	noEvidence								
Q9GZX5	Q9GZX5	VAR_019903	sequence variant	variant	472	473	S	P	rs4986771	notDisRelated			12872252					
Q9GZX5	Q9GZX5	VAR_019904	sequence variant	variant	501	502	R	S	rs2278415	notDisRelated			11090615,12872252,14702039					
Q9GZX5	Q9GZX5	VAR_019905	sequence variant	variant	524	525	V	I	rs4988337	notDisRelated			11161714,12872252					
P01009	P01009-1		signal peptide	signal pep	1	25				notDisRelated			1906855					
P01009	P01009-1	PRO_0000032377	chain	chain	25	419				notDisRelated			6093867	Alpha-1-antitrypsin	ORFPRO0684	ORFPRO0684; ORFPRO2209; PI; AAT; Serpin A1; Alpha-1-antiproteinase; Alpha-1 protease inhibitor; 1; 2; 3		
P01009	P01009-1	PRO_0000364030	peptide	peptide	375	419				noEvidence				Short peptide from AAT	SPAAT			Reversible chymotrypsin inhibitor. It also inhibits elastase, but not trypsin. Its major physiological function is the protection of the lower respiratory tract against proteolytic destruction by human leukocyte elastase (HLE).
P01009	P01009-1		region of interest	interest	368	393				noEvidence								RCL
P01009	P01009-1		site	site	352	354				notDisRelated			3533918					Microbial infection) Cleavage; by Staphylococcus aureus aureolysin/Aur
P01009	P01009-1		site	site	354	356				notDisRelated			3533918					Microbial infection) Cleavage; by Staphylococcus aureus serine and cysteine proteinases
P01009	P01009-1		site	site	382	384				noEvidence								Reactive bond
P01009	P01009-1		modified residue	phos	38	39				notDisRelated			26091039					Phosphoserine; by FAM20C
P01009	P01009-1		modified residue	modif	256	257				noEvidence								S-cysteinyl cysteine
P01009	P01009-1		modified residue	phos	383	384				notDisRelated								Phosphoserine
P01009	P01009-1		glycosylation site	glyco	70	71				notDisRelated			12754519,14760718,15084671,16263699,16335952,16622833,19159218,19838169,22171320					N-linked (GlcNAc...) (complex) asparagine
P01009	P01009-1		glycosylation site	glyco	107	108				notDisRelated			16335952,16622833,19139490,19159218,19838169					N-linked (GlcNAc...) (complex) asparagine
P01009	P01009-1		glycosylation site	glyco	271	272				notDisRelated			12754519,14760718,15084671,16335952,16622833,19139490,19159218,19838169,22171320					N-linked (GlcNAc...) (complex) asparagine
P01009	P01009-1	VSP_028890	splice variant	splicing	307	419				notDisRelated								In isoform 3.
P01009	P01009-1	VSP_028889	splice variant	splicing	356	419	AVHKAVLTIDEKGTEAAGAMFLEAIPMSIPPEVKFNKPFVFLMIEQNTKSPLFMGKVVNPTQK	VRSP		notDisRelated								In isoform 2.
P01009	P01009-1	VAR_006978	sequence variant	variant	4	5	S	L		disRelated	Z-Wrexham	Z-Wrexham	2227940					
P01009	P01009-1	VAR_006979	sequence variant	variant	26	27	D	A	rs199422212	notDisRelated	V-Munich	V-Munich	2316526					
P01009	P01009-1	VAR_051938	sequence variant	variant	37	38	T	A	rs11558262	noEvidence								
P01009	P01009-1	VAR_006980	sequence variant	variant	58	59	A	T	rs149319176	notDisRelated	M5-Karlsruhe	M5-Karlsruhe	7977369					
P01009	P01009-1	VAR_006981	sequence variant	variant	63	64	R	C	rs28931570	notDisRelated	I	I	2606478					
P01009	P01009-1	VAR_006982	sequence variant	variant	65	66	L	P	rs28931569	notDisRelated	M-Procida	M-Procida	3262617					
P01009	P01009-1	VAR_006983	sequence variant	variant	69	70	S	F	rs199687431	notDisRelated	M6-Bonn	M6-Bonn	7977369					
P01009	P01009-1	VAR_006984	sequence variant	variant	75	76				notDisRelated	M-Malton, M-Nichinan,M-Palermo	M-Malton, M-Nichinan and M-Palermo	2309708,2606478,2786335,7977369					associated with very low serum levels of AAT; homozygosity for allele M-Malton may be associated with a risk for chronic emphysema or infantile liver cirrhosis
P01009	P01009-1	VAR_006985	sequence variant	variant	77	78	S	F	rs55819880	disRelated	S-Iiyama	S-Iiyama	1905728					
P01009	P01009-1	VAR_006986	sequence variant	variant	84	85	A	T	rs111850950	notDisRelated	M6-Passau	M6-Passau	7977369					
P01009	P01009-1	VAR_006987	sequence variant	variant	91	92	G	E	rs28931568	notDisRelated	M-Mineral springs	M-Mineral springs	1967187					causes reduced AAT secretion
P01009	P01009-1	VAR_006988	sequence variant	variant	92	93	T	I	rs1490133295	disRelated	QO-Lisbon	QO-Lisbon						deficient AAT with very low serum levels
P01009	P01009-1	VAR_011620	sequence variant	variant	109	110	T	M	rs199422213	notDisRelated	Z-Bristol	Z-Bristol	9459000					deficient AA; disrupts the N-glycosylation site N-107
P01009	P01009-1	VAR_006989	sequence variant	variant	112	113	P	T	rs886044322	notDisRelated	M5-Berlin	M5-Berlin	7977369					
P01009	P01009-1	VAR_006990	sequence variant	variant	116	117	I	N	rs28931572	notDisRelated	QO-Ludwigshafen	QO-Ludwigshafen	2254451					
P01009	P01009-1	VAR_006991	sequence variant	variant	125	126	R	H	rs709932	disRelated	M2	M2						associated with D-400
P01009	P01009-1	VAR_006992	sequence variant	variant	139	140	G	S	rs11558261	disRelated	QO-Newport	QO-Newport	2227940					
P01009	P01009-1	VAR_006993	sequence variant	variant	172	173	G	R	rs112030253	notDisRelated	V,M-Nichinan	V and M-Nichinan	7977369					
P01009	P01009-1	VAR_006994	sequence variant	variant	172	173	G	W	rs112030253	notDisRelated	M2-Obernburg	M2-Obernburg	7977369					
P01009	P01009-1	VAR_006995	sequence variant	variant	180	181	Q	E	rs864622051	notDisRelated	L-Frankfurt	L-Frankfurt	7977369					
P01009	P01009-1	VAR_036746	sequence variant	variant	190	199	QGKIVDLVK	GFQNAILVR		disRelated	Aberrant form	Aberrant form						
P01009	P01009-1	VAR_006996	sequence variant	variant	228	229	E	K	rs199422208	disRelated	X	X						
P01009	P01009-1	VAR_006997	sequence variant	variant	237	238	V	A	rs6647	notDisRelated	M1A,Z	M1A and Z	17650587,23826168					associated with K-366 in Z
P01009	P01009-1	VAR_006998	sequence variant	variant	247	248	R	C	rs28929470	notDisRelated	F	F	2035534					
P01009	P01009-1	VAR_006999	sequence variant	variant	280	281	D	V	rs121912714	notDisRelated	P-Duarte/P-Cardiff/P-Lowell	P-Duarte/P-Cardiff/P-Lowell	10651487,2606478,8364590					associated with H-415 in Y-Barcelona
P01009	P01009-1	VAR_007000	sequence variant	variant	288	289	E	V	rs17580	notDisRelated	S,T	S and T	23826168					
P01009	P01009-1	VAR_009216	sequence variant	variant	305	306				notDisRelated	Basque	Basque	10612848					
P01009	P01009-1	VAR_007001	sequence variant	variant	354	355	S	F	rs201788603	notDisRelated	S-Munich	S-Munich	7977369					
P01009	P01009-1	VAR_007002	sequence variant	variant	360	361	A	T	rs1802959	disRelated	W-Bethesda	W-Bethesda	2390072					
P01009	P01009-1	VAR_007003	sequence variant	variant	365	366	D	N	rs143370956	notDisRelated	P-St.Albans/P-Donauwoerth	P-St.Albans/P-Donauwoerth	7977369					
P01009	P01009-1	VAR_007004	sequence variant	variant	366	367	E	K	rs28929474	notDisRelated	Z/Z-Augsburg/Z-Tun	Z/Z-Augsburg/Z-Tun	2339709,23826168					associated with A-237 in Z
P01009	P01009-1	VAR_007005	sequence variant	variant	382	383	M	R	rs121912713	notDisRelated	Pittsburgh	Pittsburgh	12860985,26797521,6604220					has antithrombin activity; inhibits factor VIIa activity; causes fatal bleeding diathesis
P01009	P01009-1	VAR_007006	sequence variant	variant	386	387	P	H	rs569384943	notDisRelated	Sao Tome	Sao Tome						
P01009	P01009-1	VAR_007007	sequence variant	variant	386	387	P	T	rs12233	notDisRelated	L-Offenbach	L-Offenbach	7977369					
P01009	P01009-1	VAR_007008	sequence variant	variant	387	388	E	K	rs121912712	disRelated	Christchurch	Christchurch						
P01009	P01009-1	VAR_007009	sequence variant	variant	393	394	P	L	rs199422209	notDisRelated	M-Heerlen	M-Heerlen	2784123					
P01009	P01009-1	VAR_007010	sequence variant	variant	400	401	E	D	rs1303	notDisRelated	M2,M3	M2 and M3	17650587,2394452					associated with H-125 in M2
P01009	P01009-1	VAR_007011	sequence variant	variant	415	416	P	H		notDisRelated	Y-Barcelona	Y-Barcelona	10651487					associated with V-280
P01009	P01009-1		mutagenesis site	mutagen	382	383	M	V		notDisRelated			6387509					Oxidation-resistant inhibitor of therapeutic importance.
P01009	P01009-1		sequence conflict	conflict	12	13				notDisRelated								In Ref. 4; AAA51546.
P01009	P01009-1		sequence conflict	conflict	23	24	L	P		notDisRelated								In Ref. 11; BAG38005.
P01009	P01009-1		sequence conflict	conflict	26	27	D	H		notDisRelated								In Ref. 18; AA sequence.
P01009	P01009-1		sequence conflict	conflict	39	40	H	L		notDisRelated								In Ref. 18; AA sequence.
P01009	P01009-1		sequence conflict	conflict	61	62	L	P		notDisRelated								In Ref. 9; AAF29581.
P01009	P01009-1		sequence conflict	conflict	96	97	T	A		notDisRelated								In Ref. 7; ABG73380.
P01009	P01009-1		sequence conflict	conflict	139	141	GN	DG		notDisRelated								In Ref. 1; AAB59375.
P01009	P01009-1		sequence conflict	conflict	174	175	T	H		notDisRelated								In Ref. 4; AAA51546.
P01009	P01009-1		sequence conflict	conflict	229	230	E	D		notDisRelated								In Ref. 4; AAA51546.
P01009	P01009-1		sequence conflict	conflict	273	274	T	N		notDisRelated								In Ref. 1; AAB59375.
P01009	P01009-1		sequence conflict	conflict	280	281	D	G		notDisRelated								In Ref. 7; ABG73380.
P01009	P01009-1		sequence conflict	conflict	326	327	V	I		notDisRelated								In Ref. 3; CAA25838.
P01009	P01009-1		sequence conflict	conflict	410	411	G	L		notDisRelated								In Ref. 24; AA sequence.
P01009	P01009-1		sequence conflict	conflict	414	415	N	S		notDisRelated								In Ref. 24; AA sequence.
P01009	P01009-1		turn	turn	48	51				notDisRelated								
P01009	P01009-1		helix	helix	51	69				notDisRelated								
P01009	P01009-1		strand	beta	70	73				notDisRelated								
P01009	P01009-1		strand	beta	74	77				notDisRelated								
P01009	P01009-1		helix	helix	78	90				notDisRelated								
P01009	P01009-1		helix	helix	94	104				notDisRelated								
P01009	P01009-1		turn	turn	108	111				notDisRelated								
P01009	P01009-1		helix	helix	113	128				notDisRelated								
P01009	P01009-1		helix	helix	130	134				notDisRelated								
P01009	P01009-1		strand	beta	135	146				notDisRelated								
P01009	P01009-1		strand	beta	146	149				notDisRelated								
P01009	P01009-1		helix	helix	152	163				notDisRelated								
P01009	P01009-1		strand	beta	164	170				notDisRelated								
P01009	P01009-1		strand	beta	171	174				notDisRelated								
P01009	P01009-1		helix	helix	174	189				notDisRelated								
P01009	P01009-1		turn	turn	189	192				notDisRelated								
P01009	P01009-1		strand	beta	206	221				notDisRelated								
P01009	P01009-1		helix	helix	224	227				notDisRelated								
P01009	P01009-1		strand	beta	228	236				notDisRelated								
P01009	P01009-1		strand	beta	238	257				notDisRelated								
P01009	P01009-1		turn	turn	257	261				notDisRelated								
P01009	P01009-1		strand	beta	261	280				notDisRelated								
P01009	P01009-1		strand	beta	280	283				notDisRelated								
P01009	P01009-1		helix	helix	284	291				notDisRelated								
P01009	P01009-1		helix	helix	293	302				notDisRelated								
P01009	P01009-1		strand	beta	306	314				notDisRelated								
P01009	P01009-1		strand	beta	315	323				notDisRelated								
P01009	P01009-1		helix	helix	324	330				notDisRelated								
P01009	P01009-1		helix	helix	334	337				notDisRelated								
P01009	P01009-1		turn	turn	337	340				notDisRelated								
P01009	P01009-1		turn	turn	343	346				notDisRelated								
P01009	P01009-1		strand	beta	347	350				notDisRelated								
P01009	P01009-1		strand	beta	351	365				notDisRelated								
P01009	P01009-1		strand	beta	366	382				notDisRelated								
P01009	P01009-1		strand	beta	387	390				notDisRelated								
P01009	P01009-1		strand	beta	394	401				notDisRelated								
P01009	P01009-1		turn	turn	401	404				notDisRelated								
P01009	P01009-1		strand	beta	406	415				notDisRelated								
Q99732	Q99732-1	PRO_0000084440	chain	chain	1	162				noEvidence				Lipopolysaccharide-induced tumor necrosis factor-alpha factor	LPS-induced TNF-alpha factor	LPS-induced TNF-alpha factor; PIG7; SIMPLE; p53-induced gene 7 protein; Small integral membrane protein of lysosome/late endosome; 1; 2; 3		
Q99732	Q99732-1		domain	domain	76	161				notDisRelated								LITAF
Q99732	Q99732-1		region of interest	interest	1	23				notDisRelated								Disordered
Q99732	Q99732-1		region of interest	interest	111	135				notDisRelated			27927196					Membrane-binding amphipathic helix
Q99732	Q99732-1		short sequence motif	motif	17	21				disRelated			16118794,23166352					PSAP motif; important for interaction with TSG101
Q99732	Q99732-1		short sequence motif	motif	20	24				notDisRelated			15064722,23166352,27927196					PPxY motif
Q99732	Q99732-1		compositionally biased region	biased	7	23				notDisRelated								Polar residues
Q99732	Q99732-1		binding site	bind	96	97				notDisRelated			27582497,27927196					
Q99732	Q99732-1		binding site	bind	99	100				notDisRelated			27927196					
Q99732	Q99732-1		binding site	bind	148	149				notDisRelated			27582497,27927196					
Q99732	Q99732-1		binding site	bind	151	152				notDisRelated			27927196					
Q99732	Q99732-1	VSP_016461	splice variant	splicing	127	162	CIAGCCFIPFCVDALQDVDHYCPNCRALLGTYKRL	VHSGLLLHPLLRGCPAGRGPLLSQLQSSPGHLQAFVGLSQTWREPGAAGSPFHLSSSFTPGGGSALVVSPLQGAHLHVFFWGEYVAKLTNLQTPEIAAWSRA		notDisRelated			10200294,9305847					In isoform 2.
Q99732	Q99732-1	VSP_045701	splice variant	splicing	127	162	CIAGCCFIPFCVDALQDVDHYCPNCRALLGTYKRL	QECSGTIVALRSFDLLGSCNPPSSAS		notDisRelated			14702039					In isoform 3.
Q99732	Q99732-1	VAR_024014	sequence variant	variant	23	24	Y	H		disRelated	one EMPD primary tumor	one EMPD primary tumor	15197774					somatic mutation
Q99732	Q99732-1	VAR_024015	sequence variant	variant	49	50	T	M	rs141862602	disRelated	Charcot-Marie-Tooth disease, demyelinating, 1C	CMT1C	15776429					
Q99732	Q99732-1	VAR_024016	sequence variant	variant	92	93	I	V	rs4280262	disRelated			15776429,15786462					
Q99732	Q99732-1	VAR_024017	sequence variant	variant	112	113	G	S	rs104894519	disRelated	Charcot-Marie-Tooth disease, demyelinating, 1C	CMT1C	12525712,15776429,15786462,16118794,24604904					does not abolish interaction with NEDD4 and TSG101
Q99732	Q99732-1	VAR_024018	sequence variant	variant	115	116	T	N	rs104894520	disRelated	Charcot-Marie-Tooth disease, demyelinating, 1C	CMT1C	12525712,16118794					does not abolish interaction with NEDD4 and TSG101
Q99732	Q99732-1	VAR_024019	sequence variant	variant	116	117	W	G	rs104894521	disRelated	Charcot-Marie-Tooth disease, demyelinating, 1C	CMT1C	12525712,16118794,21896645,23166352					decreases protein stability and association with early endosome membranes; impaired function in targeting endocytosed proteins for lysosomal degradation; does not abolish interaction with NEDD4 and TSG101
Q99732	Q99732-1	VAR_024020	sequence variant	variant	122	123	L	V	rs104894522	disRelated	Charcot-Marie-Tooth disease, demyelinating, 1C	CMT1C	15776429					
Q99732	Q99732-1		mutagenesis site	mutagen	17	21	PSAP	ASAA		disRelated			23166352					Impaired function in targeting endocytosed proteins for lysosomal degradation.
Q99732	Q99732-1		mutagenesis site	mutagen	17	20	PSA	AGG		disRelated			16118794					Abolishes interaction with TSG101.
Q99732	Q99732-1		mutagenesis site	mutagen	23	24	Y	A		disRelated			16118794					Abolishes interaction with NEDD4.
Q99732	Q99732-1		mutagenesis site	mutagen	23	24	Y	A		notDisRelated			15064722,27927196					Abolishes interaction with WWOX. Abolishes interaction with NEDD4. Abolishes interaction with NEDD4 and impairs location at endosomes; when associated with A-61.
Q99732	Q99732-1		mutagenesis site	mutagen	61	62	Y	A		notDisRelated			15064722,27927196					No effect on interaction with WWOX. No effect on interaction with NEDD4. Abolishes interaction with NEDD4 and impairs location at endosomes; when associated with A-23.
Q99732	Q99732-1		mutagenesis site	mutagen	96	97	C	A		notDisRelated			27582497					Abolishes association with cytoplasmic vesicle membranes.
Q99732	Q99732-1		mutagenesis site	mutagen	135	136	P	T		disRelated			21896645,23166352					Decreases protein stability and association with early endosome membranes. Impaired function in targeting endocytosed proteins for lysosomal degradation.
Q99732	Q99732-1		mutagenesis site	mutagen	144	145	V	M		notDisRelated			27927196					No effect on location at endosomes, but impairs protein stability.
Q99732	Q99732-1		mutagenesis site	mutagen	148	149	C	A		notDisRelated			27582497					Abolishes association with cytoplasmic vesicle membranes.
Q99732	Q99732-1	VAR_082859	sequence variant	variant	174	175	A	S		notDisRelated								Found as a somatic mutation in EMPD primary tumor
Q9UI95	Q9UI95	PRO_0000126119	chain	chain	1	212				noEvidence				Mitotic spindle assembly checkpoint protein MAD2B	hREV7	hREV7; MAD2-like protein 2; REV7; MAD2B; REV7 homolog; Mitotic arrest deficient 2-like protein 2		
Q9UI95	Q9UI95		domain	domain	13	204				notDisRelated								HORMA
Q9UI95	Q9UI95		region of interest	interest	21	156				noEvidence								Mediates interaction with REV1 and REV3L and homodimerization
Q9UI95	Q9UI95		region of interest	interest	150	212				noEvidence								Mediates interaction with ipaB
Q9UI95	Q9UI95	VAR_077981	sequence variant	variant	85	86	V	E	rs1057517674	disRelated	Fanconi anemia, complementation group V	FANCV	27500492					drastically reduced protein abundance
Q9UI95	Q9UI95		mutagenesis site	mutagen	63	64	Y	A		notDisRelated			20164194					Alters interaction with REV3L. Loss of interaction with REV3L; when associated with A-171.
Q9UI95	Q9UI95		mutagenesis site	mutagen	124	125	R	A		notDisRelated			20164194					Induces structural changes that increase affinity for REV3L and REV1. No effect on interaction with REV1; when associated with A-171.
Q9UI95	Q9UI95		mutagenesis site	mutagen	171	172	W	A		notDisRelated			20164194					Alters interaction with REV3L and REV1. Loss of interaction with REV3L; when associated with A-63. No effect on interaction with REV1; when associated with A-124.
Q9UI95	Q9UI95		mutagenesis site	mutagen	186	187	L	A		notDisRelated			20164194					Significantly prevents interaction with REV1; no effect on interaction with REV3L.
Q9UI95	Q9UI95		mutagenesis site	mutagen	200	201	Q	A		notDisRelated			20164194					Significantly prevents interaction with REV1; no effect on interaction with REV3L.
Q9UI95	Q9UI95		mutagenesis site	mutagen	202	203	Y	A		notDisRelated			20164194					Significantly prevents interaction with REV1; no effect on interaction with REV3L.
Q9UI95	Q9UI95		sequence conflict	conflict	17	18	D	A		notDisRelated								In Ref. 3; AAD30290.
Q9UI95	Q9UI95		sequence conflict	conflict	96	97	E	D		notDisRelated								In Ref. 2; AAF20267.
Q9UI95	Q9UI95		sequence conflict	conflict	199	200	M	V		notDisRelated								In Ref. 2; AAF20267.
Q9UI95	Q9UI95		helix	helix	6	9				notDisRelated								
Q9UI95	Q9UI95		helix	helix	10	13				notDisRelated								
Q9UI95	Q9UI95		helix	helix	13	34				notDisRelated								
Q9UI95	Q9UI95		helix	helix	39	42				notDisRelated								
Q9UI95	Q9UI95		strand	beta	42	48				notDisRelated								
Q9UI95	Q9UI95		strand	beta	50	56				notDisRelated								
Q9UI95	Q9UI95		helix	helix	58	77				notDisRelated								
Q9UI95	Q9UI95		strand	beta	80	89				notDisRelated								
Q9UI95	Q9UI95		strand	beta	90	93				notDisRelated								
Q9UI95	Q9UI95		strand	beta	94	104				notDisRelated								
Q9UI95	Q9UI95		turn	turn	106	112				notDisRelated								
Q9UI95	Q9UI95		strand	beta	112	115				notDisRelated								
Q9UI95	Q9UI95		turn	turn	115	119				notDisRelated								
Q9UI95	Q9UI95		helix	helix	119	132				notDisRelated								
Q9UI95	Q9UI95		helix	helix	133	136				notDisRelated								
Q9UI95	Q9UI95		strand	beta	145	156				notDisRelated								
Q9UI95	Q9UI95		helix	helix	156	160				notDisRelated								
Q9UI95	Q9UI95		strand	beta	162	167				notDisRelated								
Q9UI95	Q9UI95		strand	beta	169	174				notDisRelated								
Q9UI95	Q9UI95		helix	helix	176	180				notDisRelated								
Q9UI95	Q9UI95		strand	beta	185	197				notDisRelated								
Q9UI95	Q9UI95		strand	beta	198	206				notDisRelated								
Q9BS31	Q9BS31	PRO_0000251224	chain	chain	1	506				noEvidence				Zinc finger protein 649				
Q9BS31	Q9BS31		domain	domain	8	80				notDisRelated								KRAB
Q9BS31	Q9BS31		zinc finger region	zinc finger	178	201				notDisRelated								C2H2-type 1
Q9BS31	Q9BS31		zinc finger region	zinc finger	206	229				notDisRelated								C2H2-type 2
Q9BS31	Q9BS31		zinc finger region	zinc finger	234	257				notDisRelated								C2H2-type 3
Q9BS31	Q9BS31		zinc finger region	zinc finger	262	285				notDisRelated								C2H2-type 4
Q9BS31	Q9BS31		zinc finger region	zinc finger	290	313				notDisRelated								C2H2-type 5
Q9BS31	Q9BS31		zinc finger region	zinc finger	318	341				notDisRelated								C2H2-type 6
Q9BS31	Q9BS31		zinc finger region	zinc finger	346	369				notDisRelated								C2H2-type 7
Q9BS31	Q9BS31		zinc finger region	zinc finger	374	397				notDisRelated								C2H2-type 8
Q9BS31	Q9BS31		zinc finger region	zinc finger	402	425				notDisRelated								C2H2-type 9
Q9BS31	Q9BS31		zinc finger region	zinc finger	430	453				notDisRelated								C2H2-type 10
Q9BS31	Q9BS31		region of interest	interest	455	482				notDisRelated								Disordered
Q9BS31	Q9BS31		compositionally biased region	biased	463	482				notDisRelated								Polar residues
Q9BS31	Q9BS31		cross-link	cross-link	112	113				notDisRelated								Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2
Q9BS31	Q9BS31	VAR_027668	sequence variant	variant	352	353	G	D	rs6509593	noEvidence								
Q9BS31	Q9BS31	VAR_027669	sequence variant	variant	469	470	A	T	rs1433083	noEvidence								
Q9BS31	Q9BS31		sequence conflict	conflict	8	9	L	V		notDisRelated								In Ref. 2; BAB14191.
Q9BS31	Q9BS31		sequence conflict	conflict	314	315	G	E		notDisRelated								In Ref. 2; BAB14191.
P20848	P20848		signal peptide	signal pep	1	22				notDisRelated								
P20848	P20848	PRO_0000032410	chain	chain	22	422				noEvidence				Alpha-1-antitrypsin-related protein	AAT-related protein	AAT-related protein; ATR; PIL; ARGS; SERPINA2P; Serpin A2; Protease inhibitor 1-like		
P20848	P20848		site	site	385	387				notDisRelated								Reactive bond
P20848	P20848		glycosylation site	glyco	56	57				notDisRelated								N-linked (GlcNAc...) asparagine
P20848	P20848		glycosylation site	glyco	110	111				notDisRelated								N-linked (GlcNAc...) asparagine
P20848	P20848		glycosylation site	glyco	148	149				notDisRelated								N-linked (GlcNAc...) asparagine
P20848	P20848		glycosylation site	glyco	274	275				notDisRelated								N-linked (GlcNAc...) asparagine
P20848	P20848	VAR_070190	sequence variant	variant	330	331	L	P		notDisRelated	V1,V3	V1 and V3	23826168					
P20848	P20848	VAR_070191	sequence variant	variant	342	343	E	K		notDisRelated	V1	V1	23826168					
P20848	P20848		sequence conflict	conflict	9	10	I	V		notDisRelated								In Ref. 1; AAA51544 and 2; AGI62067.
P20848	P20848		sequence conflict	conflict	29	30	E	G		notDisRelated								In Ref. 1; AAA51544.
P20848	P20848		sequence conflict	conflict	67	77	ELADLSQTSN	SWLIYHNQH		notDisRelated								In Ref. 1; AAA51544.
P20848	P20848		sequence conflict	conflict	89	90	A	R		notDisRelated								In Ref. 1; AAA51544.
P20848	P20848		sequence conflict	conflict	229	230	H	R		notDisRelated								In Ref. 1; AAA51544 and 2; AGI62067.
P20848	P20848		sequence conflict	conflict	403	405	DD	EY		notDisRelated								In Ref. 1; AAA51544.
Q8N139	Q8N139-1	PRO_0000250672	chain	chain	1	1618				noEvidence				ATP-binding cassette sub-family A member 6	1	1; 2; 3; ABCA6delta-139		
Q8N139	Q8N139-1		transmembrane region	transmem	31	52				notDisRelated								Helical
Q8N139	Q8N139-1		transmembrane region	transmem	222	243				notDisRelated								Helical
Q8N139	Q8N139-1		transmembrane region	transmem	268	289				notDisRelated								Helical
Q8N139	Q8N139-1		transmembrane region	transmem	297	318				notDisRelated								Helical
Q8N139	Q8N139-1		transmembrane region	transmem	327	348				notDisRelated								Helical
Q8N139	Q8N139-1		transmembrane region	transmem	355	376				notDisRelated								Helical
Q8N139	Q8N139-1		transmembrane region	transmem	397	418				notDisRelated								Helical
Q8N139	Q8N139-1		transmembrane region	transmem	854	875				notDisRelated								Helical
Q8N139	Q8N139-1		transmembrane region	transmem	1007	1028				notDisRelated								Helical
Q8N139	Q8N139-1		transmembrane region	transmem	1062	1083				notDisRelated								Helical
Q8N139	Q8N139-1		transmembrane region	transmem	1094	1115				notDisRelated								Helical
Q8N139	Q8N139-1		transmembrane region	transmem	1127	1148				notDisRelated								Helical
Q8N139	Q8N139-1		transmembrane region	transmem	1150	1171				notDisRelated								Helical
Q8N139	Q8N139-1		transmembrane region	transmem	1194	1215				notDisRelated								Helical
Q8N139	Q8N139-1		domain	domain	478	714				notDisRelated								ABC transporter 1
Q8N139	Q8N139-1		domain	domain	1288	1514				notDisRelated								ABC transporter 2
Q8N139	Q8N139-1		binding site	bind	514	522				notDisRelated								
Q8N139	Q8N139-1		binding site	bind	1320	1328				notDisRelated								
Q8N139	Q8N139-1		glycosylation site	glyco	84	85				notDisRelated								N-linked (GlcNAc...) asparagine
Q8N139	Q8N139-1		glycosylation site	glyco	109	110				notDisRelated								N-linked (GlcNAc...) asparagine
Q8N139	Q8N139-1		glycosylation site	glyco	940	941				notDisRelated			19159218					N-linked (GlcNAc...) asparagine
Q8N139	Q8N139-1	VSP_020695	splice variant	splicing	154	186	AHCWDGYGEFSCTLTKYWNRGFVALQTAINTA	GDFPYQISLWNFSCFQHKEQRRLGNRDAFNDT		notDisRelated			15489334					In isoform 3.
Q8N139	Q8N139-1	VSP_020696	splice variant	splicing	186	1618				notDisRelated			15489334					In isoform 3.
Q8N139	Q8N139-1	VSP_020697	splice variant	splicing	636	638	LL	EK		notDisRelated								In isoform 2.
Q8N139	Q8N139-1	VSP_020698	splice variant	splicing	638	1618				notDisRelated								In isoform 2.
Q8N139	Q8N139-1	VAR_027576	sequence variant	variant	282	283	V	I	rs4968839	notDisRelated								
Q8N139	Q8N139-1	VAR_027577	sequence variant	variant	610	611	N	Y	rs9282554	noEvidence								
Q8N139	Q8N139-1	VAR_027578	sequence variant	variant	698	699	M	I	rs9282553	noEvidence								
Q8N139	Q8N139-1	VAR_027579	sequence variant	variant	875	876	M	I	rs7212506	notDisRelated								
Q8N139	Q8N139-1	VAR_027580	sequence variant	variant	1322	1323	N	S	rs2302134	notDisRelated			14702039					
Q8N139	Q8N139-1		sequence conflict	conflict	51	52	M	L		notDisRelated								In Ref. 3; AAH70125.
Q8N139	Q8N139-1		sequence conflict	conflict	147	148	L	R		notDisRelated								In Ref. 3; AAH70125.
Q8N139	Q8N139-1		sequence conflict	conflict	812	813	E	G		notDisRelated								In Ref. 4; BAC04994.
Q8N139	Q8N139-1		sequence conflict	conflict	875	877	MY	IH		notDisRelated								In Ref. 4; BAC04994.
Q8IZY2	Q8IZY2-1	PRO_0000250674	chain	chain	1	2147				noEvidence				Phospholipid-transporting ATPase ABCA7	ABCA-SSN	ABCA-SSN; Autoantigen SS-N; Macrophage ABC transporter; ATP-binding cassette sub-family A member 7; 1; 2; Type 1; Type 2		
Q8IZY2	Q8IZY2-1		transmembrane region	transmem	22	43				notDisRelated								Helical
Q8IZY2	Q8IZY2-1		topological domain	topo	43	550				notDisRelated								Extracellular
Q8IZY2	Q8IZY2-1		transmembrane region	transmem	550	571				notDisRelated								Helical
Q8IZY2	Q8IZY2-1		transmembrane region	transmem	593	614				notDisRelated								Helical
Q8IZY2	Q8IZY2-1		transmembrane region	transmem	626	647				notDisRelated								Helical
Q8IZY2	Q8IZY2-1		transmembrane region	transmem	655	676				notDisRelated								Helical
Q8IZY2	Q8IZY2-1		transmembrane region	transmem	687	708				notDisRelated								Helical
Q8IZY2	Q8IZY2-1		transmembrane region	transmem	727	748				notDisRelated								Helical
Q8IZY2	Q8IZY2-1		transmembrane region	transmem	849	870				notDisRelated								Helical
Q8IZY2	Q8IZY2-1		transmembrane region	transmem	1243	1264				notDisRelated								Helical
Q8IZY2	Q8IZY2-1		topological domain	topo	1264	1538				notDisRelated								Extracellular
Q8IZY2	Q8IZY2-1		transmembrane region	transmem	1538	1559				notDisRelated								Helical
Q8IZY2	Q8IZY2-1		transmembrane region	transmem	1584	1605				notDisRelated								Helical
Q8IZY2	Q8IZY2-1		transmembrane region	transmem	1621	1642				notDisRelated								Helical
Q8IZY2	Q8IZY2-1		transmembrane region	transmem	1649	1670				notDisRelated								Helical
Q8IZY2	Q8IZY2-1		transmembrane region	transmem	1683	1704				notDisRelated								Helical
Q8IZY2	Q8IZY2-1		transmembrane region	transmem	1729	1750				notDisRelated								Helical
Q8IZY2	Q8IZY2-1		domain	domain	807	1039				notDisRelated								ABC transporter 1
Q8IZY2	Q8IZY2-1		domain	domain	1793	2026				notDisRelated								ABC transporter 2
Q8IZY2	Q8IZY2-1		region of interest	interest	1048	1073				notDisRelated								Disordered
Q8IZY2	Q8IZY2-1		region of interest	interest	1185	1210				notDisRelated								Disordered
Q8IZY2	Q8IZY2-1		region of interest	interest	2104	2147				notDisRelated								Disordered
Q8IZY2	Q8IZY2-1		compositionally biased region	biased	1048	1067				notDisRelated								Basic and acidic residues
Q8IZY2	Q8IZY2-1		binding site	bind	841	849				notDisRelated								
Q8IZY2	Q8IZY2-1		binding site	bind	1827	1835				notDisRelated								
Q8IZY2	Q8IZY2-1		glycosylation site	glyco	312	313				notDisRelated								N-linked (GlcNAc...) asparagine
Q8IZY2	Q8IZY2-1		disulfide bond	disulf bond	75	226				notDisRelated								
Q8IZY2	Q8IZY2-1		disulfide bond	disulf bond	1345	1360				notDisRelated								
Q8IZY2	Q8IZY2-1	VSP_020701	splice variant	splicing	1	139				notDisRelated			11355874					In isoform 2.
Q8IZY2	Q8IZY2-1	VSP_020702	splice variant	splicing	139	167	AQPQPTKQSPLEPPMLDVAELLTSLLRT	MVCLGTGQSAGPLVSVQNHCPPCGLSPQ		notDisRelated			11355874					In isoform 2.
Q8IZY2	Q8IZY2-1	VAR_027581	sequence variant	variant	188	189	E	G	rs3764645	notDisRelated			11435699,12111378					
Q8IZY2	Q8IZY2-1	VAR_027582	sequence variant	variant	319	320	T	A	rs3752232	notDisRelated			12111378					
Q8IZY2	Q8IZY2-1	VAR_027583	sequence variant	variant	395	396	H	R	rs3764647	notDisRelated			12111378					
Q8IZY2	Q8IZY2-1	VAR_027584	sequence variant	variant	463	464	R	H	rs3752233	notDisRelated			12111378					
Q8IZY2	Q8IZY2-1	VAR_060985	sequence variant	variant	676	677	A	T	rs59851484	noEvidence								
Q8IZY2	Q8IZY2-1	VAR_027585	sequence variant	variant	718	719	N	T	rs3752239	notDisRelated			12111378					
Q8IZY2	Q8IZY2-1	VAR_081204	sequence variant	variant	880	881	R	Q	rs143718918	disRelated	Alzheimer disease 9	AD9	29577078					
Q8IZY2	Q8IZY2-1	VAR_027586	sequence variant	variant	1349	1350	R	Q	rs3745842	notDisRelated			10873640,11355874,12111378					
Q8IZY2	Q8IZY2-1	VAR_027587	sequence variant	variant	1527	1528	G	A	rs3752246	notDisRelated			10873640,11095984,11355874,11435699					
Q8IZY2	Q8IZY2-1	VAR_027588	sequence variant	variant	1686	1687	Q	R	rs4147918	notDisRelated			12111378					
Q8IZY2	Q8IZY2-1	VAR_027589	sequence variant	variant	2045	2046	A	S	rs4147934	notDisRelated			10873640,11355874,11435699,12111378					
Q8IZY2	Q8IZY2-1		sequence conflict	conflict	1503	1504	P	R		notDisRelated								In Ref. 1; AAF85794 and 3; BAB62294.
Q8IZY2	Q8IZY2-1		sequence conflict	conflict	1525	1526	S	F		notDisRelated								In Ref. 1; AAF85794, 2; AAN04657 and 3; BAB62294.
Q8N726	Q8N726-1	PRO_0000144180	chain	chain	1	133				noEvidence				Tumor suppressor ARF	ARF	ARF; MLM; CDKN2; p14ARF; Alternative reading frame; Cyclin-dependent kinase inhibitor 2A; 1; 2; 3; 5; p12; smARF; p14ARF; p19ARF; p16INK4a; p16gamma; tumor suppressor ARF		
Q8N726	Q8N726-1		region of interest	interest	1	65				notDisRelated			16173922					Interaction with CDK5RAP3 and MDM2
Q8N726	Q8N726-1		region of interest	interest	56	133				notDisRelated								Disordered
Q8N726	Q8N726-1	VSP_044962	splice variant	splicing	1	48				notDisRelated								In isoform smARF.
Q8N726	Q8N726-1	VAR_029287	sequence variant	variant	17	18	P	S	rs3731190	notDisRelated								
Q8N726	Q8N726-1	VAR_053033	sequence variant	variant	106	107	G	R	rs4987127	noEvidence								
Q8N726	Q8N726-1	VAR_053034	sequence variant	variant	113	114	P	L	rs34886500	noEvidence								
Q8N726	Q8N726-1	VAR_053035	sequence variant	variant	116	117	G	D	rs35741010	noEvidence								
Q8N726	Q8N726-1		sequence conflict	conflict	28	31	PRL	SWF		notDisRelated								In Ref. 6; AAH15960/AAH21998 and 7; AAP35666.
Q8N726	Q8N726-1		sequence conflict	conflict	94	95	P	L		notDisRelated								In Ref. 2; AAB01737.
Q9Y215	Q9Y215-1		signal peptide	signal pep	1	23				notDisRelated								
Q9Y215	Q9Y215-1	PRO_0000005854	chain	chain	23	456				noEvidence				Acetylcholinesterase collagenic tail peptide	AChE Q subunit	AChE Q subunit; Acetylcholinesterase-associated collagen; I; V; II; IV; VI; III; VII; VIII		
Q9Y215	Q9Y215-1		domain	domain	96	270				noEvidence								Collagen-like 1
Q9Y215	Q9Y215-1		domain	domain	277	292				noEvidence								Collagen-like 2
Q9Y215	Q9Y215-1		region of interest	interest	51	68				noEvidence								PRAD
Q9Y215	Q9Y215-1		region of interest	interest	90	283				notDisRelated								Disordered
Q9Y215	Q9Y215-1		region of interest	interest	130	134				notDisRelated								Heparan sulfate proteoglycan binding
Q9Y215	Q9Y215-1		region of interest	interest	235	239				notDisRelated								Heparan sulfate proteoglycan binding
Q9Y215	Q9Y215-1		compositionally biased region	biased	133	151				notDisRelated								Pro residues
Q9Y215	Q9Y215-1		compositionally biased region	biased	183	198				notDisRelated								Basic and acidic residues
Q9Y215	Q9Y215-1		compositionally biased region	biased	253	274				notDisRelated								Pro residues
Q9Y215	Q9Y215-1		disulfide bond	disulf bond	51	52				notDisRelated								Interchain (with T subunit
Q9Y215	Q9Y215-1		disulfide bond	disulf bond	52	53				notDisRelated								Interchain (with T subunit
Q9Y215	Q9Y215-1		disulfide bond	disulf bond	93	94				notDisRelated								Interchain
Q9Y215	Q9Y215-1		disulfide bond	disulf bond	291	292				notDisRelated								Interchain
Q9Y215	Q9Y215-1		disulfide bond	disulf bond	293	294				notDisRelated								Interchain
Q9Y215	Q9Y215-1	VSP_001175	splice variant	splicing	1	36	MVVLNPMTLGIYLQLFFLSIVSQPTFINSVLPISA	MTGSSFSLAHLLIISGLLCYSAGCL		notDisRelated			14702039					In isoform II.
Q9Y215	Q9Y215-1	VSP_001176	splice variant	splicing	73	77				notDisRelated								In isoform IV.
Q9Y215	Q9Y215-1	VSP_001177	splice variant	splicing	74	108				notDisRelated								In isoform III.
Q9Y215	Q9Y215-1	VSP_001178	splice variant	splicing	124	133				notDisRelated								In isoform V.
Q9Y215	Q9Y215-1	VSP_001179	splice variant	splicing	240	292	GQKGDSGVMGPPGKPGPSGQPGRPGPPGPPPAGQLIMGPKGERGFPGPPGRC	SSRTPCTLPRRPPVPCGQGSRSPVTVVAGNESQACLLPRFEEDYISSGTERG		notDisRelated								In isoform VI.
Q9Y215	Q9Y215-1	VSP_001180	splice variant	splicing	272	282	GQLIMGPKGE	DFCGQQPGGA		notDisRelated								In isoform VII.
Q9Y215	Q9Y215-1	VSP_001181	splice variant	splicing	273	330	QLIMGPKGERGFPGPPGRCLCGPTMNVNNPSYGESVYGPSSPRVPVIFVVNNQEELE	HMETCNAPSTATSTPRPAATSPEGREEKVGCAPQNWQQLLHCHQTGHVLAPSPPTFV		notDisRelated								In isoform VIII.
Q9Y215	Q9Y215-1	VSP_001182	splice variant	splicing	282	456				notDisRelated								In isoform VII.
Q9Y215	Q9Y215-1	VSP_001183	splice variant	splicing	292	456				notDisRelated								In isoform VI.
Q9Y215	Q9Y215-1	VSP_001184	splice variant	splicing	330	456				notDisRelated								In isoform VIII.
Q9Y215	Q9Y215-1	VAR_010133	sequence variant	variant	59	60	P	Q		disRelated	Myasthenic syndrome, congenital, 5	CMS5	10665486					abrogates binding to T subunit
Q9Y215	Q9Y215-1	VAR_048809	sequence variant	variant	312	313	S	G	rs6782980	noEvidence								
Q9Y215	Q9Y215-1	VAR_071710	sequence variant	variant	337	338	I	T	rs1057521153	disRelated	Myasthenic syndrome, congenital, 5	CMS5	24938146					
Q9Y215	Q9Y215-1	VAR_010134	sequence variant	variant	342	343	D	E	rs758554049	disRelated	Myasthenic syndrome, congenital, 5	CMS5	10665486					impairs anchoring to the basal lamina
Q9Y215	Q9Y215-1	VAR_010135	sequence variant	variant	410	411	R	Q	rs1025361623	disRelated	Myasthenic syndrome, congenital, 5	CMS5	10665486					
Q9Y215	Q9Y215-1	VAR_010136	sequence variant	variant	430	431	Y	S	rs121908923	disRelated	Myasthenic syndrome, congenital, 5	CMS5	9758617					
Q9Y215	Q9Y215-1	VAR_010137	sequence variant	variant	444	445	C	Y		disRelated	Myasthenic syndrome, congenital, 5	CMS5	10665486					
Q9Y215	Q9Y215-1		sequence conflict	conflict	370	371	D	N		notDisRelated								In Ref. 3; AAO06818.
Q9Y215	Q9Y215-1		sequence conflict	conflict	399	400	R	RD		notDisRelated								In Ref. 1; CAA12648 and 3; AAO06814/AAO06816/AAO06817/AAO06818/AAO06819.
Q9Y215	Q9Y215-1		sequence conflict	conflict	400	401	C	Y		notDisRelated								In Ref. 3; AAO06816.
Q9Y215	Q9Y215-1		sequence conflict	conflict	404	405	Y	D		notDisRelated								In Ref. 3; AAO06817.
Q9Y215	Q9Y215-1		sequence conflict	conflict	423	424	G	V		notDisRelated								In Ref. 3; AAO06819.
Q6PF04	Q6PF04-1	PRO_0000234597	chain	chain	1	618				noEvidence				Zinc finger protein 613	1	1; 2		
Q6PF04	Q6PF04-1		domain	domain	8	79				notDisRelated								KRAB
Q6PF04	Q6PF04-1		zinc finger region	zinc finger	204	227				notDisRelated								C2H2-type 1
Q6PF04	Q6PF04-1		zinc finger region	zinc finger	232	255				notDisRelated								C2H2-type 2
Q6PF04	Q6PF04-1		zinc finger region	zinc finger	260	283				notDisRelated								C2H2-type 3
Q6PF04	Q6PF04-1		zinc finger region	zinc finger	288	311				notDisRelated								C2H2-type 4
Q6PF04	Q6PF04-1		zinc finger region	zinc finger	316	339				notDisRelated								C2H2-type 5
Q6PF04	Q6PF04-1		zinc finger region	zinc finger	344	367				notDisRelated								C2H2-type 6
Q6PF04	Q6PF04-1		zinc finger region	zinc finger	372	395				notDisRelated								C2H2-type 7
Q6PF04	Q6PF04-1		zinc finger region	zinc finger	400	423				notDisRelated								C2H2-type 8
Q6PF04	Q6PF04-1		zinc finger region	zinc finger	428	451				notDisRelated								C2H2-type 9
Q6PF04	Q6PF04-1		zinc finger region	zinc finger	456	479				notDisRelated								C2H2-type 10
Q6PF04	Q6PF04-1		zinc finger region	zinc finger	484	507				notDisRelated								C2H2-type 11
Q6PF04	Q6PF04-1		zinc finger region	zinc finger	512	536				notDisRelated								C2H2-type 12
Q6PF04	Q6PF04-1	VSP_018388	splice variant	splicing	1	37				notDisRelated			14702039					In isoform 2.
Q6PF04	Q6PF04-1	VAR_028096	sequence variant	variant	84	85	D	N	rs17854933	notDisRelated			15489334					
Q6PF04	Q6PF04-1	VAR_028097	sequence variant	variant	93	94	K	E	rs8106409	noEvidence								
Q6PF04	Q6PF04-1	VAR_028098	sequence variant	variant	135	136	I	R	rs16983243	noEvidence								
Q6PF04	Q6PF04-1	VAR_057428	sequence variant	variant	163	164	S	F	rs33998555	noEvidence								
Q6PF04	Q6PF04-1	VAR_057429	sequence variant	variant	611	612	D	V	rs16983253	noEvidence								
A7E2S9	A7E2S9-1	PRO_0000341256	chain	chain	1	259				noEvidence				Putative ankyrin repeat domain-containing protein 30B-like	NCRNA00164	NCRNA00164; 1; 2		
A7E2S9	A7E2S9-1		repeat	repeat	71	101				noEvidence								ANK 1
A7E2S9	A7E2S9-1		repeat	repeat	104	134				noEvidence								ANK 2
A7E2S9	A7E2S9-1		repeat	repeat	137	167				noEvidence								ANK 3
A7E2S9	A7E2S9-1		repeat	repeat	170	200				noEvidence								ANK 4
A7E2S9	A7E2S9-1		region of interest	interest	1	22				notDisRelated								Disordered
A7E2S9	A7E2S9-1		region of interest	interest	216	259				notDisRelated								Disordered
A7E2S9	A7E2S9-1		compositionally biased region	biased	216	232				notDisRelated								Polar residues
A7E2S9	A7E2S9-1	VSP_039808	splice variant	splicing	206	259	VHQQLLEYKQKISKNSQNSNPEGTSEGTPDEAAPLAERTPDTAESLVERTPDE	TALMLAICHGSSEIVGKLLQQNVDICAEATCGMIAERYAVACGFNL		notDisRelated			15489334					In isoform 2.
Q6PD74	Q6PD74-1	PRO_0000058134	chain	chain	1	316				noEvidence				Alpha- and gamma-adaptin-binding protein p34	1	1; 2		
Q6PD74	Q6PD74-1		region of interest	interest	197	235				notDisRelated								Disordered
Q6PD74	Q6PD74-1		compositionally biased region	biased	220	235				notDisRelated								Polar residues
Q6PD74	Q6PD74-1		modified residue	phos	310	311				notDisRelated								Phosphoserine
Q6PD74	Q6PD74-1		modified residue	phos	311	312				notDisRelated								Phosphoserine
Q6PD74	Q6PD74-1	VSP_054597	splice variant	splicing	1	110				notDisRelated			14702039					In isoform 2.
Q6PD74	Q6PD74-1	VAR_021533	sequence variant	variant	132	133	I	L	rs7173826	notDisRelated			11230166,14702039					
Q6PD74	Q6PD74-1		sequence conflict	conflict	26	27	I	T		notDisRelated								In Ref. 1; CAB66649 and 3; CAG38571.
Q6PD74	Q6PD74-1		sequence conflict	conflict	77	78	V	A		notDisRelated								In Ref. 3; CAG38571.
Q6PD74	Q6PD74-1		sequence conflict	conflict	88	89	Q	R		notDisRelated								In Ref. 1; CAB66649 and 3; CAG38571.
Q6PD74	Q6PD74-1		sequence conflict	conflict	131	132	C	S		notDisRelated								In Ref. 1; CAB66649 and 3; CAG38571.
Q6PD74	Q6PD74-1		sequence conflict	conflict	265	266	L	P		notDisRelated								In Ref. 1; CAB66649 and 3; CAG38571.
Q6PD74	Q6PD74-1		sequence conflict	conflict	313	314	E	G		notDisRelated								In Ref. 1; CAB66649 and 3; CAG38571.
Q8N1M1	Q8N1M1-2	PRO_0000143121	chain	chain	1	669				noEvidence				Bestrophin-3	VMD2L3	VMD2L3; Vitelliform macular dystrophy 2-like protein 3; 2; 1; 4; 5; 6		
Q8N1M1	Q8N1M1-2		topological domain	topo	1	26				notDisRelated								Cytoplasmic
Q8N1M1	Q8N1M1-2		transmembrane region	transmem	26	47				notDisRelated								Helical
Q8N1M1	Q8N1M1-2		topological domain	topo	47	71				notDisRelated								Extracellular
Q8N1M1	Q8N1M1-2		transmembrane region	transmem	71	92				notDisRelated								Helical
Q8N1M1	Q8N1M1-2		topological domain	topo	92	179				notDisRelated								Cytoplasmic
Q8N1M1	Q8N1M1-2		transmembrane region	transmem	179	200				notDisRelated								Helical
Q8N1M1	Q8N1M1-2		topological domain	topo	200	229				notDisRelated								Extracellular
Q8N1M1	Q8N1M1-2		intramembrane region	intramem	229	250				notDisRelated								
Q8N1M1	Q8N1M1-2		topological domain	topo	250	271				notDisRelated								Extracellular
Q8N1M1	Q8N1M1-2		transmembrane region	transmem	271	292				notDisRelated								Helical
Q8N1M1	Q8N1M1-2		topological domain	topo	292	669				notDisRelated								Cytoplasmic
Q8N1M1	Q8N1M1-2		region of interest	interest	400	455				notDisRelated								Disordered
Q8N1M1	Q8N1M1-2		region of interest	interest	473	494				notDisRelated								Disordered
Q8N1M1	Q8N1M1-2		region of interest	interest	532	571				notDisRelated								Disordered
Q8N1M1	Q8N1M1-2		compositionally biased region	biased	400	417				notDisRelated								Basic and acidic residues
Q8N1M1	Q8N1M1-2		compositionally biased region	biased	532	551				notDisRelated								Polar residues
Q8N1M1	Q8N1M1-2	VSP_046979	splice variant	splicing	1	163				notDisRelated								In isoform 5.
Q8N1M1	Q8N1M1-2	VSP_008981	splice variant	splicing	1	107				notDisRelated			15489334					In isoform 4 and isoform 6.
Q8N1M1	Q8N1M1-2	VSP_008982	splice variant	splicing	161	179	GFMTTDERKLFNHLKSPH	ERTGMKPILPSSFEMQSF		notDisRelated			15489334					In isoform 4.
Q8N1M1	Q8N1M1-2	VSP_008983	splice variant	splicing	179	669				notDisRelated			15489334					In isoform 4.
Q8N1M1	Q8N1M1-2	VSP_046980	splice variant	splicing	239	290				notDisRelated								In isoform 5.
Q8N1M1	Q8N1M1-2	VSP_008977	splice variant	splicing	368	399	LSGSDFPDEEWLWDYEKHGHRHSMIRRVKRF	KQMPKNEWKMEDIKIPLPQPQFQCAKSDPGG		notDisRelated			12032738,12907679					In isoform 1.
Q8N1M1	Q8N1M1-2	VSP_008978	splice variant	splicing	399	669				notDisRelated			12032738,12907679					In isoform 1.
Q8N1M1	Q8N1M1-2	VAR_048409	sequence variant	variant	43	44	Y	H	rs1025016	noEvidence								
Q8N1M1	Q8N1M1-2	VAR_048410	sequence variant	variant	622	623	E	G	rs17106884	noEvidence								
Q9BXI3	Q9BXI3	PRO_0000144795	chain	chain	1	369				noEvidence				Cytosolic 5'-nucleotidase 1A	cN1A	cN1A; cN-I; cN-IA; 5'-deoxynucleotidase; Cytosolic 5'-nucleotidase IA		
Q9BXI3	Q9BXI3		region of interest	interest	1	23				notDisRelated								Disordered
Q9BXI3	Q9BXI3		active site	enzyme act site	211	212				notDisRelated								Nucleophile
Q9BXI3	Q9BXI3		sequence conflict	conflict	9	12				notDisRelated								In Ref. 2; AAK30000.
Q96P26	Q96P26-1	PRO_0000144796	chain	chain	1	611				noEvidence				Cytosolic 5'-nucleotidase 1B	cN1B	cN1B; cN-IB; ORFFKSG85; AIRP; Cytosolic 5'-nucleotidase IB; Autoimmune infertility-related protein; 1; 2; 3; 4; CN-Ib alpha		
Q96P26	Q96P26-1		region of interest	interest	1	35				notDisRelated								Disordered
Q96P26	Q96P26-1		region of interest	interest	101	278				notDisRelated								Disordered
Q96P26	Q96P26-1		compositionally biased region	biased	12	35				notDisRelated								Basic and acidic residues
Q96P26	Q96P26-1		compositionally biased region	biased	101	172				notDisRelated								Polar residues
Q96P26	Q96P26-1		compositionally biased region	biased	172	202				notDisRelated								Pro residues
Q96P26	Q96P26-1		compositionally biased region	biased	231	267				notDisRelated								Polar residues
Q96P26	Q96P26-1		active site	enzyme act site	467	468				notDisRelated								Nucleophile
Q96P26	Q96P26-1	VSP_010202	splice variant	splicing	1	209				notDisRelated			14702039					In isoform 3.
Q96P26	Q96P26-1	VSP_010201	splice variant	splicing	41	101				notDisRelated			15489334					In isoform 2.
Q96P26	Q96P26-1	VSP_010203	splice variant	splicing	596	611	LGSIAAYGFNKKFSS	KSLGWMS		notDisRelated			14702039					In isoform 4.
Q96P26	Q96P26-1		sequence conflict	conflict	173	174	G	R		notDisRelated								In Ref. 2; AAL11910.
Q96P26	Q96P26-1		sequence conflict	conflict	287	288	R	K		notDisRelated								In Ref. 1; AAK39108.
Q96P26	Q96P26-1		sequence conflict	conflict	297	298	S	W		notDisRelated								In Ref. 1; AAK39108.
Q96P26	Q96P26-1		sequence conflict	conflict	351	352	P	Q		notDisRelated								In Ref. 2; AAL11910.
Q96P26	Q96P26-1		sequence conflict	conflict	362	363	V	I		notDisRelated								In Ref. 3; BAC04174.
Q96P26	Q96P26-1		sequence conflict	conflict	528	529	L	P		notDisRelated								In Ref. 8; CAC44363.
Q96P26	Q96P26-1		sequence conflict	conflict	552	553	L	F		notDisRelated								In Ref. 1; AAK39108.
Q9H0P0	Q9H0P0-4	PRO_0000064387	chain	chain	1	337				noEvidence				Cytosolic 5'-nucleotidase 3A	PN-I	PN-I; P5N-1; cN-III; P5'N-1; 7-methylguanosine nucleotidase; ORFHSPC233; P5N1; NT5C3; UMPH1; p36; Cytosolic 5'-nucleotidase 3; Pyrimidine 5'-nucleotidase 1; Cytosolic 5'-nucleotidase III; Uridine 5'-monophosphate hydrolase 1; 7-methylguanosine phosphate-specific 5'-nucleotidase; 2; 1; 3; 4; p36; P5N-I; P5N-R		
Q9H0P0	Q9H0P0-4		active site	enzyme act site	88	89				notDisRelated			17405878					Nucleophile
Q9H0P0	Q9H0P0-4		active site	enzyme act site	90	91				notDisRelated			17405878					Proton donor
Q9H0P0	Q9H0P0-4		binding site	bind	88	89				notDisRelated			17405878					
Q9H0P0	Q9H0P0-4		binding site	bind	90	91				notDisRelated			17405878					
Q9H0P0	Q9H0P0-4		binding site	bind	135	136				notDisRelated								
Q9H0P0	Q9H0P0-4		binding site	bind	135	136				notDisRelated								
Q9H0P0	Q9H0P0-4		binding site	bind	156	157				notDisRelated								
Q9H0P0	Q9H0P0-4		binding site	bind	203	205				notDisRelated			17405878					
Q9H0P0	Q9H0P0-4		binding site	bind	252	253				notDisRelated								
Q9H0P0	Q9H0P0-4		binding site	bind	277	278				notDisRelated			17405878					
Q9H0P0	Q9H0P0-4		modified residue	phos	278	279				notDisRelated								Phosphoserine
Q9H0P0	Q9H0P0-4	VSP_015624	splice variant	splicing	1	52				notDisRelated			15238149					In isoform 4.
Q9H0P0	Q9H0P0-4	VSP_021565	splice variant	splicing	1	51	MRAPSMDRAAVARVGAVASASVCALVAGVVLAQYIFTLKRKTGRKTKIIE	MTNQESAVHVK		notDisRelated			11369620,15489334					In isoform 1.
Q9H0P0	Q9H0P0-4	VSP_015623	splice variant	splicing	1	51				notDisRelated			11369620,14702039					In isoform 3.
Q9H0P0	Q9H0P0-4	VAR_073160	sequence variant	variant	95	96	R	G	rs766577643	disRelated	P5N deficiency	P5ND	25153905					
Q9H0P0	Q9H0P0-4	VAR_073161	sequence variant	variant	113	114	C	R		disRelated	P5N deficiency	P5ND	18499901					reduced catalytic activity especially towards UMP
Q9H0P0	Q9H0P0-4	VAR_023511	sequence variant	variant	137	138	D	V	rs104894025	disRelated	P5N deficiency	P5ND	11369620,15604219					reduced catalytic activity
Q9H0P0	Q9H0P0-4	VAR_023512	sequence variant	variant	181	182	L	P		disRelated	P5N deficiency	P5ND	15238149,15604219,16461318					reduced catalytic activity in vitro; reduced protein stability in vivo, probably through increased proteasomal degradation
Q9H0P0	Q9H0P0-4	VAR_073162	sequence variant	variant	207	208	G	R		disRelated	P5N deficiency	P5ND	16461318,18499901					reduced catalytic activity especially towards UMP
Q9H0P0	Q9H0P0-4	VAR_023513	sequence variant	variant	229	230	N	S	rs104894028	disRelated	P5N deficiency	P5ND	12930399,15604219,15968458					almost complete loss of catalytic activity
Q9H0P0	Q9H0P0-4	VAR_023514	sequence variant	variant	280	281	G	R	rs104894029	disRelated	P5N deficiency	P5ND	15238149,15604219,15968458					greatly reduced catalytic activity
Q9H0P0	Q9H0P0-4	VAR_073163	sequence variant	variant	297	298	I	T		disRelated	P5N deficiency	P5ND	16461318,18499901					
Q9H0P0	Q9H0P0-4		mutagenesis site	mutagen	88	89	D	N		disRelated			15968458					Loss of nucleotidase and phosphotransferase activity.
Q9H0P0	Q9H0P0-4		mutagenesis site	mutagen	89	90	F	A		disRelated			15968458					Almost complete loss of nucleotidase and phosphotransferase activity.
Q9H0P0	Q9H0P0-4		mutagenesis site	mutagen	90	91	D	N		disRelated			15968458					Loss of nucleotidase and phosphotransferase activity.
Q9H0P0	Q9H0P0-4		mutagenesis site	mutagen	135	136	E	D		disRelated			15968458					No effect on nucleotidase activity. Almost complete loss of phosphotransferase activity.
Q9H0P0	Q9H0P0-4		mutagenesis site	mutagen	232	233	D	N		disRelated			15968458					No effect on nucleotidase and phosphotransferase activity.
Q9H0P0	Q9H0P0-4		mutagenesis site	mutagen	233	234	F	A		disRelated			15968458					Almost complete loss of nucleotidase and phosphotransferase activity.
Q9H0P0	Q9H0P0-4		mutagenesis site	mutagen	234	235	D	N		disRelated			15968458					No effect on nucleotidase and phosphotransferase activity.
Q9H0P0	Q9H0P0-4		sequence conflict	conflict	95	96	R	K		notDisRelated								In Ref. 10; AA sequence.
Q9H0P0	Q9H0P0-4		sequence conflict	conflict	144	145	E	Q		notDisRelated								In Ref. 10; AA sequence.
Q9H0P0	Q9H0P0-4		sequence conflict	conflict	329	330	N	R		notDisRelated								In Ref. 10; AA sequence.
Q9H0P0	Q9H0P0-4		helix	helix	65	79				notDisRelated								
Q9H0P0	Q9H0P0-4		helix	helix	80	83				notDisRelated								
Q9H0P0	Q9H0P0-4		strand	beta	83	88				notDisRelated								
Q9H0P0	Q9H0P0-4		turn	turn	90	93				notDisRelated								
Q9H0P0	Q9H0P0-4		strand	beta	96	99				notDisRelated								
Q9H0P0	Q9H0P0-4		helix	helix	106	112				notDisRelated								
Q9H0P0	Q9H0P0-4		helix	helix	118	136				notDisRelated								
Q9H0P0	Q9H0P0-4		strand	beta	138	141				notDisRelated								
Q9H0P0	Q9H0P0-4		helix	helix	142	164				notDisRelated								
Q9H0P0	Q9H0P0-4		helix	helix	167	170				notDisRelated								
Q9H0P0	Q9H0P0-4		helix	helix	170	176				notDisRelated								
Q9H0P0	Q9H0P0-4		helix	helix	185	195				notDisRelated								
Q9H0P0	Q9H0P0-4		strand	beta	199	207				notDisRelated								
Q9H0P0	Q9H0P0-4		helix	helix	207	217				notDisRelated								
Q9H0P0	Q9H0P0-4		strand	beta	224	230				notDisRelated								
Q9H0P0	Q9H0P0-4		strand	beta	231	234				notDisRelated								
Q9H0P0	Q9H0P0-4		strand	beta	237	243				notDisRelated								
Q9H0P0	Q9H0P0-4		helix	helix	252	259				notDisRelated								
Q9H0P0	Q9H0P0-4		helix	helix	260	265				notDisRelated								
Q9H0P0	Q9H0P0-4		turn	turn	265	269				notDisRelated								
Q9H0P0	Q9H0P0-4		strand	beta	271	280				notDisRelated								
Q9H0P0	Q9H0P0-4		helix	helix	280	284				notDisRelated								
Q9H0P0	Q9H0P0-4		turn	turn	284	288				notDisRelated								
Q9H0P0	Q9H0P0-4		strand	beta	292	301				notDisRelated								
Q9H0P0	Q9H0P0-4		helix	helix	304	313				notDisRelated								
Q9H0P0	Q9H0P0-4		strand	beta	315	321				notDisRelated								
Q9H0P0	Q9H0P0-4		helix	helix	326	336				notDisRelated								
O95336	O95336		initiator methionine	init Met	1	2				notDisRelated								Removed
O95336	O95336	PRO_0000090078	chain	chain	2	259				noEvidence				6-phosphogluconolactonase	6PGL	6PGL		
O95336	O95336		modified residue	acetyl	2	3				notDisRelated								N-acetylalanine
O95336	O95336		modified residue	phos	49	50				notDisRelated								Phosphoserine
O95336	O95336		modified residue	acetyl	180	181				notDisRelated								N6-acetyllysine
Q969T7	Q969T7-1	PRO_0000328948	chain	chain	1	301				noEvidence				7-methylguanosine phosphate-specific 5'-nucleotidase	7-methylguanosine nucleotidase	7-methylguanosine nucleotidase; cN-III-like protein; NT5C3L; Cytosolic 5'-nucleotidase 3B; N(7)-methylguanylate 5'-phosphatase; Cytosolic 5'-nucleotidase III-like protein; 1; 2		
Q969T7	Q969T7-1		active site	enzyme act site	41	42				notDisRelated								Nucleophile
Q969T7	Q969T7-1		active site	enzyme act site	43	44				notDisRelated								Proton donor
Q969T7	Q969T7-1		binding site	bind	41	42				notDisRelated								
Q969T7	Q969T7-1		binding site	bind	43	44				notDisRelated								
Q969T7	Q969T7-1		binding site	bind	88	89				notDisRelated								
Q969T7	Q969T7-1		binding site	bind	88	89				notDisRelated								
Q969T7	Q969T7-1		binding site	bind	156	158				notDisRelated								
Q969T7	Q969T7-1		binding site	bind	205	206				notDisRelated								
Q969T7	Q969T7-1		binding site	bind	230	231				notDisRelated								
Q969T7	Q969T7-1		modified residue	acetyl	256	257				notDisRelated								N6-acetyllysine
Q969T7	Q969T7-1	VSP_046297	splice variant	splicing	1	9				notDisRelated			15489334					In isoform 2.
Q969T7	Q969T7-1	VAR_042582	sequence variant	variant	209	210	A	V	rs1046403	notDisRelated			15489334					
Q969T7	Q969T7-1	VAR_042583	sequence variant	variant	213	214	S	C	rs1046404	notDisRelated			15489334					
Q969T7	Q969T7-1		helix	helix	1	4				notDisRelated								
Q969T7	Q969T7-1		helix	helix	7	10				notDisRelated								
Q969T7	Q969T7-1		helix	helix	18	32				notDisRelated								
Q969T7	Q969T7-1		helix	helix	33	36				notDisRelated								
Q969T7	Q969T7-1		strand	beta	36	42				notDisRelated								
Q969T7	Q969T7-1		helix	helix	42	47				notDisRelated								
Q969T7	Q969T7-1		strand	beta	49	52				notDisRelated								
Q969T7	Q969T7-1		helix	helix	59	62				notDisRelated								
Q969T7	Q969T7-1		turn	turn	62	66				notDisRelated								
Q969T7	Q969T7-1		helix	helix	71	89				notDisRelated								
Q969T7	Q969T7-1		helix	helix	95	115				notDisRelated								
Q969T7	Q969T7-1		helix	helix	121	130				notDisRelated								
Q969T7	Q969T7-1		helix	helix	138	148				notDisRelated								
Q969T7	Q969T7-1		strand	beta	152	160				notDisRelated								
Q969T7	Q969T7-1		helix	helix	160	170				notDisRelated								
Q969T7	Q969T7-1		strand	beta	177	187				notDisRelated								
Q969T7	Q969T7-1		strand	beta	190	198				notDisRelated								
Q969T7	Q969T7-1		helix	helix	207	210				notDisRelated								
Q969T7	Q969T7-1		strand	beta	224	233				notDisRelated								
Q969T7	Q969T7-1		helix	helix	233	237				notDisRelated								
Q969T7	Q969T7-1		turn	turn	237	241				notDisRelated								
Q969T7	Q969T7-1		strand	beta	246	254				notDisRelated								
Q969T7	Q969T7-1		helix	helix	257	268				notDisRelated								
Q969T7	Q969T7-1		strand	beta	269	275				notDisRelated								
Q969T7	Q969T7-1		helix	helix	279	290				notDisRelated								
A8K2U0	A8K2U0-1		signal peptide	signal pep	1	18				notDisRelated								
A8K2U0	A8K2U0-1	PRO_0000318074	chain	chain	18	1455				notDisRelated				Alpha-2-macroglobulin-like protein 1	CPAMD9	CPAMD9; C3 and PZP-like alpha-2-macroglobulin domain-containing protein 9; 1; 2		
A8K2U0	A8K2U0-1		region of interest	interest	695	727				notDisRelated								Bait region
A8K2U0	A8K2U0-1		glycosylation site	glyco	120	121				notDisRelated								N-linked (GlcNAc...) asparagine
A8K2U0	A8K2U0-1		glycosylation site	glyco	281	282				notDisRelated								N-linked (GlcNAc...) asparagine
A8K2U0	A8K2U0-1		glycosylation site	glyco	409	410				notDisRelated								N-linked (GlcNAc...) asparagine
A8K2U0	A8K2U0-1		glycosylation site	glyco	857	858				notDisRelated								N-linked (GlcNAc...) asparagine
A8K2U0	A8K2U0-1		glycosylation site	glyco	1020	1021				notDisRelated								N-linked (GlcNAc...) asparagine
A8K2U0	A8K2U0-1		disulfide bond	disulf bond	40	79				notDisRelated								
A8K2U0	A8K2U0-1		disulfide bond	disulf bond	241	292				notDisRelated								
A8K2U0	A8K2U0-1		disulfide bond	disulf bond	259	280				notDisRelated								
A8K2U0	A8K2U0-1		disulfide bond	disulf bond	464	558				notDisRelated								
A8K2U0	A8K2U0-1		disulfide bond	disulf bond	589	770				notDisRelated								
A8K2U0	A8K2U0-1		disulfide bond	disulf bond	819	848				notDisRelated								
A8K2U0	A8K2U0-1		disulfide bond	disulf bond	845	882				notDisRelated								
A8K2U0	A8K2U0-1		disulfide bond	disulf bond	919	1308				notDisRelated								
A8K2U0	A8K2U0-1		disulfide bond	disulf bond	1075	1124				notDisRelated								
A8K2U0	A8K2U0-1		disulfide bond	disulf bond	1338	1454				notDisRelated								
A8K2U0	A8K2U0-1		cross-link	cross-link	970	974				notDisRelated								Isoglutamyl cysteine thioester (Cys-Gln
A8K2U0	A8K2U0-1	VSP_057135	splice variant	splicing	2	493				notDisRelated			14702039					In isoform 2.
A8K2U0	A8K2U0-1	VAR_055463	sequence variant	variant	207	208	G	R	rs11047499	noEvidence								
A8K2U0	A8K2U0-1	VAR_081009	sequence variant	variant	255	1455				disRelated			26121085					Risk factor for otitis media
A8K2U0	A8K2U0-1	VAR_081010	sequence variant	variant	296	297	V	A	rs192888493	disRelated			26121085					
A8K2U0	A8K2U0-1	VAR_081011	sequence variant	variant	356	357	P	R	rs863224953	disRelated			26121085					May be a risk factor for otitis media
A8K2U0	A8K2U0-1	VAR_059083	sequence variant	variant	850	851	D	E	rs1860926	notDisRelated			14702039,17974005					
A8K2U0	A8K2U0-1	VAR_081012	sequence variant	variant	893	1455				disRelated			26121085					Risk factor for otitis media
A8K2U0	A8K2U0-1	VAR_055464	sequence variant	variant	970	971	C	Y	rs1558526	noEvidence								
A8K2U0	A8K2U0-1	VAR_081013	sequence variant	variant	972	1455				disRelated			26121085					Risk factor for otitis media
A8K2U0	A8K2U0-1	VAR_081014	sequence variant	variant	1001	1002	R	W	rs201725377	disRelated			26121085					May be a risk factor for otitis media
A8K2U0	A8K2U0-1	VAR_071854	sequence variant	variant	1122	1123	R	W	rs1860967	notDisRelated			14702039,17974005					
A8K2U0	A8K2U0-1	VAR_055465	sequence variant	variant	1131	1132	T	M	rs7959680	noEvidence								
A8K2U0	A8K2U0-1	VAR_059084	sequence variant	variant	1229	1230	H	R	rs10219561	notDisRelated			14702039,17974005					
A8K2U0	A8K2U0-1	VAR_071855	sequence variant	variant	1257	1258	M	V	rs7308811	notDisRelated			14702039,17974005					
A8K2U0	A8K2U0-1	VAR_071856	sequence variant	variant	1312	1313	T	M	rs201083574	notDisRelated			14702039					
A8K2U0	A8K2U0-1	VAR_055466	sequence variant	variant	1412	1413	T	A	rs7315591	noEvidence								
A8K2U0	A8K2U0-1	VAR_081015	sequence variant	variant	1431	1432	A	V	rs863224955	disRelated			26121085					
A8K2U0	A8K2U0-1		sequence conflict	conflict	733	734	F	L		notDisRelated								In Ref. 1; BAC85654/BAF83044.
A8K2U0	A8K2U0-1		sequence conflict	conflict	748	749	G	E		notDisRelated								In Ref. 2; AL832139.
A8K2U0	A8K2U0-1		sequence conflict	conflict	1150	1151	M	I		notDisRelated								In Ref. 1; BAF83044.
A8K2U0	A8K2U0-1		sequence conflict	conflict	1248	1249	L	P		notDisRelated								In Ref. 1; BAC85654.
A8K2U0	A8K2U0-1		sequence conflict	conflict	1452	1453	P	L		notDisRelated								In Ref. 2; AL832139.
A8K2U0	A8K2U0-1		strand	beta	24	33				notDisRelated								
A8K2U0	A8K2U0-1		strand	beta	35	43				notDisRelated								
A8K2U0	A8K2U0-1		strand	beta	51	58				notDisRelated								
A8K2U0	A8K2U0-1		strand	beta	62	70				notDisRelated								
A8K2U0	A8K2U0-1		strand	beta	76	83				notDisRelated								
A8K2U0	A8K2U0-1		strand	beta	87	103				notDisRelated								
A8K2U0	A8K2U0-1		strand	beta	105	117				notDisRelated								
A8K2U0	A8K2U0-1		strand	beta	121	128				notDisRelated								
A8K2U0	A8K2U0-1		strand	beta	129	132				notDisRelated								
A8K2U0	A8K2U0-1		strand	beta	136	145				notDisRelated								
A8K2U0	A8K2U0-1		strand	beta	155	162				notDisRelated								
A8K2U0	A8K2U0-1		strand	beta	167	175				notDisRelated								
A8K2U0	A8K2U0-1		strand	beta	180	187				notDisRelated								
A8K2U0	A8K2U0-1		strand	beta	194	201				notDisRelated								
A8K2U0	A8K2U0-1		turn	turn	201	205				notDisRelated								
A8K2U0	A8K2U0-1		strand	beta	205	212				notDisRelated								
A8K2U0	A8K2U0-1		strand	beta	219	224				notDisRelated								
A8K2U0	A8K2U0-1		strand	beta	227	233				notDisRelated								
A8K2U0	A8K2U0-1		strand	beta	234	245				notDisRelated								
A8K2U0	A8K2U0-1		strand	beta	252	263				notDisRelated								
A8K2U0	A8K2U0-1		strand	beta	269	272				notDisRelated								
A8K2U0	A8K2U0-1		strand	beta	278	286				notDisRelated								
A8K2U0	A8K2U0-1		strand	beta	291	298				notDisRelated								
A8K2U0	A8K2U0-1		helix	helix	298	301				notDisRelated								
A8K2U0	A8K2U0-1		strand	beta	306	321				notDisRelated								
A8K2U0	A8K2U0-1		turn	turn	321	324				notDisRelated								
A8K2U0	A8K2U0-1		strand	beta	326	337				notDisRelated								
A8K2U0	A8K2U0-1		strand	beta	338	348				notDisRelated								
A8K2U0	A8K2U0-1		strand	beta	349	352				notDisRelated								
A8K2U0	A8K2U0-1		strand	beta	357	365				notDisRelated								
A8K2U0	A8K2U0-1		strand	beta	366	369				notDisRelated								
A8K2U0	A8K2U0-1		strand	beta	375	383				notDisRelated								
A8K2U0	A8K2U0-1		strand	beta	388	393				notDisRelated								
A8K2U0	A8K2U0-1		strand	beta	398	404				notDisRelated								
A8K2U0	A8K2U0-1		strand	beta	406	409				notDisRelated								
A8K2U0	A8K2U0-1		strand	beta	413	420				notDisRelated								
A8K2U0	A8K2U0-1		strand	beta	428	431				notDisRelated								
A8K2U0	A8K2U0-1		strand	beta	434	437				notDisRelated								
A8K2U0	A8K2U0-1		strand	beta	438	445				notDisRelated								
A8K2U0	A8K2U0-1		strand	beta	448	451				notDisRelated								
A8K2U0	A8K2U0-1		strand	beta	452	456				notDisRelated								
A8K2U0	A8K2U0-1		strand	beta	466	476				notDisRelated								
A8K2U0	A8K2U0-1		turn	turn	479	482				notDisRelated								
A8K2U0	A8K2U0-1		strand	beta	483	486				notDisRelated								
A8K2U0	A8K2U0-1		strand	beta	487	496				notDisRelated								
A8K2U0	A8K2U0-1		strand	beta	498	508				notDisRelated								
A8K2U0	A8K2U0-1		helix	helix	509	512				notDisRelated								
A8K2U0	A8K2U0-1		strand	beta	516	524				notDisRelated								
A8K2U0	A8K2U0-1		strand	beta	526	529				notDisRelated								
A8K2U0	A8K2U0-1		strand	beta	533	540				notDisRelated								
A8K2U0	A8K2U0-1		strand	beta	541	544				notDisRelated								
A8K2U0	A8K2U0-1		strand	beta	545	552				notDisRelated								
A8K2U0	A8K2U0-1		strand	beta	563	572				notDisRelated								
A8K2U0	A8K2U0-1		strand	beta	575	583				notDisRelated								
A8K2U0	A8K2U0-1		strand	beta	588	596				notDisRelated								
A8K2U0	A8K2U0-1		helix	helix	596	602				notDisRelated								
A8K2U0	A8K2U0-1		strand	beta	603	607				notDisRelated								
A8K2U0	A8K2U0-1		helix	helix	609	615				notDisRelated								
A8K2U0	A8K2U0-1		strand	beta	625	628				notDisRelated								
A8K2U0	A8K2U0-1		helix	helix	671	677				notDisRelated								
A8K2U0	A8K2U0-1		turn	turn	677	680				notDisRelated								
A8K2U0	A8K2U0-1		strand	beta	680	688				notDisRelated								
A8K2U0	A8K2U0-1		strand	beta	735	744				notDisRelated								
A8K2U0	A8K2U0-1		strand	beta	748	756				notDisRelated								
A8K2U0	A8K2U0-1		strand	beta	760	772				notDisRelated								
A8K2U0	A8K2U0-1		turn	turn	772	775				notDisRelated								
A8K2U0	A8K2U0-1		strand	beta	775	779				notDisRelated								
A8K2U0	A8K2U0-1		strand	beta	782	787				notDisRelated								
A8K2U0	A8K2U0-1		strand	beta	789	796				notDisRelated								
A8K2U0	A8K2U0-1		strand	beta	798	802				notDisRelated								
A8K2U0	A8K2U0-1		strand	beta	804	815				notDisRelated								
A8K2U0	A8K2U0-1		strand	beta	816	819				notDisRelated								
A8K2U0	A8K2U0-1		strand	beta	820	827				notDisRelated								
A8K2U0	A8K2U0-1		strand	beta	832	835				notDisRelated								
A8K2U0	A8K2U0-1		helix	helix	838	841				notDisRelated								
A8K2U0	A8K2U0-1		strand	beta	841	847				notDisRelated								
A8K2U0	A8K2U0-1		strand	beta	850	861				notDisRelated								
A8K2U0	A8K2U0-1		strand	beta	864	875				notDisRelated								
A8K2U0	A8K2U0-1		helix	helix	881	884				notDisRelated								
A8K2U0	A8K2U0-1		strand	beta	890	893				notDisRelated								
A8K2U0	A8K2U0-1		strand	beta	894	905				notDisRelated								
A8K2U0	A8K2U0-1		strand	beta	906	919				notDisRelated								
A8K2U0	A8K2U0-1		strand	beta	921	931				notDisRelated								
A8K2U0	A8K2U0-1		strand	beta	943	954				notDisRelated								
A8K2U0	A8K2U0-1		turn	turn	956	964				notDisRelated								
A8K2U0	A8K2U0-1		helix	helix	971	974				notDisRelated								
A8K2U0	A8K2U0-1		helix	helix	975	990				notDisRelated								
A8K2U0	A8K2U0-1		turn	turn	990	993				notDisRelated								
A8K2U0	A8K2U0-1		helix	helix	996	1011				notDisRelated								
A8K2U0	A8K2U0-1		helix	helix	1011	1014				notDisRelated								
A8K2U0	A8K2U0-1		helix	helix	1014	1017				notDisRelated								
A8K2U0	A8K2U0-1		strand	beta	1021	1024				notDisRelated								
A8K2U0	A8K2U0-1		strand	beta	1025	1029				notDisRelated								
A8K2U0	A8K2U0-1		strand	beta	1030	1033				notDisRelated								
A8K2U0	A8K2U0-1		helix	helix	1035	1046				notDisRelated								
A8K2U0	A8K2U0-1		helix	helix	1048	1051				notDisRelated								
A8K2U0	A8K2U0-1		helix	helix	1057	1070				notDisRelated								
A8K2U0	A8K2U0-1		strand	beta	1072	1076				notDisRelated								
A8K2U0	A8K2U0-1		strand	beta	1079	1082				notDisRelated								
A8K2U0	A8K2U0-1		strand	beta	1083	1087				notDisRelated								
A8K2U0	A8K2U0-1		turn	turn	1087	1090				notDisRelated								
A8K2U0	A8K2U0-1		helix	helix	1094	1106				notDisRelated								
A8K2U0	A8K2U0-1		strand	beta	1106	1110				notDisRelated								
A8K2U0	A8K2U0-1		helix	helix	1115	1125				notDisRelated								
A8K2U0	A8K2U0-1		helix	helix	1127	1131				notDisRelated								
A8K2U0	A8K2U0-1		helix	helix	1135	1144				notDisRelated								
A8K2U0	A8K2U0-1		turn	turn	1144	1149				notDisRelated								
A8K2U0	A8K2U0-1		strand	beta	1150	1155				notDisRelated								
A8K2U0	A8K2U0-1		turn	turn	1155	1161				notDisRelated								
A8K2U0	A8K2U0-1		strand	beta	1163	1168				notDisRelated								
A8K2U0	A8K2U0-1		strand	beta	1170	1174				notDisRelated								
A8K2U0	A8K2U0-1		helix	helix	1192	1205				notDisRelated								
A8K2U0	A8K2U0-1		strand	beta	1205	1209				notDisRelated								
A8K2U0	A8K2U0-1		helix	helix	1212	1226				notDisRelated								
A8K2U0	A8K2U0-1		strand	beta	1230	1235				notDisRelated								
A8K2U0	A8K2U0-1		strand	beta	1236	1240				notDisRelated								
A8K2U0	A8K2U0-1		helix	helix	1240	1255				notDisRelated								
A8K2U0	A8K2U0-1		strand	beta	1260	1269				notDisRelated								
A8K2U0	A8K2U0-1		strand	beta	1269	1272				notDisRelated								
A8K2U0	A8K2U0-1		strand	beta	1274	1279				notDisRelated								
A8K2U0	A8K2U0-1		strand	beta	1280	1283				notDisRelated								
A8K2U0	A8K2U0-1		strand	beta	1287	1291				notDisRelated								
A8K2U0	A8K2U0-1		strand	beta	1295	1307				notDisRelated								
A8K2U0	A8K2U0-1		strand	beta	1308	1319				notDisRelated								
A8K2U0	A8K2U0-1		strand	beta	1325	1333				notDisRelated								
A8K2U0	A8K2U0-1		strand	beta	1338	1341				notDisRelated								
A8K2U0	A8K2U0-1		strand	beta	1347	1356				notDisRelated								
A8K2U0	A8K2U0-1		strand	beta	1357	1362				notDisRelated								
A8K2U0	A8K2U0-1		strand	beta	1365	1371				notDisRelated								
A8K2U0	A8K2U0-1		turn	turn	1378	1381				notDisRelated								
A8K2U0	A8K2U0-1		helix	helix	1381	1387				notDisRelated								
A8K2U0	A8K2U0-1		strand	beta	1393	1397				notDisRelated								
A8K2U0	A8K2U0-1		strand	beta	1398	1407				notDisRelated								
A8K2U0	A8K2U0-1		strand	beta	1413	1424				notDisRelated								
A8K2U0	A8K2U0-1		strand	beta	1425	1428				notDisRelated								
A8K2U0	A8K2U0-1		strand	beta	1431	1440				notDisRelated								
A8K2U0	A8K2U0-1		strand	beta	1443	1450				notDisRelated								
P11137	P11137-1	PRO_0000072747	chain	chain	1	1828				noEvidence				Microtubule-associated protein 2	MAP-2	MAP-2; 1; 2; 3; 4; MAP2b; MAP2c		
P11137	P11137-1		repeat	repeat	1661	1692				noEvidence								Tau/MAP 1
P11137	P11137-1		repeat	repeat	1692	1723				noEvidence								Tau/MAP 2
P11137	P11137-1		repeat	repeat	1723	1755				noEvidence								Tau/MAP 3
P11137	P11137-1		region of interest	interest	1	89				notDisRelated								Disordered
P11137	P11137-1		region of interest	interest	109	222				notDisRelated								Disordered
P11137	P11137-1		region of interest	interest	340	498				notDisRelated								Disordered
P11137	P11137-1		region of interest	interest	579	661				notDisRelated								Disordered
P11137	P11137-1		region of interest	interest	701	745				notDisRelated								Interaction with KNDC1
P11137	P11137-1		region of interest	interest	931	989				notDisRelated								Disordered
P11137	P11137-1		region of interest	interest	1073	1161				notDisRelated								Disordered
P11137	P11137-1		region of interest	interest	1197	1217				notDisRelated								Disordered
P11137	P11137-1		region of interest	interest	1297	1379				notDisRelated								Disordered
P11137	P11137-1		region of interest	interest	1403	1461				notDisRelated								Disordered
P11137	P11137-1		region of interest	interest	1447	1468				notDisRelated								Calmodulin-binding
P11137	P11137-1		region of interest	interest	1471	1491				notDisRelated								Disordered
P11137	P11137-1		region of interest	interest	1506	1639				notDisRelated								Disordered
P11137	P11137-1		region of interest	interest	1779	1802				notDisRelated								Disordered
P11137	P11137-1		compositionally biased region	biased	62	81				notDisRelated								Polar residues
P11137	P11137-1		compositionally biased region	biased	173	192				notDisRelated								Basic and acidic residues
P11137	P11137-1		compositionally biased region	biased	365	381				notDisRelated								Basic and acidic residues
P11137	P11137-1		compositionally biased region	biased	395	419				notDisRelated								Basic and acidic residues
P11137	P11137-1		compositionally biased region	biased	419	435				notDisRelated								Polar residues
P11137	P11137-1		compositionally biased region	biased	436	467				notDisRelated								Basic and acidic residues
P11137	P11137-1		compositionally biased region	biased	579	622				notDisRelated								Basic and acidic residues
P11137	P11137-1		compositionally biased region	biased	622	651				notDisRelated								Polar residues
P11137	P11137-1		compositionally biased region	biased	931	987				notDisRelated								Basic and acidic residues
P11137	P11137-1		compositionally biased region	biased	1100	1159				notDisRelated								Basic and acidic residues
P11137	P11137-1		compositionally biased region	biased	1314	1330				notDisRelated								Basic and acidic residues
P11137	P11137-1		compositionally biased region	biased	1349	1379				notDisRelated								Basic and acidic residues
P11137	P11137-1		compositionally biased region	biased	1559	1577				notDisRelated								Polar residues
P11137	P11137-1		compositionally biased region	biased	1583	1619				notDisRelated								Polar residues
P11137	P11137-1		compositionally biased region	biased	1780	1802				notDisRelated								Polar residues
P11137	P11137-1		modified residue	phos	136	137				notDisRelated								Phosphoserine
P11137	P11137-1		modified residue	phos	140	141				notDisRelated								Phosphoserine
P11137	P11137-1		modified residue	phos	143	144				notDisRelated								Phosphoserine
P11137	P11137-1		modified residue	phos	285	286				notDisRelated								Phosphoserine
P11137	P11137-1		modified residue	phos	498	499				notDisRelated								Phosphoserine
P11137	P11137-1		modified residue	phos	601	602				notDisRelated								Phosphoserine
P11137	P11137-1		modified residue	phos	605	606				notDisRelated								Phosphoserine
P11137	P11137-1		modified residue	phos	610	611				notDisRelated								Phosphoserine
P11137	P11137-1		modified residue	phos	629	630				notDisRelated								Phosphoserine
P11137	P11137-1		modified residue	phos	725	726				notDisRelated								Phosphoserine
P11137	P11137-1		modified residue	phos	729	730				notDisRelated								Phosphoserine
P11137	P11137-1		modified residue	phos	733	734				notDisRelated								Phosphothreonine
P11137	P11137-1		modified residue	phos	736	737				notDisRelated								Phosphoserine
P11137	P11137-1		modified residue	phos	738	739				notDisRelated								Phosphoserine
P11137	P11137-1		modified residue	phos	745	746				notDisRelated								Phosphotyrosine
P11137	P11137-1		modified residue	phos	821	822				notDisRelated								Phosphoserine
P11137	P11137-1		modified residue	phos	881	882				notDisRelated								Phosphoserine
P11137	P11137-1		modified residue	phos	890	891				notDisRelated								Phosphoserine
P11137	P11137-1		modified residue	phos	936	937				notDisRelated								Phosphoserine
P11137	P11137-1		modified residue	phos	1133	1134				notDisRelated								Phosphoserine
P11137	P11137-1		modified residue	phos	1134	1135				notDisRelated								Phosphoserine
P11137	P11137-1		modified residue	phos	1139	1140				notDisRelated								Phosphoserine
P11137	P11137-1		modified residue	phos	1154	1155				notDisRelated								Phosphothreonine
P11137	P11137-1		modified residue	phos	1155	1156				notDisRelated								Phosphoserine
P11137	P11137-1		modified residue	phos	1159	1160				notDisRelated								Phosphoserine
P11137	P11137-1		modified residue	phos	1347	1348				notDisRelated								Phosphoserine
P11137	P11137-1		modified residue	phos	1353	1354				notDisRelated								Phosphoserine
P11137	P11137-1		modified residue	phos	1534	1535				notDisRelated								Phosphoserine
P11137	P11137-1		modified residue	phos	1555	1556				notDisRelated								Phosphoserine
P11137	P11137-1		modified residue	phos	1588	1589				notDisRelated								Phosphoserine
P11137	P11137-1		modified residue	phos	1602	1603				notDisRelated								Phosphothreonine
P11137	P11137-1		modified residue	phos	1605	1606				notDisRelated								Phosphothreonine
P11137	P11137-1		modified residue	phos	1616	1617				notDisRelated								Phosphothreonine
P11137	P11137-1		modified residue	phos	1619	1620				notDisRelated								Phosphothreonine
P11137	P11137-1		modified residue	phos	1649	1650				notDisRelated								Phosphothreonine
P11137	P11137-1		modified residue	phos	1653	1654				notDisRelated								Phosphoserine
P11137	P11137-1		modified residue	phos	1679	1680				notDisRelated								Phosphoserine; by MARK1
P11137	P11137-1		modified residue	phos	1782	1783				notDisRelated								Phosphoserine
P11137	P11137-1		modified residue	phos	1787	1788				notDisRelated								Phosphoserine
P11137	P11137-1		modified residue	phos	1790	1791				notDisRelated								Phosphoserine
P11137	P11137-1		modified residue	phos	1795	1796				notDisRelated								Phosphoserine
P11137	P11137-1		modified residue	phos	1808	1809				notDisRelated								Phosphoserine
P11137	P11137-1	VSP_003197	splice variant	splicing	152	1508				notDisRelated			15489334,8294038					In isoform 2.
P11137	P11137-1	VSP_043596	splice variant	splicing	152	230	DLLTASKMEFHDQQELTPSTAEPSDQKEKESEKQSKPGEDLKHAALVSQPETTKTYPDKKDMQGTEEEKAPLALFGHT	AAGGESALAPSVFKQAKDKVSNSTLSKIPALQGSTKSPRYSSACPSTTKRATFSDSLLIQPTSAGSTDRLPYSKSGNK		notDisRelated			15489334					In isoform 4.
P11137	P11137-1	VSP_011302	splice variant	splicing	152	156				notDisRelated			8294038					In isoform 3.
P11137	P11137-1	VSP_043597	splice variant	splicing	230	1529				notDisRelated			15489334					In isoform 4.
P11137	P11137-1	VSP_043598	splice variant	splicing	1691	1692	Q	QVRILNKKIDFSKVQSRCGSKDNIKHSAGGGN		notDisRelated			15489334					In isoform 4.
P11137	P11137-1	VAR_019612	sequence variant	variant	82	83	A	G	rs2271251	noEvidence								
P11137	P11137-1	VAR_050019	sequence variant	variant	179	180	E	G	rs6749066	noEvidence								
P11137	P11137-1	VAR_036014	sequence variant	variant	277	278	E	D		notDisRelated	a colorectal cancer sample	a colorectal cancer sample	16959974					somatic mutation
P11137	P11137-1	VAR_019613	sequence variant	variant	423	424	R	K	rs741006	noEvidence								
P11137	P11137-1	VAR_036015	sequence variant	variant	705	706	P	L	rs146432517	notDisRelated	a colorectal cancer sample	a colorectal cancer sample	16959974					somatic mutation
P11137	P11137-1	VAR_050020	sequence variant	variant	976	977	H	L	rs13425372	noEvidence								
P11137	P11137-1	VAR_050021	sequence variant	variant	991	992	G	R	rs35927101	noEvidence								
P11137	P11137-1	VAR_050022	sequence variant	variant	1099	1100	M	V	rs17745550	noEvidence								
P11137	P11137-1		sequence conflict	conflict	9	10	A	G		notDisRelated								In Ref. 2; AAB48098/AAB48097.
P11137	P11137-1		sequence conflict	conflict	37	38	A	R		notDisRelated								In Ref. 1; AAA03354.
P11137	P11137-1		sequence conflict	conflict	108	109	G	A		notDisRelated								In Ref. 1; AAA03354.
P11137	P11137-1		sequence conflict	conflict	187	188	K	S		notDisRelated								In Ref. 1; AAA03354.
P11137	P11137-1		sequence conflict	conflict	1112	1113	E	Q		notDisRelated								In Ref. 1; AAA03354, 2; AAB48098 and 5; AAA59552.
P11137	P11137-1		sequence conflict	conflict	1655	1656	A	GL		notDisRelated								In Ref. 2; AAB48098/AAB48097.
P11137	P11137-1		sequence conflict	conflict	1715	1717	RH	D		notDisRelated								In Ref. 1; AAA03354.
P11137	P11137-1		sequence conflict	conflict	1736	1737	A	V		notDisRelated								In Ref. 1; AAA03354.
P11137	P11137-1		modified residue	phos	67	68				notDisRelated			15536091					Phosphotyrosine
P11137	P11137-1		modified residue	phos	323	324				notDisRelated								Phosphoserine
P11137	P11137-1		modified residue	phos	354	355				notDisRelated								Phosphoserine
P11137	P11137-1		modified residue	phos	386	387				notDisRelated								Phosphoserine
P51809	P51809-1		initiator methionine	init Met	1	2				notDisRelated								Removed
P51809	P51809-1	PRO_0000206761	chain	chain	2	221				noEvidence				Vesicle-associated membrane protein 7	VAMP-7	VAMP-7; Ti-VAMP; SYBL1; Tetanus-insensitive VAMP; Synaptobrevin-like protein 1; 1; 2; 3; Ti-VAMPa/VAMP7a; Ti-VAMPb/VAMP7b; Ti-VAMPc/VAMP7c		
P51809	P51809-1		topological domain	topo	2	189				notDisRelated								Cytoplasmic
P51809	P51809-1		transmembrane region	transmem	189	210				notDisRelated								Helical; Anchor for type IV membrane protein
P51809	P51809-1		topological domain	topo	210	221				notDisRelated								Vesicular
P51809	P51809-1		domain	domain	7	111				notDisRelated								Longin
P51809	P51809-1		domain	domain	125	186				notDisRelated								v-SNARE coiled-coil homology
P51809	P51809-1		modified residue	acetyl	2	3				notDisRelated								N-acetylalanine; partial
P51809	P51809-1		modified residue	phos	167	168				notDisRelated								Phosphoserine
P51809	P51809-1		modified residue	phos	168	169				notDisRelated								Phosphoserine
P51809	P51809-1	VSP_017508	splice variant	splicing	28	69				notDisRelated			12853575					In isoform 3.
P51809	P51809-1	VSP_017509	splice variant	splicing	145	221	DLVAQRGERLELLIDKTENLVDSSVTFKTTSRNLARAMCMKNLKLTIIIIIVSIVFIYIIVSPLCGGFTWPSCVKK	VCHLQNYQQKSCSSHVYEEPQAHYYHHHRINCVHLYHCFTSLWWIYMAKLCEEIGKKKLPLTKDMREQGVKSNPCDSSLSHTDRWYLPVSSTLFSLFKILFHASRFIFVLSTSLFL		notDisRelated								In isoform 2.
P51809	P51809-1		sequence conflict	conflict	98	99	L	P		notDisRelated								In Ref. 5; BAD96514.
P51809	P51809-1		strand	beta	5	11				notDisRelated								
P51809	P51809-1		strand	beta	13	20				notDisRelated								
P51809	P51809-1		strand	beta	21	24				notDisRelated								
P51809	P51809-1		helix	helix	26	34				notDisRelated								
P51809	P51809-1		strand	beta	38	41				notDisRelated								
P51809	P51809-1		strand	beta	42	48				notDisRelated								
P51809	P51809-1		strand	beta	50	58				notDisRelated								
P51809	P51809-1		strand	beta	60	71				notDisRelated								
P51809	P51809-1		helix	helix	72	90				notDisRelated								
P51809	P51809-1		helix	helix	91	96				notDisRelated								
P51809	P51809-1		helix	helix	103	118				notDisRelated								
P29274	P29274	PRO_0000068999	chain	chain	1	413				noEvidence				Adenosine receptor A2a	ADORA2	ADORA2		
P29274	P29274		topological domain	topo	1	8				notDisRelated			18832607					Extracellular
P29274	P29274		transmembrane region	transmem	8	33				noEvidence								Helical; Name=1
P29274	P29274		topological domain	topo	33	43				notDisRelated			18832607					Cytoplasmic
P29274	P29274		transmembrane region	transmem	43	67				noEvidence								Helical; Name=2
P29274	P29274		topological domain	topo	67	78				notDisRelated			18832607					Extracellular
P29274	P29274		transmembrane region	transmem	78	101				noEvidence								Helical; Name=3
P29274	P29274		topological domain	topo	101	121				notDisRelated			18832607					Cytoplasmic
P29274	P29274		transmembrane region	transmem	121	144				noEvidence								Helical; Name=4
P29274	P29274		topological domain	topo	144	174				notDisRelated			18832607					Extracellular
P29274	P29274		transmembrane region	transmem	174	199				noEvidence								Helical; Name=5
P29274	P29274		topological domain	topo	199	235				notDisRelated			18832607					Cytoplasmic
P29274	P29274		transmembrane region	transmem	235	259				noEvidence								Helical; Name=6
P29274	P29274		topological domain	topo	259	267				notDisRelated			18832607					Extracellular
P29274	P29274		transmembrane region	transmem	267	291				noEvidence								Helical; Name=7
P29274	P29274		topological domain	topo	291	413				notDisRelated			18832607					Cytoplasmic
P29274	P29274		region of interest	interest	391	413				notDisRelated								Disordered
P29274	P29274		binding site	bind	169	170				notDisRelated			21593763					
P29274	P29274		binding site	bind	253	254				notDisRelated			21593763					
P29274	P29274		binding site	bind	277	278				notDisRelated			21593763					
P29274	P29274		binding site	bind	278	279				notDisRelated			21593763					
P29274	P29274		glycosylation site	glyco	154	155				notDisRelated								N-linked (GlcNAc...) asparagine
P29274	P29274		disulfide bond	disulf bond	71	160				notDisRelated			18832607					
P29274	P29274		disulfide bond	disulf bond	74	147				notDisRelated			18832607					
P29274	P29274		disulfide bond	disulf bond	77	167				notDisRelated			18832607					
P29274	P29274		disulfide bond	disulf bond	259	263				notDisRelated			18832607					
P29274	P29274	VAR_011835	sequence variant	variant	50	51	A	V	rs4530	notDisRelated			10391209					
P29274	P29274	VAR_011836	sequence variant	variant	300	301	R	H	rs4990	noEvidence								
P29274	P29274	VAR_003451	sequence variant	variant	392	393	G	R	rs1277013918	noEvidence								
P29274	P29274		helix	helix	2	34				notDisRelated								
P29274	P29274		helix	helix	35	38				notDisRelated								
P29274	P29274		helix	helix	40	58				notDisRelated								
P29274	P29274		helix	helix	59	68				notDisRelated								
P29274	P29274		strand	beta	71	74				notDisRelated								
P29274	P29274		helix	helix	74	108				notDisRelated								
P29274	P29274		helix	helix	109	116				notDisRelated								
P29274	P29274		helix	helix	118	137				notDisRelated								
P29274	P29274		helix	helix	138	142				notDisRelated								
P29274	P29274		strand	beta	144	149				notDisRelated								
P29274	P29274		helix	helix	151	158				notDisRelated								
P29274	P29274		strand	beta	163	166				notDisRelated								
P29274	P29274		helix	helix	168	172				notDisRelated								
P29274	P29274		helix	helix	174	180				notDisRelated								
P29274	P29274		helix	helix	182	186				notDisRelated								
P29274	P29274		helix	helix	187	209				notDisRelated								
P29274	P29274		strand	beta	213	217				notDisRelated								
P29274	P29274		helix	helix	219	259				notDisRelated								
P29274	P29274		strand	beta	260	263				notDisRelated								
P29274	P29274		helix	helix	267	292				notDisRelated								
P29274	P29274		helix	helix	293	304				notDisRelated								
P29274	P29274		turn	turn	304	308				notDisRelated								
P29274	P29274		turn	turn	308	311				notDisRelated								
P29274	P29274		helix	helix	312	318				notDisRelated								
P29275	P29275	PRO_0000069003	chain	chain	1	333				noEvidence				Adenosine receptor A2b				
P29275	P29275		topological domain	topo	1	9				notDisRelated								Extracellular
P29275	P29275		transmembrane region	transmem	9	34				notDisRelated								Helical; Name=1
P29275	P29275		topological domain	topo	34	44				notDisRelated								Cytoplasmic
P29275	P29275		transmembrane region	transmem	44	68				notDisRelated								Helical; Name=2
P29275	P29275		topological domain	topo	68	79				notDisRelated								Extracellular
P29275	P29275		transmembrane region	transmem	79	102				notDisRelated								Helical; Name=3
P29275	P29275		topological domain	topo	102	122				notDisRelated								Cytoplasmic
P29275	P29275		transmembrane region	transmem	122	145				notDisRelated								Helical; Name=4
P29275	P29275		topological domain	topo	145	179				notDisRelated								Extracellular
P29275	P29275		transmembrane region	transmem	179	204				notDisRelated								Helical; Name=5
P29275	P29275		topological domain	topo	204	236				notDisRelated								Cytoplasmic
P29275	P29275		transmembrane region	transmem	236	260				notDisRelated								Helical; Name=6
P29275	P29275		topological domain	topo	260	268				notDisRelated								Extracellular
P29275	P29275		transmembrane region	transmem	268	292				notDisRelated								Helical; Name=7
P29275	P29275		topological domain	topo	292	333				notDisRelated								Cytoplasmic
P29275	P29275		binding site	bind	174	175				notDisRelated								
P29275	P29275		binding site	bind	254	255				notDisRelated								
P29275	P29275		binding site	bind	279	280				notDisRelated								
P29275	P29275		binding site	bind	280	281				notDisRelated								
P29275	P29275		lipid moiety-binding region	lipid	311	312				notDisRelated								S-palmitoyl cysteine
P29275	P29275		glycosylation site	glyco	153	154				notDisRelated								N-linked (GlcNAc...) asparagine
P29275	P29275		glycosylation site	glyco	163	164				notDisRelated								N-linked (GlcNAc...) asparagine
P29275	P29275		disulfide bond	disulf bond	78	172				notDisRelated								
P29275	P29275		helix	helix	5	34				notDisRelated								
P29275	P29275		helix	helix	41	70				notDisRelated								
P29275	P29275		helix	helix	75	109				notDisRelated								
P29275	P29275		helix	helix	113	117				notDisRelated								
P29275	P29275		helix	helix	119	138				notDisRelated								
P29275	P29275		helix	helix	140	143				notDisRelated								
P29275	P29275		turn	turn	147	150				notDisRelated								
P29275	P29275		helix	helix	173	176				notDisRelated								
P29275	P29275		helix	helix	179	185				notDisRelated								
P29275	P29275		helix	helix	186	191				notDisRelated								
P29275	P29275		helix	helix	192	218				notDisRelated								
P29275	P29275		helix	helix	224	260				notDisRelated								
P29275	P29275		helix	helix	262	266				notDisRelated								
P29275	P29275		helix	helix	270	291				notDisRelated								
P29275	P29275		turn	turn	291	294				notDisRelated								
P29275	P29275		helix	helix	295	308				notDisRelated								
O94911	O94911-3	PRO_0000250677	chain	chain	1	1622				noEvidence				ABC-type organic anion transporter ABCA8	KIAA0822	KIAA0822; ATP-binding cassette sub-family A member 8; 3; 1; 2		
O94911	O94911-3		transmembrane region	transmem	30	51				notDisRelated								Helical
O94911	O94911-3		transmembrane region	transmem	220	241				notDisRelated								Helical
O94911	O94911-3		transmembrane region	transmem	268	289				notDisRelated								Helical
O94911	O94911-3		transmembrane region	transmem	299	320				notDisRelated								Helical
O94911	O94911-3		transmembrane region	transmem	327	348				notDisRelated								Helical
O94911	O94911-3		transmembrane region	transmem	359	380				notDisRelated								Helical
O94911	O94911-3		transmembrane region	transmem	397	418				notDisRelated								Helical
O94911	O94911-3		transmembrane region	transmem	864	885				notDisRelated								Helical
O94911	O94911-3		transmembrane region	transmem	1019	1040				notDisRelated								Helical
O94911	O94911-3		transmembrane region	transmem	1070	1091				notDisRelated								Helical
O94911	O94911-3		transmembrane region	transmem	1106	1127				notDisRelated								Helical
O94911	O94911-3		transmembrane region	transmem	1136	1157				notDisRelated								Helical
O94911	O94911-3		transmembrane region	transmem	1161	1182				notDisRelated								Helical
O94911	O94911-3		transmembrane region	transmem	1197	1218				notDisRelated								Helical
O94911	O94911-3		domain	domain	480	716				notDisRelated								ABC transporter 1
O94911	O94911-3		domain	domain	1285	1519				notDisRelated								ABC transporter 2
O94911	O94911-3		binding site	bind	516	524				notDisRelated								
O94911	O94911-3		binding site	bind	1323	1331				notDisRelated								
O94911	O94911-3		glycosylation site	glyco	71	72				notDisRelated								N-linked (GlcNAc...) asparagine
O94911	O94911-3		glycosylation site	glyco	84	85				notDisRelated								N-linked (GlcNAc...) asparagine
O94911	O94911-3		glycosylation site	glyco	194	195				notDisRelated								N-linked (GlcNAc...) asparagine
O94911	O94911-3		glycosylation site	glyco	243	244				notDisRelated								N-linked (GlcNAc...) asparagine
O94911	O94911-3		glycosylation site	glyco	484	485				notDisRelated								N-linked (GlcNAc...) asparagine
O94911	O94911-3		glycosylation site	glyco	555	556				notDisRelated								N-linked (GlcNAc...) asparagine
O94911	O94911-3		glycosylation site	glyco	616	617				notDisRelated								N-linked (GlcNAc...) asparagine
O94911	O94911-3		glycosylation site	glyco	724	725				notDisRelated								N-linked (GlcNAc...) asparagine
O94911	O94911-3		glycosylation site	glyco	797	798				notDisRelated								N-linked (GlcNAc...) asparagine
O94911	O94911-3		glycosylation site	glyco	919	920				notDisRelated								N-linked (GlcNAc...) asparagine
O94911	O94911-3		glycosylation site	glyco	948	949				notDisRelated								N-linked (GlcNAc...) asparagine
O94911	O94911-3		glycosylation site	glyco	967	968				notDisRelated								N-linked (GlcNAc...) asparagine
O94911	O94911-3		glycosylation site	glyco	1270	1271				notDisRelated								N-linked (GlcNAc...) asparagine
O94911	O94911-3		glycosylation site	glyco	1308	1309				notDisRelated								N-linked (GlcNAc...) asparagine
O94911	O94911-3		glycosylation site	glyco	1373	1374				notDisRelated								N-linked (GlcNAc...) asparagine
O94911	O94911-3		glycosylation site	glyco	1435	1436				notDisRelated								N-linked (GlcNAc...) asparagine
O94911	O94911-3	VSP_060911	splice variant	splicing	267	1622				noEvidence								In isoform 2.
O94911	O94911-3	VSP_060912	splice variant	splicing	598	638				noEvidence								In isoform 1.
O94911	O94911-3	VAR_027590	sequence variant	variant	256	257	T	A	rs16973446	noEvidence								
O94911	O94911-3	VAR_027591	sequence variant	variant	331	332	G	S	rs4147979	notDisRelated			12111378					
O94911	O94911-3	VAR_048130	sequence variant	variant	416	417	A	V	rs35621847	notDisRelated			15489334					
O94911	O94911-3	VAR_027592	sequence variant	variant	489	490	Y	F	rs12150510	noEvidence								
O94911	O94911-3	VAR_084139	sequence variant	variant	649	650	P	R	rs144777539	notDisRelated			28882873					Affects localization at the plasma membrane; loss of cholesterol efflux to APOA1
O94911	O94911-3	VAR_048131	sequence variant	variant	659	660	L	R	rs35844316	noEvidence								
O94911	O94911-3	VAR_027593	sequence variant	variant	720	721	C	G	rs16973424	noEvidence								
O94911	O94911-3	VAR_084140	sequence variant	variant	781	1622				notDisRelated			28882873					Loss of expression; loss of cholesterol efflux to APOA1
O94911	O94911-3	VAR_048132	sequence variant	variant	1470	1471	G	S	rs35403175	noEvidence								
Q8IUA7	Q8IUA7-1	PRO_0000250680	chain	chain	1	1625				noEvidence				ATP-binding cassette sub-family A member 9	1	1; 2; 3; 4; 5; ABCA9delta+55; ABCA9delta+73; ABCA9delta-95		
Q8IUA7	Q8IUA7-1		transmembrane region	transmem	31	52				notDisRelated								Helical
Q8IUA7	Q8IUA7-1		transmembrane region	transmem	221	244				notDisRelated								Helical
Q8IUA7	Q8IUA7-1		transmembrane region	transmem	269	290				notDisRelated								Helical
Q8IUA7	Q8IUA7-1		transmembrane region	transmem	300	321				notDisRelated								Helical
Q8IUA7	Q8IUA7-1		transmembrane region	transmem	329	350				notDisRelated								Helical
Q8IUA7	Q8IUA7-1		transmembrane region	transmem	354	375				notDisRelated								Helical
Q8IUA7	Q8IUA7-1		transmembrane region	transmem	398	419				notDisRelated								Helical
Q8IUA7	Q8IUA7-1		transmembrane region	transmem	864	885				notDisRelated								Helical
Q8IUA7	Q8IUA7-1		transmembrane region	transmem	1026	1047				notDisRelated								Helical
Q8IUA7	Q8IUA7-1		transmembrane region	transmem	1065	1086				notDisRelated								Helical
Q8IUA7	Q8IUA7-1		transmembrane region	transmem	1108	1129				notDisRelated								Helical
Q8IUA7	Q8IUA7-1		transmembrane region	transmem	1136	1157				notDisRelated								Helical
Q8IUA7	Q8IUA7-1		transmembrane region	transmem	1163	1184				notDisRelated								Helical
Q8IUA7	Q8IUA7-1		transmembrane region	transmem	1200	1221				notDisRelated								Helical
Q8IUA7	Q8IUA7-1		domain	domain	481	717				notDisRelated								ABC transporter 1
Q8IUA7	Q8IUA7-1		domain	domain	1288	1522				notDisRelated								ABC transporter 2
Q8IUA7	Q8IUA7-1		binding site	bind	517	525				notDisRelated								
Q8IUA7	Q8IUA7-1		binding site	bind	1326	1334				notDisRelated								
Q8IUA7	Q8IUA7-1		glycosylation site	glyco	120	121				notDisRelated								N-linked (GlcNAc...) asparagine
Q8IUA7	Q8IUA7-1		glycosylation site	glyco	195	196				notDisRelated								N-linked (GlcNAc...) asparagine
Q8IUA7	Q8IUA7-1		glycosylation site	glyco	949	950				notDisRelated			19159218					N-linked (GlcNAc...) asparagine
Q8IUA7	Q8IUA7-1	VSP_020705	splice variant	splicing	267	1625				notDisRelated								In isoform 2.
Q8IUA7	Q8IUA7-1	VSP_020706	splice variant	splicing	268	1625				notDisRelated			15489334					In isoform 5.
Q8IUA7	Q8IUA7-1	VSP_020707	splice variant	splicing	1429	1430	L	VRAGLVVALQVP		notDisRelated								In isoform 3.
Q8IUA7	Q8IUA7-1	VSP_020708	splice variant	splicing	1429	1430	L	AGDSGHL		notDisRelated								In isoform 4.
Q8IUA7	Q8IUA7-1	VSP_020709	splice variant	splicing	1430	1625				notDisRelated								In isoform 3 and isoform 4.
Q8IUA7	Q8IUA7-1	VAR_027594	sequence variant	variant	353	354	R	H	rs1860447	notDisRelated			14702039					
Q8IUA7	Q8IUA7-1	VAR_027595	sequence variant	variant	785	786	N	S	rs17684521	noEvidence								
Q8IUA7	Q8IUA7-1	VAR_027596	sequence variant	variant	1306	1307	K	T	rs2302294	notDisRelated								
Q8IUA7	Q8IUA7-1	VAR_027597	sequence variant	variant	1356	1357	G	S	rs9916254	noEvidence								
Q8IUA7	Q8IUA7-1		sequence conflict	conflict	1430	1431	C	R		notDisRelated								In Ref. 1; AAK30024.
Q8WWZ4	Q8WWZ4-1	PRO_0000253572	chain	chain	1	1544				noEvidence				ATP-binding cassette sub-family A member 10	1	1; 2; 3; 4; 5; ABCA10delta+82; ABCA10delta-104; ABCA10delta-176		
Q8WWZ4	Q8WWZ4-1		transmembrane region	transmem	83	104				notDisRelated								Helical
Q8WWZ4	Q8WWZ4-1		transmembrane region	transmem	135	156				notDisRelated								Helical
Q8WWZ4	Q8WWZ4-1		transmembrane region	transmem	185	206				notDisRelated								Helical
Q8WWZ4	Q8WWZ4-1		transmembrane region	transmem	210	231				notDisRelated								Helical
Q8WWZ4	Q8WWZ4-1		transmembrane region	transmem	240	261				notDisRelated								Helical
Q8WWZ4	Q8WWZ4-1		transmembrane region	transmem	264	285				notDisRelated								Helical
Q8WWZ4	Q8WWZ4-1		transmembrane region	transmem	310	331				notDisRelated								Helical
Q8WWZ4	Q8WWZ4-1		transmembrane region	transmem	774	795				notDisRelated								Helical
Q8WWZ4	Q8WWZ4-1		transmembrane region	transmem	890	911				notDisRelated								Helical
Q8WWZ4	Q8WWZ4-1		transmembrane region	transmem	926	947				notDisRelated								Helical
Q8WWZ4	Q8WWZ4-1		transmembrane region	transmem	985	1006				notDisRelated								Helical
Q8WWZ4	Q8WWZ4-1		transmembrane region	transmem	1014	1035				notDisRelated								Helical
Q8WWZ4	Q8WWZ4-1		transmembrane region	transmem	1046	1067				notDisRelated								Helical
Q8WWZ4	Q8WWZ4-1		transmembrane region	transmem	1073	1094				notDisRelated								Helical
Q8WWZ4	Q8WWZ4-1		transmembrane region	transmem	1113	1134				notDisRelated								Helical
Q8WWZ4	Q8WWZ4-1		domain	domain	391	627				notDisRelated								ABC transporter 1
Q8WWZ4	Q8WWZ4-1		domain	domain	1206	1441				notDisRelated								ABC transporter 2
Q8WWZ4	Q8WWZ4-1		region of interest	interest	1153	1178				notDisRelated								Disordered
Q8WWZ4	Q8WWZ4-1		binding site	bind	427	435				notDisRelated								
Q8WWZ4	Q8WWZ4-1		binding site	bind	1239	1247				notDisRelated								
Q8WWZ4	Q8WWZ4-1	VSP_021061	splice variant	splicing	1	24				notDisRelated								In isoform 2.
Q8WWZ4	Q8WWZ4-1	VSP_021062	splice variant	splicing	67	68	E	GHNKSFCNGGVDISYWNKYEDTTFHF		notDisRelated								In isoform 3.
Q8WWZ4	Q8WWZ4-1	VSP_021063	splice variant	splicing	68	1544				notDisRelated								In isoform 3.
Q8WWZ4	Q8WWZ4-1	VSP_021064	splice variant	splicing	413	453	IFFDIYEGQITAILGHNGAGKSTLLNILSGLSVSTEGSAT	SEERLCPAAHRLRCGERLCPAAHHLGCEERPCPAATPSGN		notDisRelated			17974005					In isoform 5.
Q8WWZ4	Q8WWZ4-1	VSP_021065	splice variant	splicing	450	451	S	KKNYNGIRHAKHSRHYC		notDisRelated								In isoform 4.
Q8WWZ4	Q8WWZ4-1	VSP_021066	splice variant	splicing	451	1544				notDisRelated								In isoform 4.
Q8WWZ4	Q8WWZ4-1	VSP_021067	splice variant	splicing	453	1544				notDisRelated			17974005					In isoform 5.
Q8WWZ4	Q8WWZ4-1	VAR_028384	sequence variant	variant	203	204	P	S	rs9909216	notDisRelated			12821155,17974005					
Q8WWZ4	Q8WWZ4-1	VAR_028385	sequence variant	variant	287	288	I	V	rs11657804	notDisRelated			12821155,17974005					
Q8WWZ4	Q8WWZ4-1	VAR_028386	sequence variant	variant	916	917	M	T	rs4968849	notDisRelated								
Q8WWZ4	Q8WWZ4-1	VAR_055469	sequence variant	variant	1322	1323	R	W	rs10491178	noEvidence								
Q8WWZ4	Q8WWZ4-1		sequence conflict	conflict	140	141	C	Y		notDisRelated								In Ref. 3; CAD89903.
Q8WWZ4	Q8WWZ4-1		sequence conflict	conflict	159	160	R	G		notDisRelated								In Ref. 3; CAD89903.
Q8WWZ4	Q8WWZ4-1		sequence conflict	conflict	187	188	F	S		notDisRelated								In Ref. 3; CAD89903.
Q8WWZ4	Q8WWZ4-1		sequence conflict	conflict	324	325	L	S		notDisRelated								In Ref. 3; CAD89903.
Q8WWZ4	Q8WWZ4-1		sequence conflict	conflict	364	365	F	L		notDisRelated								In Ref. 3; CAD89903.
Q8WWZ4	Q8WWZ4-1		sequence conflict	conflict	1216	1217	R	I		notDisRelated								In Ref. 2; AAO72160/AAO72161 and 4; AAH51320.
Q86UK0	Q86UK0-1	PRO_0000093300	chain	chain	1	2596				noEvidence				Glucosylceramide transporter ABCA12	ATP-binding cassette 12	ATP-binding cassette 12; ABC12; ATP-binding cassette transporter 12; ATP-binding cassette sub-family A member 12; 1; 2		
Q86UK0	Q86UK0-1		transmembrane region	transmem	23	44				notDisRelated								Helical
Q86UK0	Q86UK0-1		transmembrane region	transmem	1065	1086				notDisRelated								Helical
Q86UK0	Q86UK0-1		transmembrane region	transmem	1112	1133				notDisRelated								Helical
Q86UK0	Q86UK0-1		transmembrane region	transmem	1145	1166				notDisRelated								Helical
Q86UK0	Q86UK0-1		transmembrane region	transmem	1174	1195				notDisRelated								Helical
Q86UK0	Q86UK0-1		transmembrane region	transmem	1200	1221				notDisRelated								Helical
Q86UK0	Q86UK0-1		transmembrane region	transmem	1250	1271				notDisRelated								Helical
Q86UK0	Q86UK0-1		transmembrane region	transmem	1747	1768				notDisRelated								Helical
Q86UK0	Q86UK0-1		transmembrane region	transmem	1979	2000				notDisRelated								Helical
Q86UK0	Q86UK0-1		transmembrane region	transmem	2035	2056				notDisRelated								Helical
Q86UK0	Q86UK0-1		transmembrane region	transmem	2072	2093				notDisRelated								Helical
Q86UK0	Q86UK0-1		transmembrane region	transmem	2103	2124				notDisRelated								Helical
Q86UK0	Q86UK0-1		transmembrane region	transmem	2187	2208				notDisRelated								Helical
Q86UK0	Q86UK0-1		transmembrane region	transmem	2270	2291				notDisRelated								Helical
Q86UK0	Q86UK0-1		domain	domain	1346	1578				notDisRelated								ABC transporter 1
Q86UK0	Q86UK0-1		domain	domain	2254	2490				notDisRelated								ABC transporter 2
Q86UK0	Q86UK0-1		region of interest	interest	2571	2596				notDisRelated								Disordered
Q86UK0	Q86UK0-1		binding site	bind	1378	1386				notDisRelated								
Q86UK0	Q86UK0-1		binding site	bind	2290	2298				notDisRelated								
Q86UK0	Q86UK0-1		glycosylation site	glyco	156	157				notDisRelated								N-linked (GlcNAc...) asparagine
Q86UK0	Q86UK0-1		glycosylation site	glyco	174	175				notDisRelated								N-linked (GlcNAc...) asparagine
Q86UK0	Q86UK0-1		glycosylation site	glyco	214	215				notDisRelated								N-linked (GlcNAc...) asparagine
Q86UK0	Q86UK0-1		glycosylation site	glyco	275	276				notDisRelated								N-linked (GlcNAc...) asparagine
Q86UK0	Q86UK0-1		glycosylation site	glyco	333	334				notDisRelated								N-linked (GlcNAc...) asparagine
Q86UK0	Q86UK0-1		glycosylation site	glyco	367	368				notDisRelated								N-linked (GlcNAc...) asparagine
Q86UK0	Q86UK0-1		glycosylation site	glyco	383	384				notDisRelated								N-linked (GlcNAc...) asparagine
Q86UK0	Q86UK0-1		glycosylation site	glyco	412	413				notDisRelated								N-linked (GlcNAc...) asparagine
Q86UK0	Q86UK0-1		glycosylation site	glyco	435	436				notDisRelated								N-linked (GlcNAc...) asparagine
Q86UK0	Q86UK0-1		glycosylation site	glyco	528	529				notDisRelated								N-linked (GlcNAc...) asparagine
Q86UK0	Q86UK0-1		glycosylation site	glyco	543	544				notDisRelated								N-linked (GlcNAc...) asparagine
Q86UK0	Q86UK0-1		glycosylation site	glyco	577	578				notDisRelated								N-linked (GlcNAc...) asparagine
Q86UK0	Q86UK0-1		glycosylation site	glyco	608	609				notDisRelated								N-linked (GlcNAc...) asparagine
Q86UK0	Q86UK0-1		glycosylation site	glyco	623	624				notDisRelated								N-linked (GlcNAc...) asparagine
Q86UK0	Q86UK0-1		glycosylation site	glyco	648	649				notDisRelated								N-linked (GlcNAc...) asparagine
Q86UK0	Q86UK0-1		glycosylation site	glyco	752	753				notDisRelated								N-linked (GlcNAc...) asparagine
Q86UK0	Q86UK0-1		glycosylation site	glyco	826	827				notDisRelated								N-linked (GlcNAc...) asparagine
Q86UK0	Q86UK0-1		glycosylation site	glyco	920	921				notDisRelated								N-linked (GlcNAc...) asparagine
Q86UK0	Q86UK0-1		glycosylation site	glyco	963	964				notDisRelated								N-linked (GlcNAc...) asparagine
Q86UK0	Q86UK0-1		glycosylation site	glyco	1170	1171				notDisRelated								N-linked (GlcNAc...) asparagine
Q86UK0	Q86UK0-1		glycosylation site	glyco	1524	1525				notDisRelated								N-linked (GlcNAc...) asparagine
Q86UK0	Q86UK0-1		glycosylation site	glyco	1663	1664				notDisRelated								N-linked (GlcNAc...) asparagine
Q86UK0	Q86UK0-1		glycosylation site	glyco	1704	1705				notDisRelated								N-linked (GlcNAc...) asparagine
Q86UK0	Q86UK0-1		glycosylation site	glyco	1769	1770				notDisRelated								N-linked (GlcNAc...) asparagine
Q86UK0	Q86UK0-1		glycosylation site	glyco	1819	1820				notDisRelated								N-linked (GlcNAc...) asparagine
Q86UK0	Q86UK0-1		glycosylation site	glyco	1835	1836				notDisRelated								N-linked (GlcNAc...) asparagine
Q86UK0	Q86UK0-1		glycosylation site	glyco	1876	1877				notDisRelated								N-linked (GlcNAc...) asparagine
Q86UK0	Q86UK0-1		glycosylation site	glyco	1921	1922				notDisRelated								N-linked (GlcNAc...) asparagine
Q86UK0	Q86UK0-1		glycosylation site	glyco	1952	1953				notDisRelated								N-linked (GlcNAc...) asparagine
Q86UK0	Q86UK0-1		glycosylation site	glyco	2178	2179				notDisRelated								N-linked (GlcNAc...) asparagine
Q86UK0	Q86UK0-1		glycosylation site	glyco	2208	2209				notDisRelated								N-linked (GlcNAc...) asparagine
Q86UK0	Q86UK0-1		glycosylation site	glyco	2223	2224				notDisRelated								N-linked (GlcNAc...) asparagine
Q86UK0	Q86UK0-1		glycosylation site	glyco	2318	2319				notDisRelated								N-linked (GlcNAc...) asparagine
Q86UK0	Q86UK0-1		glycosylation site	glyco	2542	2543				notDisRelated								N-linked (GlcNAc...) asparagine
Q86UK0	Q86UK0-1		glycosylation site	glyco	2547	2548				notDisRelated								N-linked (GlcNAc...) asparagine
Q86UK0	Q86UK0-1	VSP_011283	splice variant	splicing	1	319				notDisRelated								In isoform 2.
Q86UK0	Q86UK0-1	VSP_011284	splice variant	splicing	319	329	LLYTLDSPAQ	MFTYIKIITS		notDisRelated								In isoform 2.
Q86UK0	Q86UK0-1	VAR_055473	sequence variant	variant	199	200	W	C	rs16853238	noEvidence								
Q86UK0	Q86UK0-1	VAR_055474	sequence variant	variant	237	238	N	H	rs11890512	noEvidence								
Q86UK0	Q86UK0-1	VAR_055475	sequence variant	variant	274	275	Q	R	rs11890468	noEvidence								
Q86UK0	Q86UK0-1	VAR_055476	sequence variant	variant	287	288	R	G	rs11891778	noEvidence								
Q86UK0	Q86UK0-1	VAR_067075	sequence variant	variant	345	346	T	P	rs1295935868	disRelated	Ichthyosis, congenital, autosomal recessive 4A	ARCI4A	17508018					skin phenotype consistent with non-bullous congenital ichthyosiform erythroderma
Q86UK0	Q86UK0-1	VAR_067076	sequence variant	variant	387	388	S	N	rs746315995	disRelated	Ichthyosis, congenital, autosomal recessive 4B	ARCI4B	16675967					
Q86UK0	Q86UK0-1	VAR_084428	sequence variant	variant	434	2596				disRelated	Ichthyosis, congenital, autosomal recessive 4B	ARCI4B	16007253					
Q86UK0	Q86UK0-1	VAR_019597	sequence variant	variant	459	460	S	T	rs113112835	noEvidence								
Q86UK0	Q86UK0-1	VAR_062663	sequence variant	variant	476	477	A	V	rs370640837	notDisRelated	a pancreatic ductal adenocarcinoma sample	a pancreatic ductal adenocarcinoma sample	18772397					somatic mutation
Q86UK0	Q86UK0-1	VAR_027444	sequence variant	variant	550	551	E	G	rs16853149	noEvidence								
Q86UK0	Q86UK0-1	VAR_027445	sequence variant	variant	777	778	S	T	rs7560008	notDisRelated			12697999					
Q86UK0	Q86UK0-1	VAR_067077	sequence variant	variant	1136	1137	G	D		disRelated	Ichthyosis, congenital, autosomal recessive 4A	ARCI4A	18284401					skin phenotype consistent with non-bullous congenital ichthyosiform erythroderma
Q86UK0	Q86UK0-1	VAR_067078	sequence variant	variant	1179	1180	G	R	rs267606622	disRelated	Ichthyosis, congenital, autosomal recessive 4B	ARCI4B	16902423					
Q86UK0	Q86UK0-1	VAR_067079	sequence variant	variant	1235	1236	W	S		disRelated	Ichthyosis, congenital, autosomal recessive 4A	ARCI4A	19262603					skin phenotype consistent with non-bullous congenital ichthyosiform erythroderma
Q86UK0	Q86UK0-1	VAR_027446	sequence variant	variant	1251	1252	G	D	rs13414448	noEvidence								
Q86UK0	Q86UK0-1	VAR_019598	sequence variant	variant	1380	1381	N	S	rs28940269	disRelated	Ichthyosis, congenital, autosomal recessive 4A	ARCI4A	12915478					
Q86UK0	Q86UK0-1	VAR_019599	sequence variant	variant	1381	1382	G	E	rs28940268	disRelated	Ichthyosis, congenital, autosomal recessive 4A	ARCI4A	12915478					
Q86UK0	Q86UK0-1	VAR_084429	sequence variant	variant	1385	1386				disRelated	Ichthyosis, congenital, autosomal recessive 4B	ARCI4B	16007253					unknown pathological significance
Q86UK0	Q86UK0-1	VAR_067080	sequence variant	variant	1494	1495	I	T	rs1263698595	disRelated	Ichthyosis, congenital, autosomal recessive 4A	ARCI4A	17508018					skin phenotype consistent with non-bullous congenital ichthyosiform erythroderma
Q86UK0	Q86UK0-1	VAR_019600	sequence variant	variant	1514	1515	R	H	rs28940270	disRelated	Ichthyosis, congenital, autosomal recessive 4A	ARCI4A	12915478,19262603					
Q86UK0	Q86UK0-1	VAR_019601	sequence variant	variant	1539	1540	E	K	rs28940271	disRelated	Ichthyosis, congenital, autosomal recessive 4A	ARCI4A	12915478					
Q86UK0	Q86UK0-1	VAR_027447	sequence variant	variant	1546	1547	R	C	rs13401480	noEvidence								
Q86UK0	Q86UK0-1	VAR_067081	sequence variant	variant	1559	1560	G	V	rs1457513156	disRelated	Ichthyosis, congenital, autosomal recessive 4A	ARCI4A	22257947					skin phenotype consistent with non-bullous congenital ichthyosiform erythroderma
Q86UK0	Q86UK0-1	VAR_019602	sequence variant	variant	1651	1652	G	S	rs28940568	disRelated	Ichthyosis, congenital, autosomal recessive 4A	ARCI4A	12915478					
Q86UK0	Q86UK0-1	VAR_067082	sequence variant	variant	1798	1799	P	L	rs181314573	disRelated	Ichthyosis, congenital, autosomal recessive 4A	ARCI4A	19262603					skin phenotype consistent with non-bullous congenital ichthyosiform erythroderma
Q86UK0	Q86UK0-1	VAR_084430	sequence variant	variant	1950	2596				disRelated	Ichthyosis, congenital, autosomal recessive 4B	ARCI4B	16007253					unknown pathological significance
Q86UK0	Q86UK0-1	VAR_067083	sequence variant	variant	1980	1981	T	K	rs763858530	disRelated	Ichthyosis, congenital, autosomal recessive 4A	ARCI4A	19262603					skin phenotype consistent with non-bullous congenital ichthyosiform erythroderma
Q86UK0	Q86UK0-1	VAR_027448	sequence variant	variant	2064	2065	E	K	rs1213011	noEvidence								
Q86UK0	Q86UK0-1	VAR_027449	sequence variant	variant	2365	2366	D	N	rs726070	notDisRelated			15756637					
Q86UK0	Q86UK0-1		sequence conflict	conflict	651	652	Y	D		notDisRelated								In Ref. 1; AAP21093.
Q86UK0	Q86UK0-1		sequence conflict	conflict	811	812	Y	H		notDisRelated								In Ref. 1; AAP21093.
Q86UK0	Q86UK0-1		sequence conflict	conflict	826	827	N	D		notDisRelated								In Ref. 2; AAK54355.
Q86UK0	Q86UK0-1		sequence conflict	conflict	2079	2080	Y	H		notDisRelated								In Ref. 1; AAP21093.
Q86UQ4	Q86UQ4-1	PRO_0000253573	chain	chain	1	5059				noEvidence				ATP-binding cassette sub-family A member 13	1	1; 2; 3; 4; 5; 6; 7		
Q86UQ4	Q86UQ4-1		transmembrane region	transmem	23	44				notDisRelated								Helical
Q86UQ4	Q86UQ4-1		transmembrane region	transmem	3568	3589				notDisRelated								Helical
Q86UQ4	Q86UQ4-1		transmembrane region	transmem	3607	3628				notDisRelated								Helical
Q86UQ4	Q86UQ4-1		transmembrane region	transmem	3648	3669				notDisRelated								Helical
Q86UQ4	Q86UQ4-1		transmembrane region	transmem	3679	3700				notDisRelated								Helical
Q86UQ4	Q86UQ4-1		transmembrane region	transmem	3709	3730				notDisRelated								Helical
Q86UQ4	Q86UQ4-1		transmembrane region	transmem	3752	3773				notDisRelated								Helical
Q86UQ4	Q86UQ4-1		transmembrane region	transmem	4226	4247				notDisRelated								Helical
Q86UQ4	Q86UQ4-1		transmembrane region	transmem	4458	4479				notDisRelated								Helical
Q86UQ4	Q86UQ4-1		transmembrane region	transmem	4504	4525				notDisRelated								Helical
Q86UQ4	Q86UQ4-1		transmembrane region	transmem	4536	4557				notDisRelated								Helical
Q86UQ4	Q86UQ4-1		transmembrane region	transmem	4568	4589				notDisRelated								Helical
Q86UQ4	Q86UQ4-1		transmembrane region	transmem	4607	4628				notDisRelated								Helical
Q86UQ4	Q86UQ4-1		transmembrane region	transmem	4651	4672				notDisRelated								Helical
Q86UQ4	Q86UQ4-1		domain	domain	3842	4075				notDisRelated								ABC transporter 1
Q86UQ4	Q86UQ4-1		domain	domain	4718	4957				notDisRelated								ABC transporter 2
Q86UQ4	Q86UQ4-1		binding site	bind	3875	3883				notDisRelated								
Q86UQ4	Q86UQ4-1		binding site	bind	4754	4762				notDisRelated								
Q86UQ4	Q86UQ4-1	VSP_054633	splice variant	splicing	1	2737				notDisRelated			23266639					In isoform 5, isoform 6 and isoform 7.
Q86UQ4	Q86UQ4-1	VSP_021068	splice variant	splicing	1	2299				notDisRelated								In isoform 3.
Q86UQ4	Q86UQ4-1	VSP_021069	splice variant	splicing	300	318	IPTDTSLEKMVCSVLSST	VHMLDCFSHRWAFPGDWI		notDisRelated			14702039					In isoform 2.
Q86UQ4	Q86UQ4-1	VSP_021070	splice variant	splicing	318	5059				notDisRelated			14702039					In isoform 2.
Q86UQ4	Q86UQ4-1	VSP_054634	splice variant	splicing	4271	4272	F	FS		notDisRelated			23266639					In isoform 4, isoform 5, isoform 6 and isoform 7.
Q86UQ4	Q86UQ4-1	VSP_054635	splice variant	splicing	4478	4509				notDisRelated			23266639					In isoform 7.
Q86UQ4	Q86UQ4-1	VSP_054636	splice variant	splicing	4947	5059	FGDGYTVKVWLCKEANQHCTVSDHLKLYFPGIQFKGQHLNLLEYHVPKRWGCLADLFKVIENNKTFLNIKHYSINQTTLEQVFINFASEQQQTLQSTLDPSTDSHHTHHLPI	KLNKTN		notDisRelated			23266639					In isoform 6.
Q86UQ4	Q86UQ4-1	VAR_059087	sequence variant	variant	506	507	P	L	rs1880738	noEvidence								
Q86UQ4	Q86UQ4-1	VAR_059088	sequence variant	variant	555	556	R	H	rs2361519	noEvidence								
Q86UQ4	Q86UQ4-1	VAR_059089	sequence variant	variant	767	768	I	S	rs17712293	noEvidence								
Q86UQ4	Q86UQ4-1	VAR_059090	sequence variant	variant	799	800	E	K	rs17547816	noEvidence								
Q86UQ4	Q86UQ4-1	VAR_059091	sequence variant	variant	1434	1435	I	V	rs17132195	noEvidence								
Q86UQ4	Q86UQ4-1	VAR_055470	sequence variant	variant	1508	1509	T	I	rs6583483	noEvidence								
Q86UQ4	Q86UQ4-1	VAR_059092	sequence variant	variant	1540	1541	F	L	rs17712299	noEvidence								
Q86UQ4	Q86UQ4-1	VAR_059093	sequence variant	variant	1889	1890	I	K	rs17132197	noEvidence								
Q86UQ4	Q86UQ4-1	VAR_059094	sequence variant	variant	2033	2034	N	D	rs17661364	noEvidence								
Q86UQ4	Q86UQ4-1	VAR_059095	sequence variant	variant	2154	2155	S	L	rs17092911	noEvidence								
Q86UQ4	Q86UQ4-1	VAR_059096	sequence variant	variant	2178	2179	A	E	rs1880736	noEvidence								
Q86UQ4	Q86UQ4-1	VAR_059097	sequence variant	variant	2212	2213	L	S	rs17132198	noEvidence								
Q86UQ4	Q86UQ4-1	VAR_059098	sequence variant	variant	2436	2437	K	R	rs17132206	noEvidence								
Q86UQ4	Q86UQ4-1	VAR_059099	sequence variant	variant	2537	2538	S	A	rs17132208	noEvidence								
Q86UQ4	Q86UQ4-1	VAR_059100	sequence variant	variant	2674	2675	R	W	rs2222648	noEvidence								
Q86UQ4	Q86UQ4-1	VAR_059101	sequence variant	variant	3142	3143	A	V	rs3931814	noEvidence								
Q86UQ4	Q86UQ4-1	VAR_059102	sequence variant	variant	3851	3852	Y	F	rs17132289	notDisRelated								
Q86UQ4	Q86UQ4-1	VAR_059103	sequence variant	variant	4277	4278	N	D	rs4917152	noEvidence								
Q86UQ4	Q86UQ4-1	VAR_059104	sequence variant	variant	4302	4303	Q	R	rs4917153	noEvidence								
Q86UQ4	Q86UQ4-1	VAR_059105	sequence variant	variant	4335	4336	P	A	rs17132370	noEvidence								
Q86UQ4	Q86UQ4-1		sequence conflict	conflict	1416	1417	H	R		notDisRelated								In Ref. 1; AAP13576.
Q86UQ4	Q86UQ4-1		sequence conflict	conflict	2718	2719	P	L		notDisRelated								In Ref. 1; AAP13576.
Q86UQ4	Q86UQ4-1		sequence conflict	conflict	2831	2832	L	R		notDisRelated								In Ref. 1; AAP13576.
Q86UQ4	Q86UQ4-1		sequence conflict	conflict	2870	2871	K	E		notDisRelated								In Ref. 1; AAP13576.
Q86UQ4	Q86UQ4-1		sequence conflict	conflict	3057	3058	T	A		notDisRelated								In Ref. 5; AAO59914.
Q86UQ4	Q86UQ4-1		sequence conflict	conflict	4446	4447	K	E		notDisRelated								In Ref. 1; AAP13576 and 5; AAO59914.
Q86UQ4	Q86UQ4-1		sequence conflict	conflict	4584	4585	L	P		notDisRelated								In Ref. 1; AAP13576.
P42771	P42771-1	PRO_0000144177	chain	chain	1	157				noEvidence				Cyclin-dependent kinase inhibitor 2A	CDK4I	CDK4I; MTS-1; p16-INK4; p16INK4A; MTS1; CDKN2; p16-INK4a; Multiple tumor suppressor 1; Cyclin-dependent kinase 4 inhibitor A; 1; 2; 3; 5; p12; smARF; p14ARF; p19ARF; p16INK4a; p16gamma; tumor suppressor ARF		
P42771	P42771-1		repeat	repeat	11	41				noEvidence								ANK 1
P42771	P42771-1		repeat	repeat	44	73				noEvidence								ANK 2
P42771	P42771-1		repeat	repeat	77	107				noEvidence								ANK 3
P42771	P42771-1		repeat	repeat	110	140				noEvidence								ANK 4
P42771	P42771-1		modified residue	acetyl	1	2				notDisRelated								N-acetylmethionine
P42771	P42771-1		modified residue	phos	7	8				notDisRelated			12529334					Phosphoserine
P42771	P42771-1		modified residue	phos	8	9				notDisRelated			12529334					Phosphoserine
P42771	P42771-1		modified residue	phos	140	141				notDisRelated			12529334					Phosphoserine
P42771	P42771-1		modified residue	phos	152	153				notDisRelated			12529334					Phosphoserine
P42771	P42771-1	VSP_015864	splice variant	splicing	1	52				notDisRelated								In isoform 2.
P42771	P42771-1	VSP_015865	splice variant	splicing	52	117	MMMGSARVAELLLLHGAEPNCADPATLTRPVHDAAREGFLDTLVVLHRAGARLDVRDAWGRLPVD	GRGSAAGAGDGGRLWRTKFAGELESGSASILRKKGRLPGEFSEGVCNHRPPPGDALGAWEAKEEE		notDisRelated			10445844					In isoform 3.
P42771	P42771-1	VSP_015866	splice variant	splicing	117	157				notDisRelated			10445844					In isoform 3.
P42771	P42771-1	VSP_043577	splice variant	splicing	153	157	DIPD	EMIGNHLWVCRSRHA		notDisRelated			17486064					In isoform 5.
P42771	P42771-1	VAR_001408	sequence variant	variant	14	15	D	E	rs1819961127	disRelated	a biliary tract tumor	a biliary tract tumor						
P42771	P42771-1	VAR_001409	sequence variant	variant	16	17	L	P	rs864622263	disRelated	a biliary tract tumor,a familial melanoma	a biliary tract tumor and a familial melanoma						
P42771	P42771-1	VAR_058549	sequence variant	variant	19	20	A	ATA		disRelated	Melanoma, cutaneous malignant 2	CMM2						loss of CDK4 binding
P42771	P42771-1	VAR_001410	sequence variant	variant	20	21	A	P	rs760065045	disRelated	a lung tumor,melanoma	a lung tumor and melanoma						
P42771	P42771-1	VAR_001411	sequence variant	variant	20	21	A	S	rs760065045	disRelated	a biliary tract tumor	a biliary tract tumor						
P42771	P42771-1	VAR_001412	sequence variant	variant	23	24	G	D	rs1064794292	disRelated	a pancreas tumor,a melanoma	a pancreas tumor and a melanoma						loss of CDK4 binding
P42771	P42771-1	VAR_001413	sequence variant	variant	24	25	R	C		disRelated	Melanoma, cutaneous malignant 2	CMM2						
P42771	P42771-1	VAR_001414	sequence variant	variant	24	25	R	P	rs104894097	disRelated	Melanoma, cutaneous malignant 2	CMM2	9328469					
P42771	P42771-1	VAR_058550	sequence variant	variant	24	25	R	Q	rs104894097	disRelated			19260062					Found in  multiple primary melanoma; partial loss of CDK4 binding
P42771	P42771-1	VAR_001415	sequence variant	variant	26	27	E	D		disRelated	a biliary tract tumor	a biliary tract tumor						
P42771	P42771-1	VAR_001416	sequence variant	variant	32	33	L	P	rs878853650	disRelated	Melanoma, cutaneous malignant 2	CMM2	8595405					
P42771	P42771-1	VAR_001417	sequence variant	variant	33	34	E	D		disRelated	a biliary tract tumor	a biliary tract tumor						
P42771	P42771-1	VAR_001418	sequence variant	variant	35	36	G	A	rs746834149	disRelated	Melanoma, cutaneous malignant 2	CMM2	8595405					also found in biliary tract tumor and  uveal melanoma; partial loss of CDK4 binding
P42771	P42771-1	VAR_001419	sequence variant	variant	35	36	G	E	rs746834149	disRelated	Melanoma, cutaneous malignant 2	CMM2	8595405					
P42771	P42771-1	VAR_058551	sequence variant	variant	35	36	G	V	rs746834149	disRelated	Melanoma, cutaneous malignant 2	CMM2	19260062					loss of CDK4 binding
P42771	P42771-1	VAR_001420	sequence variant	variant	48	49	P	L		disRelated	Melanoma, cutaneous malignant 2	CMM2	10651484					also found in head and neck tumor; somatic mutation
P42771	P42771-1	VAR_001421	sequence variant	variant	49	50	I	S	rs199907548	disRelated	a biliary tract tumor	a biliary tract tumor						
P42771	P42771-1	VAR_001422	sequence variant	variant	49	50	I	T	rs199907548	disRelated			7647780,7987387					
P42771	P42771-1	VAR_001423	sequence variant	variant	50	51	Q	R	rs587778189	disRelated	Melanoma, cutaneous malignant 2	CMM2	8595405					
P42771	P42771-1	VAR_001424	sequence variant	variant	53	54	M	I	rs104894095	disRelated	Melanoma, cutaneous malignant 2	CMM2	8595405,8710906,9328469					
P42771	P42771-1	VAR_001425	sequence variant	variant	56	57	S	I	rs104894109	noEvidence								
P42771	P42771-1	VAR_001426	sequence variant	variant	57	58	A	V	rs372266620	disRelated	pancreas carcinoma	pancreas carcinoma	10651484					somatic mutation; partial loss of CDK4 binding
P42771	P42771-1	VAR_001427	sequence variant	variant	59	60	V	G	rs104894099	disRelated	Melanoma, cutaneous malignant 2	CMM2	10874641					
P42771	P42771-1	VAR_001428	sequence variant	variant	60	61	A	T	rs769382085	noEvidence								
P42771	P42771-1	VAR_053028	sequence variant	variant	60	61	A	V	rs36204594	disRelated	melanoma	melanoma						loss of CDK4 binding
P42771	P42771-1	VAR_001429	sequence variant	variant	61	63	EL	DV		noEvidence								
P42771	P42771-1	VAR_001430	sequence variant	variant	62	63	L	P		disRelated	Melanoma, cutaneous malignant 2	CMM2						
P42771	P42771-1	VAR_001431	sequence variant	variant	66	67	H	Y		notDisRelated	non-small cell lung carcinoma	non-small cell lung carcinoma	8060323					
P42771	P42771-1	VAR_058552	sequence variant	variant	67	72				disRelated	melanoma	melanoma	19260062					loss of CDK4 binding
P42771	P42771-1	VAR_058553	sequence variant	variant	67	68	G	R	rs758389471	disRelated	Melanoma, cutaneous malignant 2	CMM2	19260062					partial loss of CDK4 binding
P42771	P42771-1	VAR_001432	sequence variant	variant	68	69	A	L	rs876658534	disRelated	Melanoma, cutaneous malignant 2	CMM2						requires 2 nucleotide substitutions
P42771	P42771-1	VAR_001433	sequence variant	variant	68	69	A	T		disRelated	an esophagus tumor	an esophagus tumor						
P42771	P42771-1	VAR_001434	sequence variant	variant	68	69	A	V	rs1060501260	disRelated			8710906					
P42771	P42771-1	VAR_058554	sequence variant	variant	69	70	E	G	rs372670098	disRelated			19260062					Found in some patients with melanoma; partial loss of CDK4 binding
P42771	P42771-1	VAR_001435	sequence variant	variant	69	70	E	K		disRelated	a bladder tumor	a bladder tumor						
P42771	P42771-1	VAR_001436	sequence variant	variant	69	70	E	V		disRelated	a lung tumor	a lung tumor						
P42771	P42771-1	VAR_001437	sequence variant	variant	71	72	N	K		disRelated	Melanoma, cutaneous malignant 2	CMM2						
P42771	P42771-1	VAR_001438	sequence variant	variant	71	72	N	S	rs559848002	disRelated			7647780,7987387					
P42771	P42771-1	VAR_001439	sequence variant	variant	72	73	C	G		disRelated	an esophagus tumor	an esophagus tumor						
P42771	P42771-1	VAR_001440	sequence variant	variant	74	75	D	N	rs760640852	disRelated	a bladder tumor	a bladder tumor						
P42771	P42771-1	VAR_001441	sequence variant	variant	74	75	D	V	rs200429615	disRelated	a biliary tract tumor	a biliary tract tumor						
P42771	P42771-1	VAR_058555	sequence variant	variant	74	75	D	Y	rs760640852	disRelated	Melanoma, cutaneous malignant 2	CMM2	19260062					loss of CDK4 binding
P42771	P42771-1	VAR_058556	sequence variant	variant	77	78	T	P		disRelated	Melanoma, cutaneous malignant 2	CMM2	19260062					loss of CDK4 binding
P42771	P42771-1	VAR_001442	sequence variant	variant	80	81	R	L		disRelated	a head,neck tumor	a head and neck tumor						
P42771	P42771-1	VAR_058557	sequence variant	variant	80	81	R	P	rs1057519883	disRelated	Melanoma, cutaneous malignant 2	CMM2	19260062					loss of CDK4 binding
P42771	P42771-1	VAR_001443	sequence variant	variant	81	82	P	L	rs11552823	notDisRelated	some patients with melanoma	some patients with melanoma	7647780					impairs the function
P42771	P42771-1	VAR_058558	sequence variant	variant	81	82	P	T	rs1334828764	disRelated	Melanoma, cutaneous malignant 2	CMM2	19260062					loss of CDK4 binding
P42771	P42771-1	VAR_001445	sequence variant	variant	83	84	H	N		disRelated	a lung tumor	a lung tumor						
P42771	P42771-1	VAR_053029	sequence variant	variant	83	84	H	Q	rs34968276	noEvidence								
P42771	P42771-1	VAR_001444	sequence variant	variant	83	84	H	Y	rs121913385	disRelated	a pancreas tumor	a pancreas tumor						also found in head and neck tumor
P42771	P42771-1	VAR_001446	sequence variant	variant	84	85	D	E		disRelated	a bladder tumor	a bladder tumor						
P42771	P42771-1	VAR_001447	sequence variant	variant	84	85	D	H		notDisRelated	non-small cell lung carcinoma	non-small cell lung carcinoma	8060323					
P42771	P42771-1	VAR_001448	sequence variant	variant	84	85	D	N	rs11552822	disRelated	an esophagus tumor	an esophagus tumor						also found in head and neck tumor; also found in lung tumor
P42771	P42771-1	VAR_001449	sequence variant	variant	84	85	D	Y	rs11552822	disRelated	Melanoma, cutaneous malignant 2	CMM2	10874641					also found in lung tumor and a prostate tumor
P42771	P42771-1	VAR_001450	sequence variant	variant	85	86	A	T	rs878853646	disRelated			8710906					
P42771	P42771-1	VAR_001451	sequence variant	variant	87	88	R	P	rs878853647	disRelated	Melanoma, cutaneous malignant 2	CMM2	7647780,7987387					impairs the function
P42771	P42771-1	VAR_012317	sequence variant	variant	87	88	R	W	rs749714198	disRelated	Melanoma, cutaneous malignant 2	CMM2	10874641					partial loss of CDK4 binding
P42771	P42771-1	VAR_001452	sequence variant	variant	88	89	E	D		disRelated	a biliary tract tumor	a biliary tract tumor						
P42771	P42771-1	VAR_001453	sequence variant	variant	89	90	G	D	rs137854599	disRelated	Melanoma, cutaneous malignant 2	CMM2	10651484					somatic mutation
P42771	P42771-1	VAR_001454	sequence variant	variant	89	90	G	S	rs137854597	disRelated	Melanoma, cutaneous malignant 2	CMM2						
P42771	P42771-1	VAR_001455	sequence variant	variant	93	94	T	A		notDisRelated	non-small cell lung carcinoma	non-small cell lung carcinoma	8060323					
P42771	P42771-1	VAR_023604	sequence variant	variant	94	95	L	Q	rs1819703656	disRelated	Melanoma, cutaneous malignant 2	CMM2	14646619					
P42771	P42771-1	VAR_001456	sequence variant	variant	95	96	V	A		notDisRelated	non-small cell lung carcinoma	non-small cell lung carcinoma	8060323					
P42771	P42771-1	VAR_001457	sequence variant	variant	97	98	L	R		disRelated	Melanoma, cutaneous malignant 2	CMM2	19260062					loss of CDK4 binding
P42771	P42771-1	VAR_001458	sequence variant	variant	98	99	H	P		disRelated	Melanoma, cutaneous malignant 2	CMM2						
P42771	P42771-1	VAR_001459	sequence variant	variant	98	99	H	Q	rs752685118	disRelated	Melanoma, cutaneous malignant 2	CMM2						
P42771	P42771-1	VAR_001460	sequence variant	variant	99	100	R	P	rs754806883	disRelated	Melanoma, cutaneous malignant 2	CMM2						loss of CDK4 binding
P42771	P42771-1	VAR_001461	sequence variant	variant	99	100	R	Q	rs754806883	notDisRelated	non-small cell lung carcinoma	non-small cell lung carcinoma	8060323					
P42771	P42771-1	VAR_053030	sequence variant	variant	99	100	R	W	rs34886500	noEvidence								
P42771	P42771-1	VAR_001462	sequence variant	variant	100	101	A	L		disRelated	Melanoma, cutaneous malignant 2	CMM2						requires 2 nucleotide substitutions
P42771	P42771-1	VAR_001463	sequence variant	variant	100	101	A	P		noEvidence								
P42771	P42771-1	VAR_001464	sequence variant	variant	101	102	G	W	rs104894094	disRelated	Melanoma, cutaneous malignant 2,Familial atypical multiple mole melanoma-pancreatic carcinoma syndrome	CMM2 and FAMMMPC	10874641,7647780,7987387					impairs the function
P42771	P42771-1	VAR_015818	sequence variant	variant	102	103	A	E	rs137854598	notDisRelated			10484981					Found in seminoma and medulloblastoma tissues from Li-Fraumeni syndrome patients carrying a mutation in TP53; somatic mutation
P42771	P42771-1	VAR_053031	sequence variant	variant	102	103	A	T	rs35741010	noEvidence								
P42771	P42771-1	VAR_001465	sequence variant	variant	104	106				noEvidence								
P42771	P42771-1	VAR_001466	sequence variant	variant	107	108	R	C	rs1554654024	disRelated	Melanoma, cutaneous malignant 2	CMM2	8710906					
P42771	P42771-1	VAR_001467	sequence variant	variant	107	108	R	H	rs370823171	noEvidence								
P42771	P42771-1	VAR_001469	sequence variant	variant	108	109	D	H		disRelated	a bladder tumor	a bladder tumor						
P42771	P42771-1	VAR_001468	sequence variant	variant	108	109	D	Y	rs121913381	disRelated	a head,neck tumor	a head and neck tumor						
P42771	P42771-1	VAR_035068	sequence variant	variant	112	113	R	RR		disRelated	Melanoma, cutaneous malignant 2	CMM2	8653684					
P42771	P42771-1	VAR_001470	sequence variant	variant	114	115	P	L	rs121913386	notDisRelated	non-small cell lung carcinoma	non-small cell lung carcinoma	8060323					
P42771	P42771-1	VAR_058559	sequence variant	variant	114	115	P	S	rs104894104	disRelated			19260062					Found in some patients with melanoma; loss of CDK4 binding
P42771	P42771-1	VAR_001471	sequence variant	variant	117	118	L	M		disRelated	Melanoma, cutaneous malignant 2	CMM2	10651484					somatic mutation
P42771	P42771-1	VAR_001472	sequence variant	variant	118	119	A	T	rs1554653960	disRelated	Melanoma, cutaneous malignant 2	CMM2	9328469					
P42771	P42771-1	VAR_001473	sequence variant	variant	119	120	E	Q		disRelated	a biliary tract tumor	a biliary tract tumor						
P42771	P42771-1	VAR_001474	sequence variant	variant	120	121	E	A		notDisRelated	non-small cell lung carcinoma	non-small cell lung carcinoma	8060323					
P42771	P42771-1	VAR_001475	sequence variant	variant	120	121	E	K		notDisRelated	non-small cell lung carcinoma	non-small cell lung carcinoma	8060323					
P42771	P42771-1	VAR_035069	sequence variant	variant	122	123	G	R	rs113798404	disRelated	Melanoma, cutaneous malignant 2	CMM2	12019208					
P42771	P42771-1	VAR_001476	sequence variant	variant	122	123	G	S	rs113798404	disRelated	a biliary tract tumor	a biliary tract tumor						
P42771	P42771-1	VAR_001477	sequence variant	variant	123	124	H	Q	rs6413463	disRelated	leukemia	leukemia						
P42771	P42771-1	VAR_053032	sequence variant	variant	124	125	R	C	rs34170727	noEvidence								
P42771	P42771-1	VAR_001478	sequence variant	variant	124	125	R	H	rs747621669	disRelated	an esophagus tumor	an esophagus tumor						
P42771	P42771-1	VAR_001479	sequence variant	variant	126	127	V	D	rs104894098	disRelated	Melanoma, cutaneous malignant 2	CMM2	11506491,7647780,7987387					impairs the function
P42771	P42771-1	VAR_001480	sequence variant	variant	127	128	A	S	rs6413464	notDisRelated	squamous cell carcinoma	squamous cell carcinoma	7970734					
P42771	P42771-1	VAR_001481	sequence variant	variant	132	133	A	P		notDisRelated	non-small cell lung carcinoma	non-small cell lung carcinoma	8060323					
P42771	P42771-1	VAR_001482	sequence variant	variant	134	135	A	V	rs757497674	notDisRelated	non-small cell lung carcinoma	non-small cell lung carcinoma	8060323					
P42771	P42771-1	VAR_001483	sequence variant	variant	142	143	H	Y	rs1587330478	notDisRelated	non-small cell lung carcinoma	non-small cell lung carcinoma	8060323					
P42771	P42771-1	VAR_001484	sequence variant	variant	144	145	R	C	rs116150891	notDisRelated	squamous cell carcinoma	squamous cell carcinoma	7970734					
P42771	P42771-1	VAR_001486	sequence variant	variant	148	149	A	T	rs3731249	disRelated			10651484,7647780,7987387,8595405,8653684,8710906,9328469					
P42771	P42771-1	VAR_001487	sequence variant	variant	150	151	G	V		notDisRelated	non-small cell lung carcinoma	non-small cell lung carcinoma	8060323					
P42771	P42771-1		strand	beta	4	7				notDisRelated								
P42771	P42771-1		helix	helix	15	23				notDisRelated								
P42771	P42771-1		helix	helix	25	33				notDisRelated								
P42771	P42771-1		turn	turn	33	36				notDisRelated								
P42771	P42771-1		strand	beta	43	46				notDisRelated								
P42771	P42771-1		turn	turn	48	51				notDisRelated								
P42771	P42771-1		helix	helix	57	65				notDisRelated								
P42771	P42771-1		turn	turn	65	68				notDisRelated								
P42771	P42771-1		turn	turn	75	78				notDisRelated								
P42771	P42771-1		helix	helix	81	89				notDisRelated								
P42771	P42771-1		helix	helix	91	101				notDisRelated								
P42771	P42771-1		strand	beta	109	112				notDisRelated								
P42771	P42771-1		helix	helix	114	122				notDisRelated								
P42771	P42771-1		helix	helix	124	131				notDisRelated								
P42771	P42771-1		turn	turn	133	136				notDisRelated								
P42771	P42771-1		turn	turn	141	144				notDisRelated								
P42771	P42771-1		strand	beta	145	148				notDisRelated								
P42771	P42771-1		strand	beta	150	154				notDisRelated								
P42771	P42771-1		sequence conflict	conflict	54	55	G	R		notDisRelated								In Ref. 2; AAD11437.
P42771	P42771-1		sequence conflict	conflict	112	113	A	T		notDisRelated								In Ref. 2; AAD11437.
P30511	P30511-1		signal peptide	signal pep	1	22				notDisRelated								
P30511	P30511-1	PRO_0000018884	chain	chain	22	347				noEvidence				HLA class I histocompatibility antigen, alpha chain F	HLAF	HLAF; HLA-5.4; CDA12; HLA F antigen; Leukocyte antigen F; MHC class I antigen F; 1; 2; 3		
P30511	P30511-1		topological domain	topo	22	306				notDisRelated								Extracellular
P30511	P30511-1		transmembrane region	transmem	306	330				notDisRelated								Helical
P30511	P30511-1		topological domain	topo	330	347				notDisRelated								Cytoplasmic
P30511	P30511-1		domain	domain	206	297				notDisRelated								Ig-like C1-type
P30511	P30511-1		region of interest	interest	22	112				noEvidence								Alpha-1
P30511	P30511-1		region of interest	interest	112	204				noEvidence								Alpha-2
P30511	P30511-1		region of interest	interest	204	296				noEvidence								Alpha-3
P30511	P30511-1		region of interest	interest	296	306				noEvidence								Connecting peptide
P30511	P30511-1		short sequence motif	motif	336	339				notDisRelated			16709803					Sorting signal sequence; Golgi-retention signal; ER-retention signal
P30511	P30511-1		binding site	bind	91	92				notDisRelated			28636952					
P30511	P30511-1		binding site	bind	105	106				notDisRelated			28636952					
P30511	P30511-1		binding site	bind	164	165				notDisRelated			28636952					
P30511	P30511-1		binding site	bind	168	169				notDisRelated			28636952					
P30511	P30511-1		binding site	bind	176	177				notDisRelated			28636952					
P30511	P30511-1		glycosylation site	glyco	107	108				notDisRelated								N-linked (GlcNAc...) asparagine
P30511	P30511-1		disulfide bond	disulf bond	122	186				notDisRelated			28636952					
P30511	P30511-1		disulfide bond	disulf bond	224	281				notDisRelated			28636952					
P30511	P30511-1	VSP_038846	splice variant	splicing	204	296				notDisRelated			14705989					In isoform 2.
P30511	P30511-1	VSP_040349	splice variant	splicing	346	347	V	AYSVVSGNLMITWWSSLFLLGVLFQGYLGCLRSHSVLGRRKVGDMWILFFLWLWTSFNTAFLALQSLRFGFGFRRGRSFLLRSWHHLMKRVQIKIFD		notDisRelated			15489334					In isoform 3.
P30511	P30511-1	VAR_056525	sequence variant	variant	13	14	A	V	rs17875379	noEvidence								
P30511	P30511-1	VAR_056526	sequence variant	variant	71	72	P	Q	rs17875380	noEvidence								
P30511	P30511-1	VAR_018327	sequence variant	variant	272	273	P	S	rs1736924	notDisRelated			10727083,14574404,14705989,15489334,16570139,1688605,1707659					
P30511	P30511-1		mutagenesis site	mutagen	83	84	W	R		notDisRelated			28636952					Impairs peptide binding.
P30511	P30511-1		mutagenesis site	mutagen	336	339	RNR	AAA		notDisRelated			16709803					Impairs the interaction with 14-3-3 proteins.
P30511	P30511-1		mutagenesis site	mutagen	336	339	RNR	GKG		notDisRelated			16709803					Impairs the anterograde ER-to-Golgi transport.
P30511	P30511-1		mutagenesis site	mutagen	346	347	V	S		notDisRelated			16709803					Impairs the anterograde ER-to-Golgi transport.
P30511	P30511-1		mutagenesis site	mutagen	346	347				notDisRelated			16709803					Impairs the interaction with coat protein complex II; impairs the anterograde ER-to-Golgi transport.
P30511	P30511-1		strand	beta	24	36				notDisRelated								
P30511	P30511-1		turn	turn	36	39				notDisRelated								
P30511	P30511-1		strand	beta	39	50				notDisRelated								
P30511	P30511-1		strand	beta	52	59				notDisRelated								
P30511	P30511-1		strand	beta	61	64				notDisRelated								
P30511	P30511-1		strand	beta	67	71				notDisRelated								
P30511	P30511-1		helix	helix	71	74				notDisRelated								
P30511	P30511-1		helix	helix	78	106				notDisRelated								
P30511	P30511-1		strand	beta	115	125				notDisRelated								
P30511	P30511-1		strand	beta	128	140				notDisRelated								
P30511	P30511-1		strand	beta	142	148				notDisRelated								
P30511	P30511-1		strand	beta	154	159				notDisRelated								
P30511	P30511-1		helix	helix	161	171				notDisRelated								
P30511	P30511-1		helix	helix	173	183				notDisRelated								
P30511	P30511-1		helix	helix	184	196				notDisRelated								
P30511	P30511-1		helix	helix	197	201				notDisRelated								
P30511	P30511-1		strand	beta	207	215				notDisRelated								
P30511	P30511-1		strand	beta	216	233				notDisRelated								
P30511	P30511-1		strand	beta	235	241				notDisRelated								
P30511	P30511-1		turn	turn	246	249				notDisRelated								
P30511	P30511-1		strand	beta	249	252				notDisRelated								
P30511	P30511-1		strand	beta	258	261				notDisRelated								
P30511	P30511-1		strand	beta	262	272				notDisRelated								
P30511	P30511-1		helix	helix	275	278				notDisRelated								
P30511	P30511-1		strand	beta	278	284				notDisRelated								
P30511	P30511-1		strand	beta	287	290				notDisRelated								
P30511	P30511-1		strand	beta	291	294				notDisRelated								
P30511	P30511-1		sequence conflict	conflict	353	354	N	L		notDisRelated								In Ref. 10; AAH09260.
P0DMS8	P0DMS8-1	PRO_0000069010	chain	chain	1	319				noEvidence				Adenosine receptor A3	2	2; 1; 3; A3AR; A3AR i2; A3AR i1; A3AR i3; TMIGD3 i1; TMIGD3 i3		
P0DMS8	P0DMS8-1		topological domain	topo	1	15				notDisRelated								Extracellular
P0DMS8	P0DMS8-1		transmembrane region	transmem	15	38				notDisRelated								Helical; Name=1
P0DMS8	P0DMS8-1		topological domain	topo	38	49				notDisRelated								Cytoplasmic
P0DMS8	P0DMS8-1		transmembrane region	transmem	49	73				notDisRelated								Helical; Name=2
P0DMS8	P0DMS8-1		topological domain	topo	73	85				notDisRelated								Extracellular
P0DMS8	P0DMS8-1		transmembrane region	transmem	85	107				notDisRelated								Helical; Name=3
P0DMS8	P0DMS8-1		topological domain	topo	107	127				notDisRelated								Cytoplasmic
P0DMS8	P0DMS8-1		transmembrane region	transmem	127	149				notDisRelated								Helical; Name=4
P0DMS8	P0DMS8-1		topological domain	topo	149	178				notDisRelated								Extracellular
P0DMS8	P0DMS8-1		transmembrane region	transmem	178	199				notDisRelated								Helical; Name=5
P0DMS8	P0DMS8-1		topological domain	topo	199	232				notDisRelated								Cytoplasmic
P0DMS8	P0DMS8-1		transmembrane region	transmem	232	256				notDisRelated								Helical; Name=6
P0DMS8	P0DMS8-1		topological domain	topo	256	262				notDisRelated								Extracellular
P0DMS8	P0DMS8-1		transmembrane region	transmem	262	285				notDisRelated								Helical; Name=7
P0DMS8	P0DMS8-1		topological domain	topo	285	319				notDisRelated								Cytoplasmic
P0DMS8	P0DMS8-1		lipid moiety-binding region	lipid	303	304				notDisRelated								S-palmitoyl cysteine
P0DMS8	P0DMS8-1		glycosylation site	glyco	3	4				notDisRelated								N-linked (GlcNAc...) asparagine
P0DMS8	P0DMS8-1		glycosylation site	glyco	4	5				notDisRelated								N-linked (GlcNAc...) asparagine
P0DMS8	P0DMS8-1		glycosylation site	glyco	12	13				notDisRelated								N-linked (GlcNAc...) asparagine
P0DMS8	P0DMS8-1		disulfide bond	disulf bond	83	167				notDisRelated								
P0DMS8	P0DMS8-1	VAR_035755	sequence variant	variant	105	106	A	T	rs746154553	notDisRelated	a colorectal cancer sample	a colorectal cancer sample	16959974					somatic mutation
P0DMS8	P0DMS8-1	VAR_049366	sequence variant	variant	248	249	I	L	rs35511654	notDisRelated								
P0DMS8	P0DMS8-1	VAR_049367	sequence variant	variant	266	267	M	K	rs2800889	noEvidence								
P0DMS8	P0DMS8-1		sequence conflict	conflict	7	8	A	T		notDisRelated								In Ref. 1; AAA16365.
P0DMS8	P0DMS8-1		sequence conflict	conflict	175	176	D	V		notDisRelated								In Ref. 8; AAG35155.
P42684	P42684-1		initiator methionine	init Met	1	2				noEvidence								Removed
P42684	P42684-1	PRO_0000088052	chain	chain	2	1183				noEvidence				Tyrosine-protein kinase ABL2	ARG	ARG; ABLL; Tyrosine-protein kinase ARG; Abelson-related gene protein; Abelson tyrosine-protein kinase 2; Abelson murine leukemia viral oncogene homolog 2; 1; 2; 3; 4; 5; 6; 7; 8; IB; IA; IC; 10; 1BLCTL; 1ASCTL; 1ALCTL; 1ASCTS; 1BLCTS; 1BSCTL; 1BSCTS; 1ALCTS		
P42684	P42684-1		domain	domain	107	168				notDisRelated								SH3
P42684	P42684-1		domain	domain	173	264				notDisRelated								SH2
P42684	P42684-1		domain	domain	288	540				notDisRelated								Protein kinase
P42684	P42684-1		region of interest	interest	1	48				notDisRelated								Disordered
P42684	P42684-1		region of interest	interest	2	107				noEvidence								CAP
P42684	P42684-1		region of interest	interest	60	81				notDisRelated								Disordered
P42684	P42684-1		region of interest	interest	611	642				notDisRelated								Disordered
P42684	P42684-1		region of interest	interest	654	675				notDisRelated								Disordered
P42684	P42684-1		region of interest	interest	694	931				notDisRelated								F-actin-binding
P42684	P42684-1		region of interest	interest	763	795				notDisRelated								Disordered
P42684	P42684-1		region of interest	interest	807	852				notDisRelated								Disordered
P42684	P42684-1		region of interest	interest	964	1025				notDisRelated								Disordered
P42684	P42684-1		region of interest	interest	1020	1183				notDisRelated								F-actin-binding
P42684	P42684-1		short sequence motif	motif	427	452				notDisRelated								Kinase activation loop
P42684	P42684-1		short sequence motif	motif	658	661				notDisRelated								Nuclear localization signal
P42684	P42684-1		compositionally biased region	biased	774	794				notDisRelated								Polar residues
P42684	P42684-1		compositionally biased region	biased	807	827				notDisRelated								Polar residues
P42684	P42684-1		compositionally biased region	biased	828	852				notDisRelated								Basic and acidic residues
P42684	P42684-1		compositionally biased region	biased	966	981				notDisRelated								Basic and acidic residues
P42684	P42684-1		compositionally biased region	biased	1000	1022				notDisRelated								Polar residues
P42684	P42684-1		active site	enzyme act site	409	410				notDisRelated								Proton acceptor
P42684	P42684-1		binding site	bind	294	303				notDisRelated								
P42684	P42684-1		binding site	bind	317	318				notDisRelated								
P42684	P42684-1		binding site	bind	362	369				notDisRelated								
P42684	P42684-1		modified residue	phos	97	98				notDisRelated								Phosphoserine
P42684	P42684-1		modified residue	phos	116	117				notDisRelated								Phosphotyrosine
P42684	P42684-1		modified residue	phos	161	162				notDisRelated								Phosphotyrosine
P42684	P42684-1		modified residue	phos	174	175				notDisRelated								Phosphotyrosine
P42684	P42684-1		modified residue	phos	185	186				notDisRelated								Phosphotyrosine
P42684	P42684-1		modified residue	phos	218	219				notDisRelated								Phosphotyrosine
P42684	P42684-1		modified residue	phos	231	232				notDisRelated								Phosphotyrosine
P42684	P42684-1		modified residue	phos	261	262				notDisRelated			15735735					Phosphotyrosine; by ABL1 and autocatalysis
P42684	P42684-1		modified residue	phos	272	273				notDisRelated			12748290					Phosphotyrosine; by autocatalysis
P42684	P42684-1		modified residue	phos	275	276				notDisRelated								Phosphoserine
P42684	P42684-1		modified residue	phos	299	300				notDisRelated								Phosphotyrosine
P42684	P42684-1		modified residue	phos	303	304				notDisRelated								Phosphotyrosine
P42684	P42684-1		modified residue	phos	439	440				notDisRelated			12748290					Phosphotyrosine; by autocatalysis and SRC-type Tyr-kinases
P42684	P42684-1		modified residue	phos	459	460				notDisRelated								Phosphotyrosine
P42684	P42684-1		modified residue	phos	568	569				notDisRelated			12748290					Phosphotyrosine; by autocatalysis
P42684	P42684-1		modified residue	phos	620	621				notDisRelated								Phosphoserine
P42684	P42684-1		modified residue	phos	631	632				notDisRelated								Phosphoserine
P42684	P42684-1		modified residue	phos	633	634				notDisRelated								Phosphoserine
P42684	P42684-1		modified residue	phos	655	656				notDisRelated								Phosphoserine
P42684	P42684-1		modified residue	phos	669	670				notDisRelated								Phosphoserine
P42684	P42684-1		modified residue	phos	670	671				notDisRelated								Phosphoserine
P42684	P42684-1		modified residue	phos	671	672				notDisRelated								Phosphoserine
P42684	P42684-1		modified residue	phos	683	684				notDisRelated			12748290					Phosphotyrosine; by autocatalysis
P42684	P42684-1		modified residue	phos	718	719				notDisRelated								Phosphotyrosine
P42684	P42684-1		modified residue	acetyl	776	777				notDisRelated								N6-acetyllysine
P42684	P42684-1		modified residue	phos	783	784				notDisRelated								Phosphoserine
P42684	P42684-1		modified residue	phos	800	801				notDisRelated								Phosphothreonine
P42684	P42684-1		modified residue	phos	817	818				notDisRelated								Phosphoserine
P42684	P42684-1		modified residue	phos	820	821				notDisRelated								Phosphoserine
P42684	P42684-1		modified residue	phos	915	916				notDisRelated								Phosphoserine
P42684	P42684-1		modified residue	phos	936	937				notDisRelated								Phosphoserine
P42684	P42684-1		lipid moiety-binding region	lipid	2	3				notDisRelated								N-myristoyl glycine
P42684	P42684-1	VSP_004961	splice variant	splicing	1	74	MGQQVGRVGEAPGLQQPQPRGIRGSSAARPSGRRRDPAGRTTETGFNIFTQHDHFASCVEDGFEGDKTGGSSP	MVLGTVLLPPNSYGRDQDTSLCCLCTEASESALPDLT		notDisRelated			17974005,18810762					In isoform 2 and isoform 4.
P42684	P42684-1	VSP_017112	splice variant	splicing	1	53	MGQQVGRVGEAPGLQQPQPRGIRGSSAARPSGRRRDPAGRTTETGFNIFTQH	MVLGTVLLPPNSYGRDQDTSLCCLCTEASESALPDLT		notDisRelated			15489334					In isoform 3 and isoform 10.
P42684	P42684-1	VSP_041772	splice variant	splicing	53	74				notDisRelated			14702039,18810762					In isoform 6, isoform 7 and isoform 8.
P42684	P42684-1	VSP_041773	splice variant	splicing	550	565	EEVAEELGRAASSSS	EVLLHCANQTCITL		notDisRelated			14702039					In isoform 8.
P42684	P42684-1	VSP_041774	splice variant	splicing	565	1183				notDisRelated			14702039					In isoform 8.
P42684	P42684-1	VSP_021308	splice variant	splicing	688	791				notDisRelated			17974005,18810762					In isoform 4, isoform 5, isoform 7 and isoform 10.
P42684	P42684-1	VAR_055411	sequence variant	variant	78	79	R	H	rs55655202	notDisRelated			17344846					
P42684	P42684-1	VAR_055412	sequence variant	variant	99	100	E	Q		notDisRelated			17344846					Somatic mutation in breast cancer sample
P42684	P42684-1	VAR_055413	sequence variant	variant	519	520	R	I		notDisRelated			17344846					Somatic mutation in lung squamous cell carcinoma
P42684	P42684-1	VAR_055414	sequence variant	variant	769	770	T	S	rs55892721	notDisRelated			17344846					
P42684	P42684-1	VAR_029232	sequence variant	variant	930	931	K	R	rs17277288	notDisRelated			17344846					
P42684	P42684-1	VAR_029233	sequence variant	variant	946	947	V	M	rs28913889	notDisRelated								
P42684	P42684-1	VAR_029234	sequence variant	variant	996	997	P	R	rs28913890	notDisRelated			17344846					
P42684	P42684-1	VAR_029235	sequence variant	variant	1085	1086	S	N	rs28913891	notDisRelated								
P42684	P42684-1	VAR_029236	sequence variant	variant	1101	1102	T	A	rs28913892	notDisRelated								
P42684	P42684-1		sequence conflict	conflict	343	345	NL	TI		notDisRelated								In Ref. 9; no nucleotide entry.
P42684	P42684-1		sequence conflict	conflict	435	436	T	I		notDisRelated								In Ref. 3; AK311045.
P42684	P42684-1		sequence conflict	conflict	981	982	K	R		notDisRelated								In Ref. 4; CAD98092.
P42684	P42684-1		strand	beta	111	117				notDisRelated								
P42684	P42684-1		strand	beta	133	140				notDisRelated								
P42684	P42684-1		strand	beta	141	151				notDisRelated								
P42684	P42684-1		strand	beta	153	159				notDisRelated								
P42684	P42684-1		helix	helix	159	162				notDisRelated								
P42684	P42684-1		strand	beta	162	165				notDisRelated								
P42684	P42684-1		helix	helix	168	171				notDisRelated								
P42684	P42684-1		strand	beta	174	178				notDisRelated								
P42684	P42684-1		helix	helix	180	188				notDisRelated								
P42684	P42684-1		strand	beta	194	200				notDisRelated								
P42684	P42684-1		strand	beta	207	214				notDisRelated								
P42684	P42684-1		strand	beta	216	222				notDisRelated								
P42684	P42684-1		strand	beta	226	229				notDisRelated								
P42684	P42684-1		strand	beta	230	234				notDisRelated								
P42684	P42684-1		strand	beta	236	241				notDisRelated								
P42684	P42684-1		helix	helix	241	249				notDisRelated								
P42684	P42684-1		strand	beta	255	258				notDisRelated								
P42684	P42684-1		strand	beta	280	283				notDisRelated								
P42684	P42684-1		helix	helix	285	288				notDisRelated								
P42684	P42684-1		strand	beta	288	294				notDisRelated								
P42684	P42684-1		helix	helix	294	298				notDisRelated								
P42684	P42684-1		strand	beta	300	308				notDisRelated								
P42684	P42684-1		helix	helix	308	311				notDisRelated								
P42684	P42684-1		strand	beta	312	319				notDisRelated								
P42684	P42684-1		helix	helix	326	338				notDisRelated								
P42684	P42684-1		strand	beta	347	352				notDisRelated								
P42684	P42684-1		strand	beta	353	357				notDisRelated								
P42684	P42684-1		strand	beta	358	363				notDisRelated								
P42684	P42684-1		helix	helix	369	376				notDisRelated								
P42684	P42684-1		turn	turn	378	381				notDisRelated								
P42684	P42684-1		helix	helix	383	403				notDisRelated								
P42684	P42684-1		helix	helix	412	415				notDisRelated								
P42684	P42684-1		strand	beta	415	418				notDisRelated								
P42684	P42684-1		helix	helix	419	422				notDisRelated								
P42684	P42684-1		strand	beta	423	426				notDisRelated								
P42684	P42684-1		strand	beta	435	438				notDisRelated								
P42684	P42684-1		strand	beta	438	441				notDisRelated								
P42684	P42684-1		helix	helix	449	452				notDisRelated								
P42684	P42684-1		helix	helix	454	460				notDisRelated								
P42684	P42684-1		helix	helix	464	480				notDisRelated								
P42684	P42684-1		helix	helix	491	494				notDisRelated								
P42684	P42684-1		helix	helix	494	500				notDisRelated								
P42684	P42684-1		helix	helix	512	522				notDisRelated								
P42684	P42684-1		helix	helix	526	529				notDisRelated								
P42684	P42684-1		helix	helix	532	546				notDisRelated								
P42684	P42684-1		helix	helix	1069	1072				notDisRelated								
P42684	P42684-1		turn	turn	1076	1079				notDisRelated								
P42684	P42684-1		helix	helix	1080	1084				notDisRelated								
P42684	P42684-1		helix	helix	1086	1100				notDisRelated								
P42684	P42684-1		helix	helix	1106	1124				notDisRelated								
P42684	P42684-1		helix	helix	1124	1127				notDisRelated								
P42684	P42684-1		helix	helix	1130	1153				notDisRelated								
P42684	P42684-1		strand	beta	1155	1159				notDisRelated								
P42684	P42684-1		helix	helix	1165	1182				notDisRelated								
P42684	P42684-1		modified residue	phos	647	648				notDisRelated								Phosphotyrosine
P42684	P42684-1	VAR_082895	sequence variant	variant	12	13	S	T	rs1318056	notDisRelated			18810762					
P42684	P42684-1		modified residue	phos	683	684				notDisRelated								Phosphotyrosine
P42684	P42684-1		modified residue	phos	662	663				notDisRelated								Phosphotyrosine
P42684	P42684-1		modified residue	phos	668	669				notDisRelated								Phosphotyrosine
Q96D53	Q96D53-1	PRO_0000271797	chain	chain	1	545				noEvidence				Atypical kinase COQ8B, mitochondrial	ADCK4	ADCK4; Coenzyme Q protein 8B; AarF domain-containing protein kinase 4; 1; 2		
Q96D53	Q96D53-1		transmembrane region	transmem	92	109				notDisRelated								Helical
Q96D53	Q96D53-1		domain	domain	191	424				noEvidence								Protein kinase
Q96D53	Q96D53-1		region of interest	interest	45	87				notDisRelated								Disordered
Q96D53	Q96D53-1		short sequence motif	motif	155	159				notDisRelated								KxGQ motif
Q96D53	Q96D53-1		short sequence motif	motif	216	220				notDisRelated								AAAS motif
Q96D53	Q96D53-1		compositionally biased region	biased	51	87				notDisRelated								Basic and acidic residues
Q96D53	Q96D53-1		active site	enzyme act site	367	368				notDisRelated								Proton acceptor
Q96D53	Q96D53-1		binding site	bind	219	220				notDisRelated								
Q96D53	Q96D53-1		binding site	bind	237	238				notDisRelated								
Q96D53	Q96D53-1		binding site	bind	324	328				notDisRelated								
Q96D53	Q96D53-1		binding site	bind	372	373				notDisRelated								
Q96D53	Q96D53-1		binding site	bind	386	387				notDisRelated								
Q96D53	Q96D53-1	VSP_022357	splice variant	splicing	123	164				notDisRelated			15489334					In isoform 2.
Q96D53	Q96D53-1	VAR_041420	sequence variant	variant	78	79	R	C	rs11538384	notDisRelated			17344846					
Q96D53	Q96D53-1	VAR_076861	sequence variant	variant	98	99	L	R		disRelated	Nephrotic syndrome 9	NPHS9	25967120					
Q96D53	Q96D53-1	VAR_029995	sequence variant	variant	174	175	H	R	rs3865452	notDisRelated			17344846					
Q96D53	Q96D53-1	VAR_070552	sequence variant	variant	178	179	R	W	rs398122978	disRelated	Nephrotic syndrome 9	NPHS9	24270420,25967120					
Q96D53	Q96D53-1	VAR_070553	sequence variant	variant	286	287	D	G	rs398122979	disRelated	Nephrotic syndrome 9	NPHS9	24270420					
Q96D53	Q96D53-1	VAR_076862	sequence variant	variant	310	311	P	L		disRelated	Nephrotic syndrome 9	NPHS9	25967120					
Q96D53	Q96D53-1	VAR_041421	sequence variant	variant	318	319	T	M	rs55899516	notDisRelated			17344846					
Q96D53	Q96D53-1	VAR_070554	sequence variant	variant	320	321	R	W	rs369573693	disRelated	Nephrotic syndrome 9	NPHS9	24270420					
Q96D53	Q96D53-1	VAR_070555	sequence variant	variant	343	344	R	W	rs398122981	disRelated	Nephrotic syndrome 9	NPHS9	24270420					
Q96D53	Q96D53-1	VAR_041422	sequence variant	variant	352	353	T	R	rs36012476	notDisRelated			17344846					
Q96D53	Q96D53-1	VAR_041423	sequence variant	variant	462	463	T	M	rs56083906	notDisRelated			17344846					
Q96D53	Q96D53-1	VAR_070556	sequence variant	variant	477	478	R	Q	rs1057519347	disRelated	Nephrotic syndrome 9	NPHS9	24270420					
Q96D53	Q96D53-1	VAR_076863	sequence variant	variant	498	499	A	E		disRelated	Nephrotic syndrome 9	NPHS9	25967120					
Q96D53	Q96D53-1		sequence conflict	conflict	164	167	DNS	GTA		notDisRelated								In Ref. 2; BAB14004.
Q9NTW7	Q9NTW7-1	PRO_0000047308	chain	chain	1	646				noEvidence				Zinc finger protein 64	Zfp-64	Zfp-64; ZNF338; Zinc finger protein 338; 3; 4; 5; 6; 1; 2; ZNF338		
Q9NTW7	Q9NTW7-1		zinc finger region	zinc finger	175	198				notDisRelated								C2H2-type 1
Q9NTW7	Q9NTW7-1		zinc finger region	zinc finger	203	226				notDisRelated								C2H2-type 2
Q9NTW7	Q9NTW7-1		zinc finger region	zinc finger	231	254				notDisRelated								C2H2-type 3
Q9NTW7	Q9NTW7-1		zinc finger region	zinc finger	299	325				notDisRelated								C2H2-type 4; atypical
Q9NTW7	Q9NTW7-1		zinc finger region	zinc finger	330	353				notDisRelated								C2H2-type 5
Q9NTW7	Q9NTW7-1		zinc finger region	zinc finger	358	381				notDisRelated								C2H2-type 6
Q9NTW7	Q9NTW7-1		zinc finger region	zinc finger	386	409				notDisRelated								C2H2-type 7
Q9NTW7	Q9NTW7-1		zinc finger region	zinc finger	414	437				notDisRelated								C2H2-type 8
Q9NTW7	Q9NTW7-1		zinc finger region	zinc finger	442	466				notDisRelated								C2H2-type 9
Q9NTW7	Q9NTW7-1		zinc finger region	zinc finger	467	490				notDisRelated								C2H2-type 10
Q9NTW7	Q9NTW7-1		zinc finger region	zinc finger	495	518				notDisRelated								C2H2-type 11
Q9NTW7	Q9NTW7-1		zinc finger region	zinc finger	523	547				notDisRelated								C2H2-type 12
Q9NTW7	Q9NTW7-1		zinc finger region	zinc finger	580	603				notDisRelated								C2H2-type 13
Q9NTW7	Q9NTW7-1		region of interest	interest	543	568				notDisRelated								Disordered
Q9NTW7	Q9NTW7-1		region of interest	interest	600	646				notDisRelated								Disordered
Q9NTW7	Q9NTW7-1		compositionally biased region	biased	543	561				notDisRelated								Basic and acidic residues
Q9NTW7	Q9NTW7-1		compositionally biased region	biased	608	633				notDisRelated								Polar residues
Q9NTW7	Q9NTW7-1	VSP_007285	splice variant	splicing	1	220				notDisRelated			14702039					In isoform 4.
Q9NTW7	Q9NTW7-1	VSP_046896	splice variant	splicing	16	19	IPG	S		notDisRelated								In isoform 6.
Q9NTW7	Q9NTW7-1	VSP_060092	splice variant	splicing	96	150				noEvidence								In isoform 2.
Q9NTW7	Q9NTW7-1	VSP_007286	splice variant	splicing	220	255	KHLRIHSDERPFKCQICPYASRNSSQLTVHLRSHT	MSRRKQAKPQHLNSEEPRPARRECAEVAPQVAGEP		notDisRelated			14702039					In isoform 4.
Q9NTW7	Q9NTW7-1	VSP_046897	splice variant	splicing	236	391				notDisRelated								In isoform 6, isoform 1 and isoform 2.
Q9NTW7	Q9NTW7-1	VSP_038213	splice variant	splicing	411	416	DTPFQ	CCYVA		notDisRelated								In isoform 5.
Q9NTW7	Q9NTW7-1	VSP_046898	splice variant	splicing	412	646	TPFQCWLCSAKFKISSDLKRHMIVHSGEKPFKCEFCDVRCTMKANLKSHIRIKHTFKCLHCAFQGRDRADLLEHSRLHQADHPEKCPECSYSCSSAAALRVHSRVHCKDRPFKCDFCSFDTKRPSSLAKHVDKVHRDEAKTENRAPLGKEGLREGSSQHVAKIVTQRAFRCETCGASFVRDDSLRCHKKQHSDQSENKNSDLVTFPPESGASGQLSTLVSVGQLEAPLEPSQDL	APFQCWLCSAKFKISSDLKRHMRVHSGEKPFKCEFCNVRCTMKGNLKSHIRIKHSGNNFKCPHCDFLGDSKATLRKHSRVHQSEHPEKCSECSYSCSSKAALRIHERIHCTDRPFKCNYCSFDTKQPSNLSKHMKKFHGDMVKTEALERKDTGRQSSRQVAKLDAKKSFHCDICDASFMREDSLRSHKRQHSEYSESKNSDVTVLQFQIDPSKQPATPLTVGHLQVPLQPSQVPQFSEGRVKIIVGHQVPQANTIVQAAAAAVNIVPPALVAQNPEELPGNSRLQILRQVSLIAPPQSSRCPSEAGAMTQPAVLLTTHEQTDGATLHQTLIPTASGGPQEGSGNQTFITSSGITCTDFEGLNALIQEGTAEVTVVSDGGQNIAVATTAPPVFSSSSQQELPKQTYSIIQGAAHPALLCPADSIPD		notDisRelated								In isoform 6, isoform 1 and isoform 2.
Q9NTW7	Q9NTW7-1	VSP_038214	splice variant	splicing	416	646				notDisRelated								In isoform 5.
Q9NTW7	Q9NTW7-1	VAR_028019	sequence variant	variant	68	69	Q	P	rs7353222	noEvidence								
Q9NTW7	Q9NTW7-1	VAR_028020	sequence variant	variant	139	140	P	L	rs6021773	noEvidence								
Q9NTW7	Q9NTW7-1	VAR_035564	sequence variant	variant	593	594	D	E		notDisRelated	a breast cancer sample	a breast cancer sample	16959974					somatic mutation
Q9NTW7	Q9NTW7-1	VAR_035565	sequence variant	variant	609	610	K	N		notDisRelated	a breast cancer sample	a breast cancer sample	16959974					somatic mutation
Q9NTW7	Q9NTW7-1		sequence conflict	conflict	240	241	S	G		notDisRelated								In Ref. 3; BAD96432.
Q9NTW7	Q9NTW7-1		sequence conflict	conflict	521	522	R	C		notDisRelated								In Ref. 2; AAP88762 and 6; BC021087.
Q9NTW7	Q9NTW7-1		turn	turn	178	181				notDisRelated								
Q9NTW7	Q9NTW7-1		helix	helix	187	194				notDisRelated								
Q9NTW7	Q9NTW7-1		helix	helix	194	197				notDisRelated								
Q9NTW7	Q9NTW7-1		strand	beta	202	205				notDisRelated								
Q9NTW7	Q9NTW7-1		strand	beta	206	209				notDisRelated								
Q9NTW7	Q9NTW7-1		strand	beta	211	215				notDisRelated								
Q9NTW7	Q9NTW7-1		helix	helix	215	225				notDisRelated								
Q9NTW7	Q9NTW7-1		strand	beta	234	238				notDisRelated								
Q9NTW7	Q9NTW7-1		strand	beta	239	243				notDisRelated								
Q9NTW7	Q9NTW7-1		helix	helix	243	251				notDisRelated								
Q9NTW7	Q9NTW7-1		strand	beta	494	497				notDisRelated								
Q9NTW7	Q9NTW7-1		strand	beta	498	502				notDisRelated								
Q9NTW7	Q9NTW7-1		strand	beta	503	507				notDisRelated								
Q9NTW7	Q9NTW7-1		helix	helix	507	515				notDisRelated								
Q9NTW7	Q9NTW7-1		helix	helix	515	518				notDisRelated								
Q9NTW7	Q9NTW7-1		strand	beta	522	525				notDisRelated								
Q9NTW7	Q9NTW7-1		strand	beta	526	530				notDisRelated								
Q9NTW7	Q9NTW7-1		strand	beta	531	535				notDisRelated								
Q9NTW7	Q9NTW7-1		helix	helix	535	547				notDisRelated								
Q9NTW7	Q9NTW7-1		modified residue	phos	545	546				notDisRelated								Phosphoserine
Q9NTW7	Q9NTW7-1		cross-link	cross-link	286	287				notDisRelated								Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2
Q9NTW7	Q9NTW7-1		cross-link	cross-link	397	398				notDisRelated								Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2
Q9NTW7	Q9NTW7-1	VAR_082942	sequence variant	variant	425	426	F	Y	rs16996517	notDisRelated								
Q9NTW7	Q9NTW7-1	VAR_082943	sequence variant	variant	451	452	S	N	rs3746414	notDisRelated			15489334					
